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Reduced activity of Fragile X mental retardation protein (FMRP) in brain neurons 
results in the most common form of heritable mental retardation in humans, Fragile X 
Syndrome (FXS).  FMRP is a selective RNA-binding protein that is implicated in the 
translational regulation of specific mRNAs in neurons.  Although very few direct targets 
of FMRP have been identified and verified in vivo, FXS is thought to result from the 
aberrant regulation of potentially hundreds of mRNAs causing defects in neuron 
morphology and synapse function.  Identifying additional targets will be important for 
elucidating the mechanism of FMRP regulation as well as the etiology of FXS.   
Drosophila melanogaster offers a unique and powerful system for studying the 
function of FMRP.  Flies with loss of FMRP activity have neuronal and behavioral 
defects similar to those observed in humans with FXS. Importantly, FMRP regulates 
common target mRNAs in neurons in both mice and flies. Here, I will describe our 
discovery of a previously unknown requirement for Drosophila FMRP (dFMRP) during 
the cleavage stage of early embryonic development.  First, we identified a requirement 
 viii 
for dFMRP for proper cleavage furrow formation and found that dFMRP functions to 
regulate the expression of specific target mRNAs during the cleavage stage.  Among 
these is trailer hitch (tral) mRNA, which encodes a translational regulator as well, and 
represents a new in vivo target of dFMRP translational regulation.  In addition, I have 
identified twenty-eight proteins that change in expression in the absence of dFMRP using 
a comparative proteomics based screen for dFMRP targets.  One of these is the 
Chaperonin containing tcp-1 complex (CCT), a previously unidentified target, which I 
found is itself also required for cleavage furrow formation.  Finally, we have identified a 
new dFMRP protein-binding partner, Caprin, and found that together dFMRP and Caprin 
are required for the proper timing of the MBT.  This set of work has led to a better 
understanding of the mechanism of dFMRP-dependent regulation of cellular 
morphogenesis in early embryos and has the potential to lead to a better understanding of 
the etiology of FXS. 
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Chapter 1:  General Introduction 
1.1  FRAGILE X MENTAL RETARDATION PROTEIN 
Mental retardation is a prevalent intellectual and developmental disability 
affecting as many as 3% of children and their families in the United States (Inlow and 
Restifo 2004).  Fragile X Syndrome (FXS) is the most common form of heritable mental 
retardation as well as a leading known cause of autism.  FXS results from the reduced 
activity of the Fragile X Mental Retardation Protein (FMRP) as a consequence of either 
the transcriptional silencing of or mutations within the FMR1 gene.  Common symptoms 
of FXS include learning and behavioral disabilities, sleep disorders, delayed speech, 
facial dismorphia, and macroorchidism (O'donnell and Warren 2002).  Although some 
progress has been made in understanding the effects of loss of FMRP activity, there is 
still much to learn about the mechanism of FMRP action. 
1.1.1  FMRP and target mRNAs 
In addition to the symptoms mentioned above, FXS has been associated with 
more specific cellular phenotypes.  FXS patients have been reported to have an elongated 
dendritic spine morphology in brain neurons, which is often associated with mental 
retardation (Hinton et al. 1991).  A similar phenotype has been reported in FMR1 knock-
out mice, suggesting that reduced activity of FMRP in brain neurons is responsible for 
the neuronal defects (Penagarikano et al. 2007).  Dendritic spines are dynamic structures 
that are found along the entire length of a dendrite and are responsible for receiving 
signals from the axon terminals of other signal-sending neurons.  These structures are 
home to the postsynaptic density (PSD), which is a multiprotein complex that is required 
for the targeting of neurotransmitter receptors to their sites of function at the synapse 
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(Sheng 2001).  The initial development and maintenance of dendritic spines requires 
appropriate local translation of specific ‘target’ messenger RNAs (mRNAs) for their 
proper function.   Important known regulators of synaptic development and remodeling 
include effectors of the actin and microtubule (MT) cytoskeletons and membrane 
trafficking (Kennedy and Ehlers 2006).   
FMRP is a selective RNA-binding protein that is implicated in the translational 
regulation of specific mRNAs in neurons.  It contains two types of RNA-binding 
domains: two K homology (KH) domains and an arginine glycine rich motif, also 
referred to as an RGG box (Figure 1.1; Siomi et al. 1993).  The KH2 domain has been 
implicated in binding to a complex tertiary RNA structure referred to as a kissing 
complex, which is hypothesized to mediate binding between FMRP and polyribosomes 
(Darnell et al. 2005).  The RGG box of FMRP has high affinity for G-quartet RNA 
motifs as shown by in vitro selection with human FMRP and microarray analysis using 
murine brain tissue (Brown et al. 2001; Darnell et al. 2001).  Although few direct targets 
of FMRP-dependent regulation have been identified, efforts have been made to identify 
target mRNAs using a variety of approaches including bioinformatics, 
immunoprecipitation and microarray analysis, antibody-positioned RNA amplification, 
and proteome analysis (Brown et al. 2001; Darnell et al. 2001; Schaeffer et al. 2001; 
Miyashiro et al. 2003; Todd et al. 2003; Liao et al. 2008).  These approaches have been 
successful in producing long lists of candidate RNAs although, few direct targets have 
been shown to be physiologically relevant in vivo targets underscoring the importance of 







Figure 1.1  Human FMRP and Drosophila FMRP protein domains 
Percent identity between hFMRP and dFMRP are shown below protein schematic.          
K homology domains (KH) and RGG box indicate RNA binding domains.    I3047N 
indicates a missense mutation that causes severe FXS phenotype.  Amino terminus (N), 
carboxy terminus (C), nuclear localization signal (NLS), and nuclear export signal (NES) 
are located as indicated.  Figure is adapted from Zhang et al. 2001. 
 
1.1.2  FMRP and translational regulation 
 Although very few direct targets of FMRP have been verified in vivo, FXS is 
thought to result from the aberrant translational regulation of potentially hundreds of 
mRNAs causing defects in neuron morphology and synapse function (Brown et al. 2001).  
Although FMRP is generally thought to function as a repressor of translation and can 
repress translation of reporter mRNAs in translation assays, there is also evidence that it 
can also function to activate translation (Brown et al. 2001; Darnell et al. 2001; 
Laggerbauer et al. 2001; Schaeffer et al. 2001; Miyashiro et al. 2003; Todd et al. 2003; 
Liao et al. 2008).  mRNA translation can be inhibited at various steps through the 
process, including inititation, elongation, and termination.  While global regulation is 
generally regulated at the level of initiation, there are thought to be more diverse 
mechanisms that control mRNA-specific regulation that affect elongation and termination 
(Gebauer and Hentze 2004).  Although the mechanism of regulation is not well 
understood, some studies suggest that FMRP affects translation elongation or termination 
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on polyribosomes, whereas others suggest it is excluded from polyribosomes and affects 
translation initiation (Zalfa et al. 2006).  FMRP has been shown to directly interact with 
the 60S ribosomal subunit (Khandjian et al. 1996; Siomi et al. 1996), which could 
support either model.  Nevertheless, FMRP has been reported to be associated with 
polyadenylated mRNAs on actively translating polyribosomes, and a missense mutation 
causing a severe form of FXS (I304N) abolishes this association in human cell culture 
(Corbin et al. 1997; Feng et al. 1997), consistent with an effect on elongation or 
termination.  FMRP has also been shown to localize to RNA granules, which are dynamic 
sites of translational repression, storage, transport and degradation of mRNAs (Mazroui 
et al. 2002; Costa et al. 2005; Barbee et al. 2006).  Many different types of RNA granules 
have been described, each containing a unique and sometimes overlapping constellation 
of proteins and RNAs:  somatic processing bodies (GW/P bodies), stress granules, 
neuronal granules, and germ cell (polar) granules (Anderson and Kedersha 2006).  GW/P 
bodies are generally sites of mRNA decay and contain components of the mRNA decay 
and silencing machinery, while stress granules are generally structures that house stalled 
preinitiation complexes during times of stress (Anderson and Kedersha 2006).  Neuronal 
granules contain translationally repressed mRNAs that are to be transported to dendritic 
spines where the mRNAs are released for translation in response to external cues.  
Finally, germ cell granules contain maternal mRNA that is required for germ cell 
specification.  Although FMRP seems to localize to different types of granules (neuronal 
and stress granules in mammalian cells and neuronal and P body-like granules in 
Drosophila), it seems clear that it is present in structures that are translationally 
quiescent.  These observations are consistent with FMRP functioning to inhibit initiation 
of translation, possibly by sequestering mRNAs away from the translation machinery or 
by affecting the translational competency of mRNAs.  Interestingly, mammalian FMRP 
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has been shown to associate with Dicer and Argonaute 1 (AGO1), components of the 
RNA silencing machinery, in vitro (Jin et al. 2004).  Drosophila FMRP has also been 
shown to physically interact with Argonaute 2 (AGO2) in cell culture and genetically 
interact with AGO1 (Caudy et al. 2002; Jin et al. 2004).  It is still unclear how FMRP 
may be interacting with the RNA silencing machinery in vivo.   Taken together it is clear 
that FMRP is a translational regulator, but its method of action may be dynamic and 
varies with cellular context. 
1.1.3  Drosophila FMRP 
Drosophila has a single FMR1 ortholog called dfmr1, and the fly and human 
protein sequences share a high degree of similarity in the known functional domains 
(Figure 1.1).  The dfmr1 mRNA and protein product (dFMRP) are expressed throughout 
the developing embryo with elevated expression in the mesoderm and central nervous 
system (CNS) (Wan et al. 2000).  dfmr1 mutants are viable and display defects in 
circadian rhythm and courtship activity (Dockendorff et al. 2002).  These abnormal 
behaviors are likely the result of abnormal arborization of dendrites as seen in the 
neocortex of human FXS patients and mutant mice (Gao 2002; Penagarikano et al. 2007).  
dfmr1 mutants also have defects in synapse morphology and function in the 
neuromuscular junction (NMJ) (Zhang et al. 2001).  Because of the similar behavioral 
and cell morphological phenotypes seen in dfmr1 mutant Drosophila, FMR1 knock-out 
mice, and FXS patients, Drosophila is a useful model system for studying FMRP 
function.    
Roles for dFMRP outside of the nervous system have been identified during 
oogenesis (Costa et al. 2005), pole cell formation (Deshpande et al. 2006), and 
spermatogenesis (Zhang et al. 2004).  In the ovary, dFMRP is required for the down 
regulation of the Orb (oo18 RNA binding) pathway which is required for the 
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establishment of the anterior–posterior and dorsal–ventral axes of the developing egg 
(Costa et al. 2005).  Loss of dfmr1 causes defects in cyst formation and oocyte 
specification, a likely consequence of the misregulation of the Orb pathway.  In embryos 
laid by dfmr1 mutant females mated to dfmr1 mutant males, initial pole bud formation is 
perturbed and pole cells are not properly separated from the underlying syncytial layer 
(Deshpande et al. 2006).  Orb levels appear normal in these embryos, so the pole cell 
defect is suggested to be a result of the misregulation of the actomyosin cytoskeleton.  
Finally, dFMRP is required during spermatogenesis for the structural integrity of the 
sperm tail axoneme (Zhang et al. 2004).  Although it is still unclear how dFMRP affects 
axoneme development, it has been suggested that dFMRP may be required for the 
stabilization of the central pair of microtubules through the translational regulation of MT 
stability factors (Zhang et al. 2004).  Interestingly, the axoneme phenotype was also 
observed in mouse FMR1 knockout mice, suggesting that this role for FMRP is 
evolutionarily conserved (Zhang et al. 2004).  Despite these studies, the specific 
molecular function of dFMRP remains elusive.  Identification and validation of new 
direct targets and investigation of FMRP in developmental systems outside of the nervous 
system may be important for fully understanding how FMRP functions.  
1.1.4  dFMRP and target mRNAs 
A handful of direct targets of dFMRP regulation has been identified and verified 
in neurons including futsch, Rac1, pickpocket (ppk1), and chickadee (chic, Profilin) 
(Zhang et al. 2001; Lee et al. 2003; Xu et al. 2004; Reeve et al. 2005).  Futsch is the 
homolog of mammalian MAP1B, a MT-associated protein that regulates the MT 
cytoskeleton in neurons (Zhang et al. 2001) that has also been found to be a target of 
FMRP regulation in mice (Lu et al. 2004).  dFMRP is normally required for the 
translational repression of futsch (Zhang et al. 2001).  The upregulation of Futsch in 
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dfmr1 mutants seems to account for the defects observed in the NMJ but not in other 
types of neurons because loss of futsch in a dfmr1 mutant specifically rescues the NMJ 
neuronal phenotype (Zhang et al. 2001).  Rac1, a regulator of the actin cytoskeleton, has 
been identified as a target of FMRP regulation in Drosophila and mouse neurons (Lee et 
al. 2003; Castets et al. 2005).  Profilin, a regulator of the actin cytoskeleton, and PPK1, a 
specialized sodium channel subunit, have been reported as targets of dFMRP in 
Drosophila neurons, although, so far, mammalian homologs have not been identified as 
FMRP targets (Reeve et al. 2005).  These observations are consistent with dFMRP 
having a role in regulating the cytoskeleton as well as having common targets as 
mammalian FMRP in neurons.   
Identifying additional targets will be important for elucidating the mechanism of 
FMRP regulation as well as the etiology of FXS.  To this end we have used the cleavage 
stage Drosophila embryo as a system to study the mechanisms of FMRP function and the 
role of mRNA translational control in early embryonic morphogenesis. 
 
1.2  THE DROSOPHILA CLEAVAGE STAGE  
The initial cleavage divisions of embryogenesis in most animals are remarkably 
rapid and synchronous and have reduced or no gap phases.  Following these unique 
divisions, animal embryos undergo a monumental transition, referred to as the 
midblastula transition (MBT), when the embryo shifts from dependence on maternal to 
zygotic genetic control.  The hallmark of the MBT in Drosophila is the process of 
cleavage furrow formation, also referred to cellularization, which is unique to the insect 
cleavage stage.  Although the mechanism for how the actual cleavage divisions occur 
varies greatly between animals, several of the known regulators of the MBT are 
functionally conserved throughout the animal kingdom suggesting that the molecular 
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mechanisms regulating the MBT are also conserved.  In addition, the cleavage stage is 
characterized by a dramatic shift in post-transcriptional genetic control, making it well 
suited for the study of dFMRP function.  
1.2.1  Cell cycles of the Drosophila cleavage stage 
Drosophila embryos undergo superficial cleavage, wherein nuclear divisions occur 
within a common cytoplasm in the absence of cytokinesis.  The first 9 nuclear cycles 
(NCs) are extremely fast and synchronous, lasting only about 8 minutes.  During 
interphase of NC10 a small number of nuclei at the posterior pole of the embryo are 
cellularized and become pole cells, which will eventually give rise to the gametes of the 
adult fly.  The somatic nuclei migrate to the cortex by NC10 where they undergo four 
additional divisions, which successively lengthen in duration (NC10 = 12 min, NC11 = 
13 min, NC12 = 15 min, and NC13 = 26 min at 25°C) (Figure 1.2; Foe and Alberts 
1983).  During interphase of NC14, the cortically positioned nuclei are encapsulated by 
plasma membrane furrows, transforming the syncytial embryo into a cellular blastoderm 
through the process of cellularization.  The mitosis of NC14 is the first completely 
asynchronous mitosis, with domains of cells progressing into mitosis at different rates, 










Figure 1.2  Cell cycles lengthen at the MBT and a shift from maternal to zygotic 
genetic control occurs at nuclear cycle 14 during the cleavage stage 
Top grey bars indicate general phases of the cleavage stage.  Nuclear cycle number and 
corresponding duration in minutes is shown under the black lines which indicate relative 
length of interphase (I) and black boxes which indicate relative length of mitosis (M).  
Duration of cycles at 25°C is indicated in minutes.  Cartoon of embryo morphology at the 
different stages of cleavage and as a gastrula (far right).  Red and green triangles show 
relative abundance of maternal transcripts that are degraded and zygotic transcripts that 






1.2.2  Cleavage furrow formation (cellularization) 
Cleavage furrow formation is a specialized form of cytokinesis whereby cortically 
positioned nuclei are encapsulated by invaginating plasma membrane furrows.  During 
this process, cleavage furrows ingress at two distinct rates.  First, furrowing occurs 
slowly until the furrow front reaches the basal ends of nuclei.  The rate then abruptly 
increases during the fast phase until the cells are formed and cellularization is complete.  
During the slow phase the nuclei elongate at a constant rate.  This process requires a 
dramatic reorganization of the actin and MT cytoskeletons.  F-actin is organized into an 
array of interlocking contractile rings under the plasma membrane and during furrow 
formation is positioned at the ingressing furrow front (Figure 1.3).  At the onset of 
cellularization microtubule arrays emanate from pairs of cortically positioned 
centrosomes, extending their plus-ends into the interior of the embryo, forming ‘inverted 
baskets’ around individual nuclei (Figure 1.3).  These microtubules are thought to 
provide some mechanical force required for nuclear elongation, as well as act as tracts for 
the secretory machinery (Foe and Alberts 1983).  Cellularization is completed when 
furrows extend well past the basal ends of the nuclei into the basal cytoplasm and 
cleavage furrows constrict during basal closure.  The embryo begins gastrulation prior to 
the completion of cellularization, and most cells retain an open cytoplasmic stalk well 
into gastrulation (Bate and Martinez Arias 1993). 
Despite much effort, only a relatively small number of genes have been shown to 
be essential for Drosophila embryonic cleavage furrow formation (Mazumdar and 








Figure 1.3  Cleavage furrow formation depends on changes in the MT and Actin 
cytoskeletons 
Surface (A) and sagittal (B) immunofluorescence (IF) images of wild type (WT) embryos 
undergoing cleavage furrow formation showing F-actin (red), centrosomes (blue), and 
microtubules (MTs, green).  Cartoons depict positioning of nuclei and plasma membrane  
(PM) in IF images. 
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1.2.3  MT and Actin regulators and furrow formation 
As in conventional animal cell cytokinesis, many of the genes known to be 
required for cleavage furrow formation during cellularization are implicated in the 
regulation of the actin cytoskeleton (Glotzer 2001). Maternal-effect cleavage furrow 
formation defects have been described for mutations in many genes that are known to 
regulate the actin cytoskeleton, including scraps (scra, anillin), peanut (pnut, septin), 
diaphanous (dia), Src oncogene at 64B (Src64), and Btk family kinase at 29A (Btk29A) 
(Schupbach and Wieschaus 1989; Adam et al. 2000; Afshar et al. 2000; Thomas and 
Wieschaus 2004; Field et al. 2005).  Mutations in dia, scra and pnut cause defects in 
contractile ring formation and furrow ingression (Adam et al. 2000; Afshar et al. 2000; 
Field et al. 2005).  DIA, a Formin Homology protein involved in many actin-mediated 
cellular processes, is required to recruit actin, Anillin, and PNUT to the furrow front early 
in furrow formation (Afshar et al. 2000).  In turn, Anillin and PNUT function together at 
the furrow front to assemble and organize the F-actin cytoskeleton, which is essential for 
the organization and ingression of new plasma membrane (Field et al. 2005; Sokac and 
Wieschaus 2008).  Src64 and Btk29A are required for providing tension in cleavage 
furrows through the regulation of the actin cytoskeleton.  In Src64 and Btk29A mutants, 
furrows do not advance completely and basal closure of furrows does not occur (Thomas 
and Wieschaus 2004).  In addition, three zygotic genes [nullo, serendipity-a (sry-a), and 
bottleneck (bnk)] are required for regulation of the actin cytoskeleton specifically during 
cellularization but not at any other time in development suggesting that they do not 
function during normal cytokinesis (Merrill et al. 1988; Wieschaus and Sweeton 1988; 
Schejter et al. 1992).  Regardless, the mechanism for the activation of this unique set of 
genes may be important for a more complete understanding of the regulation that governs 
 13 
the MBT (see section 1.3.4).  While this list is hardly exhaustive of all the actin 
regulators that are required for cleavage furrow formation, it demonstrates that these actin 
regulatory genes are required for different aspects of furrow formation. 
Although actomyosin based contraction has been considered to be a main driving 
force for furrow ingression during cellularization, it has been suggested that non-muscle 
Myosin II activity is dispensable for proper furrow ingression and is only required for 
constriction that occurs during basal closure (Royou et al. 2004).  Many studies are now 
focused on possible roles for actin organization in targeted membrane secretion for 
providing the force required for furrow ingression. 
1.2.4  Membrane trafficking and furrow formation 
 In addition to the reorganization of the actin cytoskeleton, MT-based targeted 
membrane secretion is also required for Drosophila embryonic cleavage furrow 
formation (Lecuit and Wieschaus 2000; Sisson et al. 2000).  The amount of plasma 
membrane required to form the thousands of cells in the blastoderm is dependent on a 
huge increase in surface area, and it has been demonstrated that internal stores of 
membrane contribute to the formation of these furrows (Lecuit and Wieschaus 2000; 
Sisson et al. 2000).  Furthermore, as mentioned above, it is possible that the addition of 
this new membrane drives furrows inward, rather than depending solely on actomyosin 
contraction (Lecuit and Wieschaus 2000; Royou et al. 2004; Thomas and Wieschaus 
2004).  Although many of the genes required for furrow formation that have been 
identified are involved in regulating the actin cytoskeleton, requirements for players in 
membrane trafficking and secretion have also been found.  Specifically, Shibire (SHI), 
the Drosophila homolog of Dynamin and a protein implicated in endo- and exocytosis, is 
required for cleavage furrow formation (Swanson and Poodry 1981).  In addition, 
proteins involved in recycling endosome (RE) trafficking [eg. Rab11 and Nuclear-fallout 
 14 
(NUF)], Golgi trafficking [eg. Lava Lamp (LVA)], and targeted secretion (eg. 
Syntaxin1A) have also been shown to be necessary for cleavage furrow formation 
(Burgess et al. 1997; Rothwell et al. 1998; Sisson et al. 2000; Pelissier et al. 2003; Riggs 
et al. 2003).  The requirement for these proteins in cleavage furrow formation 
underscores the importance of membrane trafficking mechanisms for this process, but the 
relationships between these different proteins and the mechanism of their regulation 
within the context of cleavage furrow formation are still not understood.   
 Identifying new genes involved in furrow formation will be essential to expand 
our understanding of the underlying mechanisms controlling the process as well as to 
contribute to our knowledge of conventional animal cell cytokinesis.  As I will describe 
in the following chapters, in our efforts to identify these new genes, we found a 
requirement for dFMRP for cleavage furrow formation and cell cycle regulation during 
the MBT.  This discovery has led us in many new directions, revealing previously 
unexplored regulatory pathways that depend on dFMRP. 
 
1.3  THE DROSOPHILA MBT 
The MBT varies among species with respect to its timing and duration, however it 
is generally characterized by a sudden onset in zygotic transcription and a 
desynchronization of the cell cycle.  While in some animals this occurs during the 
midblastula stage (1000’s of cells), others undergo the transition much earlier.  The 
process was first described in amphibians where the transition occurs at the midblastula 
stage accompanied by the acquisition of cell motility and was originally termed the 
midblastula transition (MBT) (Newport and Kirschner 1982). 
In Drosophila, zygotic gene expression begins prior to the MBT, with some 
transcripts beginning to be expressed as early as NC8 (Pritchard and Schubiger 1996).  
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Unlike the MBT described in Xenopus where the maternal to zygotic transition (MZT) is 
concomitant with the MBT, in Drosophila the MZT occurs prior to the MBT with 
maximal activation occuring during late interphase of NC14 (Edgar and Schubiger 1986).  
Microarray analysis of global gene transcription during the cleavage stage of Drosophila 
embryogenesis has revealed a highly dynamic program of mRNA expression (Arbeitman 
et al. 2002; Tadros and Lipshitz 2005; Pilot et al. 2006; De Renzis et al. 2007).  These 
studies reveal that over half (~7800 genes) of the genome is maternally expressed and 
loaded into the embryo, and of the transcripts expressed during the transition, at least 
1600 maternal transcripts (~20% of loaded mRNAs) are degraded and over 1000 zygotic 
transcripts increase in abundance at the MBT during cleavage furrow formation.  In 
addition, much progress has been made in the identification of factors and description of 
the mechanisms involved in maternal and zygotic mRNA turnover prior to and during the 
MBT.  In this section, I will discuss the progress that has been made towards 
understanding the non-RNA-based mechanisms that control the MBT in Drosophila, 
which include counting of the nucleocytoplasmic ratio, cell cycle control through 
fluctuations in activity of the cell cycle machinery, and activation of the DNA 
damage/replication checkpoint pathway as well as the mechanisms governing mRNA 
degradation, localization, and translational regulation during the MBT. 
1.3.1  Nuclear to cytoplasmic ratio 
The phenomena associated with the MBT (desychronization of individual cell 
cycles, activation of transcription, and acquisition of cell motility) respond to the nuclear 
to cytoplasmic ratio (N:C ratio) (Newport and Kirschner 1982; Newport and Kirschner 
1982).  It is thought that there is a cytoplasmic titrating factor that ‘counts’ the DNA 
content relative to cytoplasm.  As the embryo undergoes successive rounds of replication, 
the factor is titrated out of the cytoplasm by the exponentially increasing content of DNA, 
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resulting in a lengthening of the cell cycle followed by the events of the MBT.  It is likely 
that the general N:C ratio counting mechanism for controlling the timing of the MBT is 
well conserved.  In Drosophila, mutations in maternal haploid (mh), a gene required for 
pronuclear fusion, give rise to haploid embryos (Edgar et al. 1986).  Embryos derived 
from mh females progress through the first 13 nuclear cycles relatively normally, albeit at 
a slower rate.  When the embryos reach interphase of NC14 they have the same number 
of nuclei as a wild type embryo at NC14, but they have half the amount of total DNA.  
Instead of lengthening interphase and cellularizing, almost all mh embryos undergo a 
metasynchronous mitosis 14 and then cellularize during interphase of NC15.  Cleavage 
furrows often begin to form and ingress during the abbreviated NC14 but are interrupted 
and regress during the precocious mitosis 14.  This observation demonstrates that the N:C 
ratio is one essential component in regulating the Drosophila MBT.  
1.3.2  CDK activity and cell cycle regulation 
Regulation of cell cycle control is also an essential aspect of the MBT and 
employs key conserved components.  The classic studies of cell cycle progression first 
described by Hartwell, Hunt and Nurse found that the activity of Cyclin dependent 
kinases (CDKs) dictates the timing of cell cycle progression.  CDK activity and substrate 
specificity is controlled in part by its association with a specific Cyclin protein (CYC) 
and its phosphorylation state.  CDK protein levels remain constant through the cell cycle, 
but Cyclin protein levels alter causing a fluctuation in the activity of CDK.  The system 
controlling CDK activity involves many additional regulatory factors that are able to 
integrate internal and external signals into an effect on CDK activity.  In Drosophila 
embryos prior to NC10, nuclei proliferate with constant levels of CYC, and M-CDK 
(CDK that is associated with a mitosis specific Cyclin) activity presumably remains 
constant (Edgar et al. 1994).  With regards to the MBT, CYC levels begin to oscillate at 
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NC10 with progressively higher percentages of total CYC being degraded with each 
successive nuclear division (Edgar et al. 1994).  In order for interphase to lengthen long 
enough for furrow formation to occur, M-CDK activity needs to be inhibited.  There are a 
number of factors that act to repress and activate M-CDK activity and their concerted 
regulation is important to achieve the appropriate state of M-CDK activity (Figure 1.4). 
In Drosophila, the cdc2 gene encodes CDK1, and its association with Cyclins A, 
B, and B3 are important for progression into and through mitosis during the cleavage 
divisions.  In 10% of embryos that are maternally provided with 1X CycA and 1X CycB, 
mitosis of NC13 fails to initiate and embryos cellularize during an extended interphase of 
NC13 (Stiffler et al. 1999).  On the other hand, ~8% of embryos expressing 4X CycB fail 
to elongate interphase of NC11-13 and cellularization never occurs (Stiffler et al. 1999).  
These observations suggest that the degradation of CYCB is essential for the elongation 
of interphase prior to the MBT.  The dynamics of CYCB expression prior to and during 
the MBT are thought to result from degradation or translational repression of the CycB 
mRNA and the spindle-associated synthesis and degradation of CYCB (Huang and Raff 
1999).  The precise mechanism for controlling CycB mRNA metabolism is unknown, but 
appears to be independent of the major maternal degradation pathway controlled by 
Smaug protein discussed in section 1.3.4 (Tadros et al. 2007).  It is known that the 
spindle-associated degradation of CYCB is APC-CDC20-dependent (Raff et al. 2002).  
Based on precedent from vertebrate studies and the localization of CycB mRNA to 
mitotic spindles in cleavage stage embryos, local polyadenylation-dependent translational 
activation may account for nuclear cycle-specific synthesis of CYCB during the MBT in 
Drosophila.  
Two effectors of M-CDK1 activity include CDC25, a phosphatase that activates 
CDK1, and Wee1, a kinase that inactivates M-CDK1.  In Drosophila, two genes encode 
 18 
 
Figure 1.4  Proper regulation of M-CDK1 activity during the MBT is essential for 





Figure 1.5  Levels of cell cycle regulators fluctuate during the MBT 
Lines indicate fluctuations in protein levels over time as indicated at bottom.  Figure 





CDC25, string (stg) and twine (twe), which are degraded during NC14.  In a minor 
fraction (~2-5%) of embryos that contain 4X or 6X copies of either of these genes, 
embryos undergo a premature mitosis 14 and cellularize during interphase of NC15 
(Edgar and Datar 1996).  In 16% of embryos that are maternally provided with 1X twe 
and 0X stg, cellularization occurs during interphase of NC13 (Edgar and Datar 1996).  
These phenotypes are presumably due to a disruption in M-CDK1 activity during NC14.  
Prior to and during the MBT, Wee1 activity is constant, resulting in limited M-CDK1 
activity during NC14.  Loss of Wee1 activity results in abnormal cortical syncytial 
divisions and a failure to lengthen interphase due to a loss of M-CDK1 inhibition (Price 
et al. 2002).   
 In addition, there are zygotically encoded factors that affect M-CDK1 activity.  
Frühstart (FRS) and Tribbles (TRBL) are two zygotically encoded proteins that promote 
NC14 interphase lengthening (Grosshans and Wieschaus 2000).  Although loss-of-
function mutations in frs or trbl have no effect on divisions prior to NC13, they cause a 
premature mitosis 14 and cellularization during NC15 in ~8% of embryos (Grosshans and 
Wieschaus 2000).  FRS is thought to inhibit the low levels of active M-CDK1 present at 
the start of NC14 by directly binding to CYCB, preventing specific substrate interactions 
(Gawlinski et al. 2007).  TRBL, on the other hand, is required for CDC25 degradation 
(Mata et al. 2000).  Introduction of ectopic frs or trbl mRNAs causes inhibition of mitosis 
at the sites of injection consistent with an inhibitory function (Grosshans and Wieschaus 
2000).   
 Concerted regulation of these maternal and zygotic factors contributes to the 
inhibition of M-CDK1 activity and promotes the lengthening of interphase at NC14 
through the degradation of CDC25 and directs inhibition of M-CDK1 through CYCB 
binding and inhibitory phosphorylation.  Nearly all haploid embryos derived from 
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maternal haploid mutant females, where the N:C ratio is disrupted, fail to extend 
interphase of NC14 and attempt to cellularize in NC15.  Yet, loss-of-function mutations 
in frs and trbl result in relatively low penetrance of premature mitosis of NC14, and the 
overexpression of CDC25 has a similar penetrance.  Therefore, additional mechanisms 
beyond those already described are thought to regulate the timing of the MBT.  In chapter 
4, I will discuss how dFMRP is likely contributing to this regulation by impinging on M-
CDK1 activity during the MBT. 
1.3.3  DNA damage/replication checkpoint pathway  
The lengthening of interphase after NC10 is also mediated by a cell cycle 
checkpoint mechanism.  The DNA-replication damage checkpoint in Drosophila 
embryos can be considered to have been co-opted in order to gradually lengthen the cycle 
cycles after NC10.  It is thought that during these later cycles S-phase takes longer to 
complete and a maternal replication factor is titrated out of the cytoplasm, resulting in a 
lengthening in interphase (Sibon et al. 1997).  Meanwhile, the cell cycle oscillator 
controlling M-CDK1 activity continues to drive the cell cycle forward.  Maternal 
expression of components of a conserved DNA-replication/damage checkpoint pathway, 
grapes (grp)/checkpoint kinase-1 (chk1) and meiosis-41 (mei-41), is required to respond 
to the state of DNA synthesis and delay M-phase (Sibon et al. 1997; Sibon et al. 1999).  
This checkpoint pathway is thought to mediate the inhibitory phosphorylation of CDK1 
(CDC2), which inhibits its ability to initiate mitosis (Sibon et al. 1999).  Checkpoint 
mutants cause severe mitotic spindle defects at NC12, block initiation of zygotic 
transcription, and fail to cellularize (Fogarty et al. 1994; Sibon et al. 1997; Sibon et al. 
1999).  In addition, it has been shown that GRP/CHK1 normally delays the nuclear 
accumulation of CYCB, preventing activation  of CDK1 and delaying the cell cycle at the 
MBT (Royou et al. 2005).  
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1.3.4  Maternal and zygotic mRNA degradation pathways 
In addition to cell cycle regulation and activation of zygotic transcription, 
regulation of mRNA degradation, localization, and translational control play key roles in 
the execution of the events of the MBT.  Messenger RNA turnover is in part mediated by 
the precise coordination of maternally and zygotically encoded degradation pathways.  
The maternal mRNA degradation pathway begins at or shortly following egg 
activation and does not require fertilization (Bashirullah et al. 1999).  One of the major 
pathways that influences the degradation of unstable maternal mRNAs following egg 
activation is regulated by Smaug (SMG), a multifunctional RNA-binding protein that is 
able to translationally repress as well as direct the degradation of target transcripts 
(Tadros et al. 2007).  Smaug protein accumulates after egg activation, and the mRNA and 
protein are degraded just prior to NC14 (Dahanukar et al. 1999).  Prior to egg activation, 
smg mRNA is translationally repressed through its association with Pumilio and other 
repressive factors.  Following egg activation, the Pan Gu Kinase acts through the smg 
3’UTR to activate translation by relieving repression.  SMG then mediates maternal 
transcript degradation by recruiting the CCR4-POP2-NOT deadenylase complex to a 
large number of the newly polyadenylated maternal mRNAs to mediate their 
deadenylation and subsequent degradation (Semotok et al. 2005).  In addition, SMG can 
mediate translational repression by inhibiting initiation of translation via its known 
interaction with eIF4E and CUP (Nelson et al. 2004).  Embryos derived from smg mutant 
females develop normally until NC11, at which point mitotic spindle defects are observed 
and cellularization fails to occur (Dahanukar et al. 1999).  Analysis of gene expression in 
embryos from wild type and smg- females using microarray-based gene expression 
profiling shows that nearly 2/3rds of unstable maternal mRNAs are degraded in a SMG-
dependent manner (Tadros et al. 2007). Messenger RNAs that are degraded in a SMG-
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dependent manner are enriched for gene ontology terms related to the cell cycle, and the 
mis-expression of these mRNAs may be at least partially responsible for the smg- 
phenotypes.  Although the interpretation of the smg- phenotype has focused on the 
demonstrable degradation of maternal mRNAs, it is possible that the SMG-mediated 
translational repression of some maternal mRNAs significantly contributes to the smg-
phenotype.  Despite this possibility, it remains clear that maternal mRNA degradation is 
required to execute the events of the MBT, and SMG-dependent degradation is a 
dominant pathway.   
The zygotic degradation pathway becomes active 1.5-2hr after fertilization and 
functions with the maternal pathway to degrade specific mRNAs at the MZT/MBT 
(Bashirullah et al. 1999).  The zygotic pathway is necessary to fully degrade mRNAs 
targeted by the maternal pathway as well as mRNAs that are unaffected by the maternal 
pathway.  The identity of any zygotic factors that mediate the degradation of mRNAs at 
the MZT/MBT is unknown.  Although recent progress has been made towards identifying 
these factors.  In a set of elegant experiments, a combination of chromosome ablation and 
microarray analysis was used to determine what contribution the maternal and zygotic 
genomes make to the total amount of mRNA present at the MBT as well as how the 
degradation of maternal mRNAs is correlated with the activation of the zygotic genome 
(De Renzis et al. 2007).  This analysis found that zygotically active genes at the MBT are 
enriched for transcription factors and that mRNAs that are first ubiquitously expressed 
maternally are ‘re-expressed’ zygotically in localized patterns during the MBT.  This 
observation is likely important for the subsequent determination of cell fate.  In addition, 
cis-regulatory heptad DNA sequences, referred to as TAGteam sites, are enriched in 
genes zygotically expressed at the MBT.  Bicoid stability factor (BSF), a protein 
previously implicated in translational regulation, was found to be capable of binding to 
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these sites and activate transcription (De Renzis et al. 2007).  Recently it has also been 
shown that a transcriptional activator, Zelda (ZLD), is responsible for the activation of a 
large number of zygotic genes and also acts through binding to TAGteam sites (Liang et 
al. 2008).  Embryos derived from zld- females are normal up to NC14 when then fail to 
cellularize or undergo cellularization with abnormal cleavage furrows.  In addition, some 
embryos undergo what may be a premature mitosis of NC14 as seen in frs mutants.  
Indeed, the same study shows by microarray analysis that frs mRNA as well as mRNAs 
of other zygotically expressed genes required for proper cellularization (ie. slam, nullo, 
and bnk) are significantly downregulated in the zld- embryos.  In the future, identification 
and further analysis of targets of BSF and ZLD transcriptional activation may reveal 
mediators of the zygotic degradation pathway as well as new effectors of the MBT. 
Although this progress has been very important for identifying the major 
pathways and targets for maternal mRNA degradation at the MBT, these studies only 
focus on those mRNAs that are activated or degraded and have not identified mRNAs 
that are translationally repressed, which could represent a functionally important group of 
mRNAs. 
1.3.5  Translational regulation 
Degradation and transcriptional activation are clearly essential for the MBT, but 
there is also accumulating evidence that translational regulation also plays an important 
role in mediating the events of the MBT.  Maternally expressed genes encoding 
conserved proteins that function in RNA translational control and localization such as 
valois (vls) and staufen (stau) have been shown to be required for pole cell formation and 
proper cleavage furrow formation during the MBT, although the context with which these 
translational regulators are functioning to mediate the events of the MBT is unknown 
(Schupbach and Wieschaus 1989; Sullivan et al. 1993).  Given what we know about 
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dFMRP, it is an excellent candidate for also having a role in translational regulation 
during the MBT.  I will present evidence for this in the following chapters.  
There are also interesting links between the MBT and the RNA silencing 
pathways in Drosophila.  Regulation of translation via silencing is used in many cellular 
and developmental processes in animals.  Critical components of the RNA silencing 
pathway are members of the Argonaute protein family, and proteins of this family contain 
a PAZ domain, implicated in RNA-binding, as well as a PIWI domain, implicated in 
ribonuclease activity (Hutvagner and Simard 2008).  Argonaute proteins associate with 
small, 22-25 nucleotide RNAs and guide them to their complementary mRNAs.  About 
half of embryos derived from ago2- females have defects in pole cell formation and early 
nuclear divisions and migrations prior to the MBT (Deshpande et al. 2005; Meyer et al. 
2006).  In addition, ago1 genetically interacts with an amorphic allele of ago2 
specifically during the MBT, suggesting that they have redundant activities at this time in 
development (Meyer et al. 2006).  Though, it is unclear if this interaction is affecting the 
degradation or translational repression of mRNAs. It was originally thought that in 
Drosophila AGO1 functions in micro RNA (miRNA)-mediated RNA silencing via 
translational repression and AGO2 functions in small interfering RNA (siRNA)-mediated 
RNA silencing via mRNA degradation, although these relationships are likely more 
complex.  Meyer et al., suggest that AGO1 and AGO2 are present in some type of mRNP 
degradation complex, possibly P bodies, and that the RNA silencing machinery is 
required for mediating the events of the MBT.  
There is precedent for a requirement for miRNA-mediated translational regulation 
during vertebrate MBT.  Zebrafish miR-430 is expressed at the MBT and is required for 
the downregulation of several hundred maternally expressed mRNAs (Giraldez et al. 
2006).  More direct studies have investigated the effects of miRNA loss-of-function 
 25 
during the Drosophila MBT.  Embryos injected with miR-9 antisense oligos to disrupt 
miR-9 function have severe defects in nuclear division and morphology, although it is 
unclear what the primary defect is in these embryos (Leaman et al. 2005).  More recently, 
the miR-309 cluster (containing miR-3, miR4, miR5, miR6, miR286 and miR-309) was 
deleted in flies, and although there are no effects on embryonic development, microarray 
analysis reveals that a distinct set of maternal mRNAs is upregulated in the absence of 
the miRNAs (Bushati et al. 2008).  The absence of an embryonic phenotype is possibly 
due to redundant function of miRNAs.  It may be necessary to delete additional, 
redundant miRNA clusters that are specifically expressed during the MBT in order to 
detect embryonic phenotypes associated with disruptions in the MBT.  The study 
suggests that a set of miRNAs is required to promote the deadenylation and clearence of 
maternal mRNAs at the MBT.  Once again, this type of analysis would not identify 
mRNAs that are translationally repressed and not degraded in the absence of the 
miRNAs.  Together these observations suggest that the RNA silencing machinery and 
miRNAs expressed at the MBT may represent the factors involved in the zygotic 
degradation pathway for the MBT. 
As previously mentioned, there is evidence that FMRP functions with the RNA 
silencing pathways.  Future studies exploring this relationship during the MBT could lead 
to a better understanding of RNA metabolism/translational regulation during the MBT as 
well as FMRP function. 
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Chapter 2:  dFMRP is required for cleavage furrow formation and 
controls trailer hitch expression 
 
The data described in this chapter have been published in The Proceedings of the 
National Academy of Sciences (Monzo et al. 2006). 
 
2.1  INTRODUCTION 
During the cleavage stage of animal embryogenesis, cell numbers increase 
dramatically without growth, and a shift from maternal to zygotic genetic control occurs 
called the midblastula transition (MBT).  Although these processes are fundamental to 
animal development, the molecular mechanisms controlling them are poorly understood. 
Here, we demonstrate that Drosophila fragile X mental retardation protein (dFMRP) is 
required for cleavage furrow formation and functions within dynamic cytoplasmic 
ribonucleoprotein (RNP) bodies during the MBT.  dFMRP is observed to colocalize with 
the cytoplasmic RNP body components Maternal expression at 31B (ME31B) and Trailer 
Hitch (TRAL) in a punctate pattern throughout the cytoplasm of cleavage stage embryos. 
Complementary biochemistry demonstrates that dFMRP does not associate with 
polyribosomes, consistent with its reported exclusion from many cytoplasmic RNP 
bodies.  By using a conditional mutation in small bristles (sbr), which encodes an mRNA 
nuclear export factor, to disrupt the normal cytoplasmic accumulation of zygotic 
transcripts at the MBT, we observe the formation of large, abnormal  dFMRP/TRAL-
associated structures, suggesting that dFMRP and TRAL dynamically regulate RNA 
metabolism at the MBT.  Furthermore, we show that dFMRP associates with endogenous 
tral mRNA and is required for normal TRAL protein expression and localization, 
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revealing it as a previously undescribed target of dFMRP control.  We also show 
genetically that tral itself is required for cleavage furrow formation.  Together, these data 
suggest that in cleavage stage Drosophila embryos, dFMRP affects protein expression by 
controlling the availability and/or competency of specific transcripts to be translated. 
 
2.2  RESULTS 
2.2.1  dfmr1 is required for female and male fertility 
We tested the fertility of dfmr13/Df(3R)Exel6265 (hereafter referred to as dfmr1-) 
females, which lack detectable dFMRP protein (Figure 2.1A), and examined their 
progeny for embryonic phenotypes.  Wild type (WT, also referred to as Oregon-R in 
figures) and dfmr1- females were found to produce morphologically normal eggs at 
similar rates when crossed to WT males; however, fewer of the embryos from dfmr1- 
females hatch (Figure 2.1B).  To test whether the embryos that hatch from dfmr1- 
females reflect partial rescue by the paternal chromosome containing a WT copy of 
dfmr1, dfmr1- females were crossed to heterozygous fmr13/TM3-GFP males and progeny 
were scored.  Comparable numbers of dfmr1-/dfmr1- and dfmr1-/TM3-GFP embryos 
hatched, indicating that the viability of these embryos is determined by the maternal 
genotype (Figure 2.1B).  We also verified that dfmr1- mutant males are sterile, as 
described in Zhang et al. 2004 (Figure 2.1B).  
2.2.2  dFMRP activity is essential for cleavage furrow formation 
Aside from a subtle effect on the duration of nuclear cycles 12 and 13 (see A2.1), 




Figure 2.1  Maternal expression of dfmr1 is required for cleavage furrow formation     
(A) Immunoblots of 15 µg of Oregon-R (WT) and dfmr1- (dfmr13/Df) adult female 
extracts probed for dFMRP and Myosin II (MYOII, control). (B) The number of F1 
embryos laid (white plus gray) and hatched (gray) are shown as bars for each cross.  
Hatch percentages (hatched/laid) are indicated on each bar. The striped region of bar 4 
indicates the number of dfmr13/TM3-GFP hatchlings. (C) The average rate of furrow 
ingression is shown for embryos derived from the indicated female genotypes at 25°C.   
dfmr1- embryos with severe furrowing defects (D Right) were not quantified.  Error bars 
and n indicate the standard deviation (SD) and number of movies measured, respectively. 
(D) Sequential frames from representative differential interference contrast movies of 
WT and dfmr1- embryos undergoing normal (Left), delayed (Center), and severely 
disrupted (Right) furrow formation at 25°C. The percentage of dfmr1- embryos in each 
phenotypic class is shown in parentheses. White arrowheads and brackets indicate the 
furrow front position and nuclear elongation, respectively. Times (t minutes) are relative 






observed in live embryos derived from dfmr1- females crossed to WT males (hereafter 
referred to as dfmr1- embryos; Figure 2.1C and D).  Approximately 75% of dfmr1- 
embryos display significant reduction in the rate of furrow ingression (Figure 2.1C and 
D), whereas the remaining 25% display dramatic furrowing defects characterized by 
abnormal nuclear morphology and uneven furrow ingression (Figure 2.1D).  These 
phenotypes are rescued by maternal expression of a WT copy of dfmr1 from a single P 
element transgene (Figure 2.1C) (Dockendorff et al. 2002).  Immunofluorescence (IF) 
analysis of fixed cleavage stage dfmr1- embryos reveals no significant alteration in the 
appearance of MTs, Myosin II, Anillin, cortical F-actin, or Lava Lamp (LVA) associated 
Golgi bodies (Figure 2.5A).  Together these observations suggest that dFMRP is required 
for proper cleavage furrow formation and that the phenotype is not likely due to gross 
defects in the MT or actin cytoskeletons. 
2.2.3  dFMRP associates with cytoplasmic RNP bodies in cleavage stage embryos 
Our phenotypic analysis indicates that the earliest measurable requirement for 
dfmr1 occurs in the cleavage stage, hours before nervous system formation.  To explore 
its function at this time, we examined the subcellular localization of dFMRP by indirect 
IF in fixed cleavage stage embryos.  This analysis reveals a punctate distribution 
throughout the cytoplasm that increases in intensity over the course of furrow formation 
(Figure 2.2).  Some dFMRP-associated structures associate with the advancing furrow 
front (Figure 2, arrow and bracket) and frequently are found adjacent to LVA-associated 
Golgi compartments but do not significantly colocalize with them (<2.5% of dFMRP 




Figure 2.2  dFMRP localizes to punctate cytoplasmic structures in cleavage stage 
embryos  
IF analysis of fixed WT embryos at progressive stages of cellularization shows punctate 
dFMRP localization throughout the cytoplasm (Left) and corresponding cortical F-actin 
marking plasma membrane furrows (Right).  dFMRP puncta often are positioned at the 
furrow front (arrow and bracket).  Asterisks indicate nuclei.  Scale bar indicates 10 µm. 
early  
          late 
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The localization pattern of dFMRP in embryos resembles the punctate localization 
described for the cytoplasmic RNP body protein components ME31B and TRAL in 
female germ-line cells, which are implicated in mRNA sequestration, transport, and 
translational suppression (Nakamura et al. 2001; Wilhelm et al. 2005). Also, RNase-
treatment of fixed WT embryos causes a sharp and specific reduction in dFMRP 
detection by IF (Figure 2.3).  Whether due to extraction of dFMRP or structural alteration 
of its epitope, this suggests that the dFMRP-associated structures contain RNA. 
Therefore, we assessed whether dFMRP colocalized with ME31B and TRAL in fixed 
embryos by IF.  Indeed, quantification of IF images reveals a significant colocalization of 
dFMRP puncta with TRAL (42%, P = 3.9 × 10−17) and ME31B (35%, P = 2.6 × 10−10) 
puncta, particularly in the apical cytoplasm (Figure 2.4A; Table 2.1).  Because dFMRP 
has been shown to associate with dAGO2 in Drosophila S2 cells (Caudy et al. 2002; 
Ishizuka et al. 2002) and mammalian argonaute proteins associate with cytoplasmic RNP 
bodies (Jakymiw et al. 2005; Liu et al. 2005; Sen and Blau 2005), we also tested whether 
dFMRP and dAGO2 colocalize. Punctate dAGO2 localization is seen almost exclusively 
in the basal cytoplasm where moderate colocalization of dFMRP puncta is observed with 
dAGO2 (Figure 2.4A, and 16%, P = 8.8 × 10−9; Table 2.1). 
To further explore the relationship between dFMRP, TRAL, ME31B, and 
dAGO2, we separated RNP complexes from cleavage stage embryos on sucrose density 
gradients and determined the sedimentation profiles for these proteins by immunoblot 
analysis. The majority of dAGO2 cosediments with polyribosomes (Figure 2.4B). By 
contrast, all detectable dFMRP sediments near the top of the gradient and does not 
associate with polyribosomes (Figure 2.4B), which are thought to be excluded from 





Figure 2.3  dFMRP IF detection is RNase-sensitive 
Wild-type cleavage stage embryos were either not treated (Left) or treated (Right) with 
RNase A after fixation and before antibody incubation for IF. The RNase-treatment 
efficiently digested the cytoplasmic RNA (propidium iodide, PI), marginally affected 
LVA localization, and caused a significant reduction in dFMRP detection. The latter 
could result from the RNase-treatment extracting dFMRP or structurally altering the 
dFMRP epitope. In either case, these results suggest that the dFMRP-associated 
structures contain RNA.  Scale bar indicates 10 µm. 
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TRAL ME31B dAGO2 LVA LVA 
Measurement 
(apical) (apical) (basal) (apical) (basal) 
% dFMRP 




0.5 0.6 0.4 1.4 1.6 
Total no. of 





Student's t test 
score (P value) 4 × 10
-17 3 × 10-10 9 × 10-9 0.6 0.7 
Table 2.1  dFMRP significantly colocalizes with TRAL, ME31B, and dAGO2 
The percentages shown represent the number of dFMRP puncta that colocalize with 
either TRAL, ME31B, dAGO2, or LVA puncta in the apical or basal cytoplasm (as 
indicated) in original or control IF images.  See A3.2.5 for method of quantification. 
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Figure 2.4  dFMRP associates with cytoplasmic RNP bodies in cleavage stage 
embryos  
(A) IF analysis of fixed WT cleavage stage embryos shows considerable colocalization of 
dFMRP with TRAL and ME31B throughout the cytoplasm (apical cytoplasm shown) and 
partial colocalization with dAGO2 (only observed in the basal cytoplasm) in oblique 
optical sections. Arrows indicate examples of colocalization.  Scale bar indicates 10 µm. 
(B) A UV absorbance trace (A254) indicates the positions of ribosomal subunits and 
polyribosomes across fractions 1–22 from a sucrose gradient.  Immunoblots reveal the 
sedimentation profiles of proteins indicated at the left. (C and D) Immunoblots showing 
supernatant (sup) and pellet (pel) fractions from IPs performed with anti-FLAG 
(control) or anti-dFMRP antibodies (C) and BSA (control) or anti-TRAL antibody 
(D) by using WT embryo extracts. Blots were probed for the proteins indicated 






Similarly, TRAL and ME31B sediment near the top of the gradient as does dmP68, a 
DEAD-box-containing RNA helicase that associates with dFMRP and dAGO2 in 
Drosophila S2 cells (Ishizuka et al. 2002).  These results are consistent with our IF data, 
indicating that dFMRP associates with translationally quiescent cytoplasmic RNP bodies. 
Although most dFMRP, TRAL, ME31B, and dmP68 cosediment in sucrose gradients, 
anti-dFMRP antibody does not coimmunoprecipitate (co-IP) TRAL, ME31B, or dmP68 
(Figure 2.4C; dmP68 not shown), nor does anti-TRAL antibody co-IP dFMRP (Figure 
2.4D).  dAGO2 also does not co-IP with dFMRP in embryo extracts (Figure 2.4C).  
Therefore, dFMRP, TRAL, and ME31B probably exist in distinct complexes that 
associate with a common cytoplasmic structure.  
2.2.4  dFMRP/TRAL-associated cytoplasmic RNP bodies are dynamic 
If the dFMRP-associated cytoplasmic RNP bodies were metabolically active and 
associated with zygotic transcripts at the MBT, then a change in their composition and/or 
structure would be expected to occur upon disrupting the normal cytoplasmic 
accumulation of zygotic transcripts during the MBT.  To test this possibility, we used a 
well characterized conditional mutation in small bristles (sbr), which encodes the 
Drosophila mRNA nuclear export factor NXF-1, to specifically block nuclear export of 
newly synthesized transcripts at the MBT (Wilkie et al. 2001).  WT and sbrts148 embryos 
were either kept at the permissive temperature or shifted to the restrictive temperature for 
25 min during the MBT, fixed, and examined by IF.  Normal dFMRP, TRAL, and 
ME31B localization is observed in WT embryos at either temperature and in sbrts148 
embryos at the permissive temperature (Figure 2.5). By contrast, temperature shifted 
sbrts148 embryos display a rapid and dramatic change in dFMRP and TRAL localization 
(Figure 2.4).  Both proteins colocalize to large polymorphic structures (average 
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diameter= 2.8 μm) in the apical cytoplasm, which likely reflect the spatial coalescence of 
RNA processing intermediates containing dFMRP and TRAL. ME31B localization is 
unaffected in temperature-shifted sbrts148 embryos (data not shown), indicating that the 
effect on dFMRP and TRAL is specific. 
  
 
Figure 2.5  dFMRP/TRAL cytoplasmic RNP bodies are dramatically affected by 
disrupting the MBT 
IF analysis of cleavage stage WT or sbrts148 embryos fixed at 32°C or 20°C (indicated at 
left) shows dFMRP and TRAL localization in sagittal and surface views (indicated at 
right). The WT and sbrts148 embryos were shifted to 32°C at 5 and 15 min into nuclear 
cycle 14, respectively. Arrows indicate colocalization.  Arrowheads indicate the furrow 
front.  Scale bar indicates 10 µm. 
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2.2.5  dFMRP associates with endogenous tral mRNA and is required for TRAL 
expression and localization 
We next evaluated whether dFMRP is required for TRAL and ME31B expression 
in cleavage stage embryos. Because dFMRP binds futsch mRNA and suppresses its 
translation in Drosophila neurons (Zhang et al. 2001), we tested futsch expression in 
cleavage stage embryos as a control.  As expected, quantitative reverse transcription PCR 
(qRT-PCR) showed comparable futsch mRNA levels between dfmr1- and WT embryos 
(Figure 2.6C), whereas quantification of Futsch protein revealed a 70% increase in fixed 
dfmr1- embryos over controls by IF (Figure 2.6A).  Interestingly, in dfmr1- embryos 
TRAL localizes to numerous abnormal punctate structures in the apical cytoplasm 
(Figure 2.6B, 3.5 puncta per 10 μm2).  Although these structures are spherical and smaller 
(average diameter = 1.8 μm) than the polymorphic structures observed in sbrts148 mutants, 
they localize to the apical cytoplasm and lack detectable ME31B, as in sbrts148 embryos 
(data not shown).  They are also observed before the MBT, but they are fewer in number 
(1.7 puncta per 10 μm2), smaller (average diameter = 1.1 μm), and have no apparent 
phenotypic effect.  Quantitative immunoblots show TRAL protein levels are reduced 2-
fold in whole cleavage stage embryo extracts, whereas again ME31B is unaffected 
(Figure 2.6C).  Paradoxically, instead of a decrease, we observe a significant increase in 
tral mRNA levels by quantitative PCR in dfmr1- embryos (Figure 2.6D). me31b mRNA 
levels are not significantly affected (Figure 2.6D).  To test whether dFMRP associates 
with endogenous tral mRNA, we performed qRT-PCR on mRNA IPd from WT and 
dfmr1- embryo extracts using an anti-dFMRP antibody.  Background levels of RpL32 
mRNA served as a control (Figure 2.6E).  A nearly 10-fold enrichment of tral mRNA is 
observed in WT IPs over the background levels observed in dfmr1- IPs (Figure 2.6E).  
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These results suggest that in cleavage stage embryos dFMRP associates with a tral mRNP 
complex and possibly controls its competency and/or accessibility for translation. 
To address whether the misexpression of TRAL might contribute to the furrow 
formation phenotype observed in dfmr1- embryos, we examined live tral mutant embryos 
undergoing cleavage furrow formation.  Embryos laid by tral2/tral3, tral2/+, fmr13/+, 
tral2/fmr13, and Df(3L)iro-2/+ females crossed to WT males were examined and will be 
referred to using the female genotype for simplicity. The tral2 and fmr13 are protein null 
alleles, tral3 is a hypomorph, and Df(3L)iro-2 removes the tral gene (tral alleles 
described in (Wilhelm et al. 2005).  All tral2/tral3 embryos have a severe cleavage furrow 
formation phenotype that resembles the strong dfmr1- phenotype, and both tral2/+ and 
Df(3L)iro-2/+ embryos have a moderate phenotype resembling the phenotype seen in 
most dfmr1- embryos (Figure 2.6; Figure 2.1; Df(3L)iro-2 data not shown). Although 
fmr13/+ embryos furrow normally, the absence of a single copy of dfmr1 in tral2/fmr13 
embryos mildly enhances the tral2/+ phenotype (Figure 2.6).  Together these 
observations suggest that dFMRP is required for the normal expression of TRAL and that 
the misexpression of TRAL likely at least partially contributes to the dfmr1- cleavage 




Figure 2.6  tral mRNA is a target of dFMRP regulation  
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Figure 2.6 on previous page. 
(A and B) IF analysis of fixed WT and fmr1 cleavage stage embryos show Futsch, Lava 
Lamp (LVA), F-actin, TRAL, and dFMRP localization.  Quantified fluorescence signal 
intensity (level in fmr1  / level in WT) is indicated in A Lower Right.  (B) Sagittal (Top) 
and surface (Middle) optical sections show abnormal TRAL structures in the apical 
cytoplasm of fmr1-  embryos.  Scale bar indicates 10 µm.  (C) Quantitative immunoblots 
show levels of the proteins indicated to the left in WT and fmr1-  cleavage stage embryo 
extracts.  Each signal was independently normalized to an internal loading control 
Myosin II (MYOII).  The ratios of normalized signal intensities (fmr1- / WT) are shown 
to the right (dAGO2 ratio 0.85, data not shown).  (D) Quantification of futsch, tral, and 
me31B mRNA levels in cleavage stage WT and fmr1- embryos by qRT-PCR shows a 
2.7-fold increase in tral mRNA in fmr- embryos.  futsch and me31B mRNA levels show 
no significant difference.  (E) qRT-PCR of RpL32 and tral mRNA in anti-dFMRP 
immunoprecipitates from cleavage stage WT and fmr1- embryo extracts.  Significance 
was assessed by using the Student’s t test (**, P   0.005); P   0.003 in d; and P  0.001 in 





Figure 2.7 Maternal expression of tral is required for cellularization 
(A) Sequential frames from representative DIC movies of embryos undergoing normal 
(WT and fmr13/TM6B) or disrupted (tral2/tral3, tral2/TM6B, and fmr13/tral2) furrow 
formation at 25°C.  Arrowheads and brackets indicate the furrow front position and 
nuclear elongation, respectively. Times (t) in minutes are relative to nuclear cycle 14 
onset.  Scale bar indicates 10 µm.   (B)  Shown are the average rates of furrow ingression 
of embryos derived from WT,  fmr13/TM6B, tral2/TM6B,  fmr13/tral2, and tral2/tral3 






2.3  DISCUSSION 
In this study, we demonstrate that maternal dFMRP activity is required for 
Drosophila cleavage furrow formation and functions within dynamic cytoplasmic RNP 
bodies at the MBT.  Our data suggest that in cleavage stage Drosophila embryos, dFMRP 
affects translational initiation of specific mRNAs within cytoplasmic RNP bodies by 
controlling their availability and/or modulating their competency to be translated. 
dFMRP does not measurably associate with polyribosomes under a wide range of 
conditions in cleavage stage Drosophila extracts (Figure 2.4B), similar to results obtained 
for Drosophila S2 cells (Ishizuka et al. 2002), but in contrast to reports in other systems 
(Zalfa et al. 2006).  Whether the cytoplasmic RNP bodies that dFMRP associates with are 
similar to P bodies or stress bodies or possibly a hybrid of the two is unknown and should 
be addressed in future studies.  Instead, we observe dFMRP colocalize and cosediment 
with TRAL and ME31B, known components of translationally quiescent cytoplasmic 
RNP bodies (Nakamura et al. 2001; Wilhelm et al. 2005). Although dAGO2 cosediments 
with polyribosomes in cleavage stage embryo extracts and could directly suppress 
translational elongation or termination, a similar role for dFMRP is unlikely.  In fact, 
there is no indication that endogenous dFMRP directly interacts with dAGO2 in cleavage 
stage Drosophila embryos, in contrast to their observed association in Drosophila S2 cell 
extracts (Caudy et al. 2002; Ishizuka et al. 2002). This discrepancy could result from a 
fundamental difference in RNA metabolism between S2 cells and cleavage stage 
embryos undergoing the MBT. 
tral mRNA represents a previously undescribed in vivo target of dFMRP 
regulation. Although there is no direct evidence that dFMRP and TRAL form a stable 
complex in cleavage stage embryos, dFMRP activity is clearly required for normal TRAL 
protein expression in vivo. Mislocalization of TRAL but not ME31B in both dfmr1- and 
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sbrts148 embryos suggests that a specific functional relationship exists between dFMRP 
and TRAL.  In dfmr1- embryos, TRAL protein levels also are reduced 2-fold (Figure 
2.6C), indicating that TRAL does not simply get redistributed into abnormal structures, 
its rate of synthesis and/or degradation must also be affected. The co-IP of tral mRNA 
with dFMRP from WT embryo extracts demonstrates that dFMRP and tral mRNA form a 
stable RNP complex and suggests that dFMRP is involved in tral mRNA metabolism. 
Although we have not yet determined whether dFMRP directly binds tral mRNA, our 
analysis of the tral mRNA sequence, by using the algorithm RNABOB 
(www.genetics.wustl.edu/eddy/software) and search parameter guidelines described in 
Darnell et al. 2001 identified a single G-quartet stem-loop structure within the tral 3′ 
UTR, a motif that FMRP can bind with high affinity (Brown et al. 2001; Darnell et al. 
2001).  Regardless of whether dFMRP binds tral mRNA directly, dFMRP could control 
the assembly of a translationally competent tral mRNP complex and/or its localized 
delivery for translation.  The transient association of tral mRNA with cytoplasmic RNP 
bodies in a translationally quiescent state might be required for dFMRP to promote the 
assembly of a translationally competent tral mRNP. Alternatively, the restricted 
translation of tral mRNA, controlled by dFMRP-dependent localized release from 
cytoplasmic RNP bodies, might promote the normal assembly of a functional TRAL RNP 
complex. In either case, lower steady-state TRAL protein levels resulting from decreased 
synthesis and/or increased degradation in dfmr1- embryos could be related to abnormal 
TRAL RNP complex assembly, observed as large structures by IF. Interestingly, the 
higher steady-state level of tral mRNA observed in dfmr1- embryo extracts is reminiscent 
of the increased levels of another dFMRP target, pickpocket mRNA, observed in dfmr1- 
embryo extracts and may reflect a common feature of dFMRP mRNA processing (Xu et 
al. 2004). 
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In conclusion, we believe that a system of cytoplasmic RNP bodies exists in 
cleavage stage embryos that associates with maternal and zygotic mRNAs to mediate 
their degradation or processing for subsequent release for translation during the MBT.  It 
is likely that the cleavage furrow formation defect observed in dfmr1- mutants is at least 
in part the result of disrupting TRAL function.  Indeed, we have shown that tral- embryos 
have a cleavage furrow formation phenotype that resembles that of dfmr1- embryos. 
TRAL has also been shown to associate with specific mRNAs at endoplasmic reticulum 
(ER) exit sites and is required for proper ER morphology and secretion during oogenesis 
(Wilhelm et al. 2005).  Furthermore, depletion of the C. elegans homolog car-1 causes 
defects in ER morphology as well as a defects in cleavage furrow formation during 
embryogenesis (Audhya et al. 2005).  tral may represent a link between mRNA 
metabolism and the secretory pathway in cleavage stage embryos.  Exploring the 
relationship between dFMRP and tral mRNA will be important for a better understanding 
of the function of FMRP in other systems as well as the process of cleavage furrow 
formation.  However, as with FXS, it is likely that the altered expression of many targets 
is responsible for the full dfmr1- cleavage furrow formation phenotype. 
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Chapter 3:  Identification of new targets of dFMRP translational 
regulation  
The following manuscript describing the work in this chapter is in preparation: 
Monzo K, Dowd SR, Minden JS, and Sisson JC.  The chaperonin containing TCP-1 
 (CCT) complex is a target of Fragile X mental retardation protein-dependent 
 regulation in Drosophila cleavage stage embryos. 
 
 
3.1  INTRODUCTION 
We have previously demonstrated that dFMRP is required in early embryos for 
cleavage furrow formation during the midblastula transition (MBT).  In an effort to 
identify new effectors of cleavage furrow formation and new targets of dFMRP-
dependent regulation, we used two-dimensional difference gel electrophoresis (2D DIGE) 
combined with mass spectrometry to identify proteins that are misexpressed in dfmr1- 
embryos compared to stage-matched control embryos.  Twenty-eight proteins were 
identified whose expression differs between control and dfmr1- cleavage stage embryos, 
and these proteins represent potential direct and indirect targets of dFMRP-dependent 
translational regulation.  Of these candidates, three subunits of the chaperonin containing 
TCP-1 (CCT) show altered expression and the corresponding mRNAs specifically co-
immunoprecipitate with dFMRP, suggesting that they are direct targets of dFMRP-
dependent translational regulation.  In addition, biochemical analysis reveals that the 
assembly of the CCT holocomplex is disrupted in dfmr1- embryo extracts.  Genetic 
interaction tests between cct and dfmr1 mutants strongly suggest that disrupted CCT 
function is relevant to the dfmr1- furrow formation phenotypes.  Furthermore, we have 
found that the septin Peanut, a substrate of yeast CCT and a protein required for 
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cytokinesis, is mislocalized in both cct and in dfmr1 mutant embryos, which may 
contribute to the dfmr1- cleavage furrow formation defects.  Based on these results we 
propose that dFMRP-dependent translational regulation of specific CCT subunits is 
required for normal CCT holocomplex activity during the MBT and that at least one of its 
substrates required for cytokinesis is affected in dfmr1- embryos suggesting it may 
contribute to the dfmr1- cleavage furrow formation defect.  Additional characterization of 
these candidate targets should provide insight into the mechanism of dFMRP-dependent 
regulation of cellular morphogenesis in early embryos and the etiology of FXS. 
 
3.2  RESULTS 
3.2.1  Comparative proteomic analysis of WT and dfmr1- cleavage stage embryos 
The goal of this study was to identify direct and indirect targets of dFMRP-
dependent translational regulation that contribute to the morphogenesis defects observed 
during cleavage furrow formation in Drosophila embryos derived from 
fmr13/Df(3R)Exel6265 females (after this referred to as dfmr1- embryos) (Monzo et al. 
2006).  To identify proteins that are differentially expressed in dfmr1- compared to wild 
type cleavage stage embryos, a proteomic screen using 2D differential gel electrophoresis 
followed by mass spectrometry (2D DIGE/MS) (Viswanathan et al. 2006) was performed 
(Figure 3.1A), an approach that has been previously taken to identify dFMRP targets in 
fly brain and testis (Zhang et al. 2004; Zhang et al. 2005).  This screen was a 
collaboration with Dr. Jonathan Minden.  I performed the 2D DIGE/MS experiments in 
his laboratory at Carnegie Mellon University with assistance from Dr. Susan Dowd and 




Figure 3.1  Comparative proteomic analysis of control and dfmr1- cleavage stage 
embryos. 
(A)  Schematic showing general procedure for 2D DIGE analysis.  Differential 
interference contrast (DIC) images of control and dfmr1- embryos show the 
morphological stage of sorted embryos.  (B)  A master gel is pseudocolored with control 
extracts labeled with CY3 (red) and dfmr1- extracts labeled with CY5 (green).  The 
approximate isoelectric point (pI) is indicated at the top of the gel and the approximate 
molecular weight (MW) is indicated to the left.  Difference spots are indicated with white 
arrow and numbered.  The labeled difference spots were observed in at least four gel 
replicates.  (C)  High magnification examples of difference spots are shown with red 
arrows, and corresponding spot number in (C) is indicated to left.  (D)  The 28 difference 
proteins identified by mass spectrometry are categorized by proposed gene ontology. 
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cleavage stage embryo lysates representing a small fraction of total protein spots 
observed in our gel conditions (Figure 3.1B).  Twenty-eight proteins were identified by 
Maldi-TOF mass spectrometry with fold changes in abundance ranging from 1.3 to 56.7 
(Table 3.1).  The majority of proteins (13/28) increase in abundance in the mutant lysates, 
five decrease in abundance, and four shift in pI and/or molecular weight.  The 28 proteins 
can be classified into five general gene ontology categories based on reported function: 
metabolism, protein stability, translation, cytoskeleton and membrane trafficking, and 
unknown (Figure 3.1D). 
3.2.2  Secondary analysis of candidate targets to identify direct targets 
The 28 proteins identified that reveal a difference in expression by 2D DIGE/MS 
represent potential direct or indirect targets of dFMRP-dependent translational regulation.  
To classify the candidate targets, a secondary screen was performed to identify the 
proteins whose mRNAs specifically associate with dFMRP and could be considered 
direct targets of dFMRP regulation.  The amount of mRNA corresponding to the 
difference proteins in dFMRP immunoprecipitations (IPs) from WT and dfmr1- 
cellularizing embryo extracts was quantified and normalized to the amount of a standard 
control mRNA (RpL32) (Figure 3.2).  An enrichment of at least two-fold of the mRNA in 
WT compared to dfmr1- IPs was considered significant and likely suggests that the 
mRNA is associated with a dFMRP complex and subject to direct translational regulation 
by dFMRP.  The fold enrichment of a previously described target, trailer hitch (tral), was 
measured as a positive control (Monzo et al. 2006).  In these experiments tral mRNA 
was found to be enriched 3.5 fold in WT IPs (Figure 3.2).  The mRNAs for five 
candidates were found to be at least two-fold enriched: CG5525, Cctγ, Tcp-1η, β’cop, 
and Aats-gly.  The mRNA sequence of all the potential candidates was analyzed using the  
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Change of protein 
levels in dfmr1- 
21 CG8351 Tcp-1η          Cct7 
Chaperonin-containing 
T-complex protein 60.0 6.0 127 31 12 increase +1.38 
39 CG4463 Hsp23 
Heat shock protein 
chaperone/actin 
binding 
20.7 5.6 66 33 6 increase +3.71 
35 CG4904 Pros35 Proteasome core complex 31.0 6.1 158 60 12 increase +1.39 
31 CG18174 Rpn11 Proteosome regulatory particle 26.2 6.77 63 20 4 increase +1.51 
12 CG6699 β'Cop 
COP I vesicle 
coat/protein 
transporter activity 
102.7 5.1 153 30 17 increase +4.87 
19 CG8308 α-Tub67C  
α-Tubulin/Maternal 
and CNS specific 51.9 5.1 101 32 10 increase +4.81 
37 CG7823 RhoGDI  Rho GDP-dissociation inhibitor activity 23.2 5.4 65 32 5 increase NR 
27 CG3612 blw ATP-synthase subunit alpha 59.6 9.1 112 28 11 increase +13.7 
40 CG1633  Jafrac1 Thioredoxin peroxidase activity 21.9 5.5 81 39 6 increase +2.13 
29 CG2985  Yp1 Yolk protein 48.7 7.2 90 25 6 increase +56.7 
32 CG8327  SpdS Spermidine synthase activity 32.7 5.5 128 41 8 increase +1.41 
45 CG17820  fit unknown 14.0 7.1 61 36 5 increase +4.11 
18 CG11596  unknown 51.3 5.1 133 37 12 increase +2.83 
26 CG5525  Tcp-1δ          Cct4 
Chaperonin-containing 
T-complex protein 57.8 7.5 70 21 7 decrease -2.55 





54.9 8.8 70 20 7 decrease -3.03 
17 CG6186  Tsf1 Iron ion transporter activity 72.9 6.7 158 29 12 decrease -1.40 
43 CG11793 Sod Superoxide dismutase activity 15.2 5.7 96 57 6 decrease -1.45 
38 CG4381 GstD3 Glutathione S transferase activity 22.9 5.3 68 39 4 decrease -1.26 
7, 8 CG6603 Hsc70Cb Molecular chaperone 89.0 5.31 209 33 17 shift left NR 
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42, 




17.4 6.74 149 60 9 shift left +1.6/-1.34 
15, 
16 CG6778  Aat-gly 
Glycyl-tRNA 
synthetase 76.6 6.0 82 15 7 shift left 
+1.88/-
17.7 




139.6 6.15 222 31 22 shift left +2.32/-1.22 
22, 
23 CG8977
  Tcp-1γ          Cct3 
Chaperonin-containing 
T-complex protein 58.5 6.38 173 41 17 shift right NR 
24, 
25 CG3590   
Adenylosuccinate 




11 CG12005 Mms19 
nucleic acid binding, 
transcription cofactor 
activity 
107.5 5.58 89 16 10 shift right -5.77/+2.32 
36 CG7490  RpLp0 Ribosomal protein 34.3 6.5 79 33 7 shift up NR 
34 CG5269  vib Phosphatidylinositol transfer activity 32.7 5.49 115 36 6 
shift 
down NR 










Table 3.1  Identified difference proteins 
Table begins on previous page. 
Flybase, www.flybase.org 
Mascot score >59 considered significant (Perkins et al. 1999) 
% Seq. cov., percent sequence coverage 





Figure 3.2   Immunoprecipitation of candidate target mRNAs with dFMRP. 
(A)  Immnuoblots showing input and supernatant (S) and pellet (P) fractions of IPs 
performed using an anti-dFMRP antibody with WT and dfmr1- extracts probed with 
dFMRP and Tubulin antibodies.  Although no Tubulin co-IPd with dFMRP, IgG heavy 
chain (HC) was present in equal volumes in the P fraction of each IP as indicated with 
asterisks.  (B)  RNA was extracted from P fractions shown in (A) and subjected to qRT-
PCR.  Histogram shows the fold enrichment of each mRNA in WT vs. dfmr1- IPs 
normalized to RpL32.  tral mRNA is a know target of dFMRP and its enrichment was 
tested as a positive control in these experiments.  Error bars indicate standard deviations 
(SD).  Significance was assessed using the Student’s t test (*, P≤0.05 and **, P≤0.005).  






algorithm RNABOB (www.genetics.wustl.edu/eddy/software) for G-quartet motifs, a 
known dMFRP binding motif.  This analysis revealed putative G-quartets in the coding 
sequence of CG5525, Cctγ, Tcp-1η, and β’cop mRNAs, however we have not tested if 
these sequences contribute to their association with dFMRP. Together, these observations 
suggest that CG5525, Cctγ, Tcp-1η, β’cop, and Aats-gly are potential direct targets of 
dFMRP regulation. 
3.2.3  Three subunits of the CCT complex are misregulated in dfmr1- embryos 
Protein sequence analysis showed that CG5525, Cctγ, Tcp-1η encode three of the 
eight subunits of the Chaperonin Containing TCP-1 (CCT) complex (also referred to as 
TCP-1 or TCP-1 Ring Complex (TRiC)).  The genes encoding the other five subunits 
were also identified within the Drosophila genome based on protein sequence homology 
(Figure 3.4).  I will refer to the complex as CCT and the independent eight subunits as 
CCT1-8 for simplicity.  CCT is a group II chaperonin that assists in the folding or in the 
assembly of protein substrates in an ATP-dependent manner (Liou and Willison 1997).  
The CCT holocomplex is composed of two rings containing eight distinct subunits 
(Figure 3.3).  Each subunit is expressed stoichiometrically from an individual gene.  The 
eight different cct genes encode conserved regions and a variable region, termed the 
apical domain, which confers substrate specificity (Liou and Willison 1997).  Although 
CCT was initially thought to exclusively fold actin and tubulin, between 2-7% of 
cytosolic proteins have been recently identified to interact with CCT in yeast and 
mammalian cells (Dekker et al. 2008; Yam et al. 2008).  Most of these newly identified 
CCT substrates are functionally and structurally diverse and cannot be easily predicted 
based on function or sequence alone.  All eight of the cct genes are essential for 
eukaryotic cell viability, and it has been shown that temperature sensitive (ts) alleles of 
cct4 in budding yeast cause cytokinesis defects, a cellular process analogous to 
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Drosophila cellularization (Dekker et al. 2008).  A comprehensive comparison of the D. 
melanogaster CCT protein sequences with those of S.cerevisiae and H. sapiens reveals a 
high degree of conservation for each (Figure 3.4), suggesting conserved functionality.  
Interestingly, the D. melanogaster cct sequences are more conserved with the cct 
sequences of H. sapiens than S.cerevisiae (Figure 3.4).  Although CCT protein levels for 
all eight subunits were not assessed by immunoblot analysis due to availability of 
antibodies, we tested for the association of dFMRP with the mRNAs for five subunits not 
identified in the screen (cct1, 2, 5, 6 and 8) and found that they do not associate with 
dFMRP during the cleavage stage (Figure 3.2).  Because three subunits (CCT3, CCT4, 
and CCT7) of this complex are misexpressed in dfmr1- mutant embryos, we chose to 







Figure 3.3  The CCT complex and known substrates. 
Shown is a cartoon of the general double barrel structure of the CCT complex along with 
a subset of the known classes of substrates.  Lower cartoon shows one orientation for 







Figure 3.4  CCT subunits in Drosophila melanogaster. 
(A)  Table shows known genetic and molecular information for each of the eight CCT 
subunits in fly.  Percentages of identity and similarity in protein sequence for each of the 
subunits was compared between fly and budding yeast and fly and human.  The protein 
difference detected in dfmr1- embryos the 2D DIGE gels is indicated for those proteins 
identified in the screen.  (B)  A Clustal-W alignment of the protein sequences of the fly 




3.2.4  CCT is required for proper cleavage furrow formation 
In order to assess the requirement for CCT during fly development, cleavage 
furrow formation was examined in embryos laid by females lacking a single copy of one 
or three different cct genes.  While all WT embryos complete furrow formation in about 
55 minutes, half of the embryos examined from females lacking a copy of cct1, cct4, and 
cct6 display a delay in furrowing rate (Figure 3.5A) similar to what is observed in the 
majority of dfmr1- embryos (Figure 2.1).  One embryo displayed moderate disruptions in 
nuclear morphology although furrowing rates appeared normal.  Furrowing proceeded 
normally in embryos derived from heterozygous females of cct1, cct3, cct4, cct6, cct7, 
and cct8 (data not shown).  Significantly, when a single copy of cct4 is removed in a 
dfmr1- background, the percentage of embryos displaying severe disruptions in furrow 
formation is enhanced from 25% (dfmr1-) to 75% (cct4-/+, dfmr1-/-) (Figure 3.5B).  This 
is the expectation if the decrease in CCT4 levels are relevant to the dfmr1- phenotype.  A 
similar effect was observed in cct6-/+, dfmr1-/- (Figure 3.5B).  This interaction appears 
to be specific as removing a copy of a general translational regulator, ribosomal protein 
gene (RpS13), or a known effector of cleavage furrow formation, the scraps gene, which 
encodes Anillin, does not enhance the dfmr1- severe furrow formation phenotype (Figure 
3.5B).  Together, these observations suggest that the misregulation of CCT in dfmr1- 




Figure 3.5  CCT is required for proper cleavage furrow formation and loss of cct 
enhances dfmr1- phenotype. 
(A)  Frames from representative DIC movies of WT and cct- cleavage stage embryos.   
Time (t) is in minutes from the start of interphase of nuclear cycle 14.  Percentage and 
number of embryos examined (n) with shown phenotype is indicated at top.  Arrowheads 
and brackets indicate the furrow front position and nuclear elongation, respectively.  
Scale bar indicates 10 µm.  (B)  Bar graph shows percentage of embryos with severe 
cleavage furrow phenotype.  Genotypes are indicated at the bottom with the total  number 
of embryos observed (n).  The inset is a representative DIC image of an embryo with a 







3.2.5  CCT holocomplex assembly is disrupted in dfmr1- embryos 
Based on the initial observation that dFMRP is required for the proper expression 
of CCT subunits and that CCT is required for proper cleavage furrow formation, I 
expected that CCT function is compromised in dfmr1- embryos.  To test if the CCT 
holocomplex is disrupted in dfmr1- cleavage stage embryos, embryonic extracts were 
separated by gel filtration chromatography and immunoblot analysis.  The CCT1 
antibody used in this study was generated against a rat CCT1 peptide and detects a single 
band with a molecular weight of the predicted size of approximately 60 kDa in cleavage 
stage embryo extracts (Figure 3.6A).  The abundance of CCT1 is not affected in dfmr1- 
embryos, as quantified in 1D SDS-PAGE gels (Figure 3.6A).  The majority of CCT1 in 
WT and dfmr1- extracts fractionates near 660kDa (fraction 11/20, Figure 3.6B).  
Interestingly, about 40% of CCT1 in dfmr1- extracts fractionates near 60kDa (Figure 
3.6B).  This fractionation profile was observed in 3 of 5 experiments.  Consistent with 
these results, it was previously shown that reduction of a single CCT subunit by siRNA in 
mouse fibroblasts disrupts assembly of the other CCT subunits into the holocomplex 
(Grantham et al. 2006).  These observations suggest that in WT cleavage stage embryos 
the vast majority of CCT1 is incorporated into a large holocomplex, and in dfmr1- 
embryos the assembly of CCT holocomplex is at least partially disrupted with some 
CCT1 left in monomeric or unassembled form.   
To further characterize the nature of the disruption of the CCT complex in dfmr1- 
embryos, cleavage stage dfmr1- embryos were fixed and stained to assess subcellular 
localization of the CCT complex.  In WT embryos CCT, as detected with the antibody 
against CCT1, is seen in a diffuse punctate pattern throughout the cytoplasm and to a 
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somewhat lesser extent in the nuclei (Figure 3.6C).  This general pattern is very similar in 
dfmr1- embryos except that larger ectopic puncta of CCT are observed in the apical 
cytoplasm (Figure 3C).  These ectopic puncta are never observed in WT and may 
represent CCT1 that is not assembled into CCT holocomplex, consistent with the 
fractionation profile of CCT1 in dfmr1- embryos.  Although much smaller, the ectopic 
CCT apical puncta are reminiscent of how the previously described target, TRAL, is 
misexpressed in large aggregates in the apical cytoplasm in dfmr1- embryos.  Double 
immunofluorescence of TRAL and CCT1 reveal that the two proteins are mislocalized to 
different compartments in the apical cytoplasm of dfmr1- embryos (data not shown).  
Together the results of the CCT fractionation and fixed analysis of dfmr1- embryos 
suggest that CCT holocomplex does not assemble properly in dfmr1- due to a 
misregulation of individual subunit stoichiometry which may lead to reduced or abnormal 
CCT function. 
3.2.6  The septin Peanut is mislocalized in cct- and dfmr1- cleavage stage embryos 
As previously mentioned, CCT substrates are functionally diverse.  Recently, the septins 
and septin effectors were identified as a new class of physiologically relevant substrates 
in yeast by virtue of their physical association and genetic interaction with CCT and cct 
genes (Dekker et al. 2008).  Conditional alleles of cct genes cause ectopic localization of 
the septin Cdc3p and have low penetrance cytokinesis defects (Dekker et al. 2008).  In 
addition, CCT loss of function in yeast does not affect de novo septin polypeptide 
folding, and it appears to be involved in regulating the assembly of septin filaments 
(Dekker et al. 2008).  To test if the septins are conserved substrates of CCT in the fly, 
Septin localization was assessed in cleavage stage embryos from females lacking a copy 
of cct1, cct4, and cct6 (cct-).  In fixed WT embryos, the septin PNUT tightly localizes to 
the leading edge of the furrow front along with F-actin.  In fixed cct loss of function 
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embryos, the majority of PNUT localizes to the furrow front as it does in WT, in addition 
to ectopic accumulation along the lateral membranes (Figure 3.7A).  This ectopic 
accumulation is reminiscent of what is observed in yeast cct4 ts mutants.  In WT budding 
yeast cells undergoing division septins tightly localize to the neck between the mother 
and bud.  In cct4 ts mutants expressing a Cdc3p-GFP at the restrictive temperature, the 
GFP is seen as the neck as well at other parts of the plasma membrane (Dekker et al. 
2008).  PNUT localization was also assessed in dfmr1- embryos.  Again, PNUT was seen 
localized to the furrow front as in WT embryos but also ectopically localized along the 
lateral membranes to an even greater extent than what was observed in cct- embryos 
(Figure 3.7B).  Importantly, F-actin and other F-actin binding proteins, such as Anillin 
and Myosin II, that normally localize to the furrow front are not affected in these mutants 
(Figures 2.6A, 3.6A and B and data not shown), suggesting that the effect on PNUT 
localization is specific and is not a secondary effect from a general disorganization of the 
cortical membrane.  Finally, to further investigate the possibility that PNUT is a bona fide 
substrate of CCT in flies, IPs were performed to test if CCT and PNUT physically 
associate.  A small amount of CCT1 specifically co-IPs with PNUT in WT cleavage stage 
embryos, consistent with PNUT being a substrate of CCT (Figure 3.7C).  This interaction 
appears to be slightly disrupted in dfmr1- embryos as the amount of CCT that co-IPs with 
PNUT is slightly decreased (Figure 3.7C).  Together, these observations suggest that 
septins are a likely conserved substrate of CCT in flies and that the ectopic localization of 
PNUT in dfmr1- embryos is due to the misregulation of CCT and may at least partially 




Figure 3.6  CCT holocomplex assembly is disrupted in dfmr1- embryos. 
(A)  Quantitative immunoblot (IB) of WT and dfmr1- cleavage stage embryo extracts 
probed with antibodies against CCT1, dFMRP, and Myosin II (MYOII, loading control) 
indicated to right.  MW in kDa is indicated to the left.  (B)  IB of fractions collected from 
1.3 mg of WT and dfmr1- cleavage stage embryo extracts separated using a Superose 6 
column and probed with anti-CCT1 antibody.  10mg of protein loaded onto column is 
indicated at far left of blots.  660kDa complex was present in fraction 11 of 20.  Cartoon 
representation of possible state of CCT complex formation indicated below blots.  (C)  
Immunofluorescence analysis of fixed cleavage stage WT and dfmr1- embryos shows 
CCT1 localization in surface (top) and sagittal (bottom) views.  Arrows indicate 









Figure 3.7  PNUT localization is dependent on CCT and is a likely substrate of CCT 
(A)  IF analysis of fixed cleavage stage WT and cct- embryos shows PNUT and F-actin 
(Phalloidin) localization.  (B)  IF analysis of fixed WT and dfmr1- embryos shows PNUT 
and Anillin localization.  Arrow heads indicate normal localization of PNUT and Anillin 
to furrow fronts, and arrows indicate abnormal accumulation of PNUT along lateral 
membrane.  Scale bar indicates 10 µm.  (C)  Immunoblots showing PNUT IPs from WT 
and dfmr1- extracts.  5 µg starting extract was loaded in input lanes (2% of total input).  
10 µg of supernatants (S) and 50% of pellet (P) from mock and anti-PNUT IPs was 




3.3  DISCUSSION 
Here, a comparative proteomic approach was used to identify new targets of 
dFMRP-dependent regulation.  Twenty-eight proteins showed differences in abundance 
between WT and dfmr1- embryos, representing potential direct and indirect targets of 
dFMRP.  The majority of the identified proteins function in metabolic pathways, some of 
which have previously been implicated in FMRP regulation.  Many of the identified 
proteins are also involved in regulating the actin and MT cytoskeletons and membrane 
trafficking, and the majority of the genes known to be required for proper furrow 
formation are involved in regulating these pathways (see sections 1.2.3 and 1.2.4).  Other 
interesting classes of identified proteins have roles in translational regulation and protein 
stability.  Identification of these classes of targets suggests a tiered or hierarchical mode 
of regulation by FMRP, whereby modulation of expression of one of these targets affects 
the expression of an additional class of targets.  Consistent with this, we have previously 
shown that dFMRP regulates the expression of a known translational regulator, tral, 
whose targets are at this point unknown (Monzo et al. 2006).  We chose to follow-up on 
the misregulation of the chaperonin CCT in dfmr1- cleavage stage embryos because three 
of the eight CCT subunits are misregulated, suggesting significant regulation of this 
complex is potentially relevant during the cleavage stage.  The identification of the CCT 
complex as a target of dFMRP regulation is also consistent with a hierarchal mode of 
regulation by dFMRP as CCT has a complex set of substrates itself.   
3.3.1  dFMRP and classes of targets  
The majority of targets identified in this screen are generally involved in 
metabolism, which could be a result of an inherent property of this type of analysis.  
Many of the proteins that can be easily and reproducibly identified using 2D DIGE/MS 
are present at relatively high abundance and include many metabolic proteins.  Such 
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targets are still potentially relevant based on observations made in other studies.  Three 
targets identified in this screen were also identified in 2D DIGE screens performed using 
Drosophila testis or heads (Table 1).  One of these proteins, Jafrac1 or Thioredoxin, is 
involved in oxidative stress response, and it has been observed that FMR1 mutant mice 
are sensitive to oxidative stress suggesting that the stress response is perturbed in the 
mutants (El Bekay et al. 2007).  Two other proteins with known or predicated roles in 
oxidative stress response, Superoxide dismutase (SOD) and the protein encoded by 
CG6045, were found to be misregulated in dfmr1- embryos in this screen, suggesting that 
modulation of the oxidative stress response pathways may be regulated at least in part by 
FMRP.  Furthermore, SOD1 was previously identified as a target of FMRP in mouse 
neurons (Miyashiro et al. 2003).  The identification of these targets is consistent with 
reported observations of known FMRP targets. 
About 18% of the identified targets are involved in regulation of the actin and MT 
cytoskeletons and membrane trafficking, pathways that are known to be important for 
cleavage furrow formation and neuron morphology.  β’cop represents a potentially 
interesting target of dFMRP.  β’COP is a subunit of the COPI coat which is required for 
forming vesicles that are destined for retrograde trafficking from the Golgi to the 
endoplasmic reticulum (Girod et al. 1999).  The amount of plasma membrane required to 
form the thousands of cells during cleavage furrow formation is dependent on a huge 
increase in surface area, and it has been demonstrated that internal stores of Golgi-
derived membrane contribute to the formation of these furrows (Sisson et al. 2000).  
Proper trafficking between the various endomembrane compartments is crucial for proper 
furrow formation, and this trafficking also seems to be important in the maintenance of 
neuronal morphology and function (Kennedy and Ehlers 2006).  An effector of COPI 
vesicle formation, the GTPase activating protein Arf1 GAP, is essential for dendritic 
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growth and outbranching (Moore et al. 2007).  FMRP is also involved in dendritic growth 
and branching, suggesting a possible connection between the two pathways.  Validation 
and further characterization of β’cop as a target of dFMRP could be important for 
understanding how FMRP affects membrane trafficking. 
Aats-gly, also known as glycyl-tRNA synthetase (gars), was also identified as a 
target of dFMRP regulation.  In the screen, Aats-gly was identified as a protein that shifts 
in pI in dfmr1- embryos, and overall protein abundance decreases in the mutant.  We also 
showed that the Aats-gly mRNA likely associates with a dFMRP complex, suggesting it 
is a direct target of dFMRP.  Glycyl-tRNA synthetase is important for catalyzing tRNA 
aminoacylation, a critical step in protein translation.  Aats-gly is the ortholog of the 
human GARS gene that is associated with Charcot-Marie-Tooth neuropathy type 2D 
(CMT2D), a heritable disease that causes defects in motor and sensory neurons (Chihara 
et al. 2007).  Similar to dfmr1 mutants, Aats-gly mutants have defects in dendritic 
arborization as a result of perturbing protein translation (Chihara et al. 2007).  The 
relationship between FMRP and Aats-gly expression may be relevant for both cleavage 
furrow formation during the MBT as well as aspects of development in the nervous 
system.  
Together, these findings suggest that genes normally thought of as functioning in 
a general ‘housekeeping’ capacity, such as those functioning in metabolic processes and 
protein synthesis, may have more specific functions during development and cell 
maintenance and their precise regulation is important for cellular processes.  
3.3.2  CCT and dFMRP regulation 
The manner in which the three CCT subunits are affected in dfmr1- is complex.  
CCT3 was identified as shifting in pI to a more basic state in the mutant extracts, CCT4 
was identified as decreasing 2.6 fold in mutant extracts, and CCT7 was identified as 
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increasing 1.4 fold in mutant extracts (Table 1).  It should be noted that overall 
abundance of CCT3 was difficult to assess because the labeled spots were not well 
resolved.  Despite the differences in how protein abundance is affected, dFMRP appears 
to associate with all three mRNAs suggesting that dFMRP is conferring different types of 
regulation on the different transcripts.  In addition, nearly 70% of FMRP-associated 
mRNAs identified in a microarray screen contain putative G-quartet motifs (Brown et al. 
2001), and the mRNA sequences of cct3, cct4, and cct7 contain G-quartets.  The increase 
in abundance of CCT7 is most consistent with the prevailing idea that FMRP primarily 
functions as a repressor of translation.  If dFMRP directly regulates the expression of 
CCT4 or any of the proteins identified as decreasing in abundance in the mutant, it would 
suggest that dFMRP normally activates the translation of these targets.  There is evidence 
for activation by FMRP, but translational competency of specific transcripts will be the 
focus of future work.  Many (~35%) of the proteins, including CCT3, identified shift in 
molecular weight and/or pI suggesting that normal post-translational modification is 
altered in the mutant lysates.  This would likely result from indirect regulation by 
dFMRP.  Given our observation that dFMRP associates with the cct3 mRNA, an 
alternative hypothesis is that cct3 represents a normal direct target of dFMRP that is 
translated inappropriately in the wrong subcellular compartment.  The inappropriate 
translation leads to CCT3 being abnormally modified post-translationally in the absence 
of dFMRP.  Alternatively, the overall abundance of the protein may be affected although 
this is difficult to discern due to the resolution of the different protein spots.  Again, 
detailed biochemical analysis on the nature of the association of dFMRP and these targets 
and its affect on translation will be the focus of future studies. 
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3.3.3  Septins and CCT  
The septins are a known class of CCT substrates in yeast and are themselves 
required for cytokinesis and cleavage furrow formation (Field et al. 1996; Adam et al. 
2000).  I have found that the septins are a conserved family of CCT substrates in fly, and 
specifically, that the septin PNUT depends on CCT and dFMRP for its proper 
localization in the fly embryo.  This observation is consistent with previous reports that in 
early dfmr1- embryos PNUT is mislocalized  (Deshpande et al. 2006), although it is still 
unclear if the misregulation of the septin contributes to the furrow formation defects 
observed in both cct- and dfmr1- embryos.  It is known that PNUT associates with Septin 
1 (SEPT1) and Septin 2 (SEPT2) and is required for SEPT1 localization to the furrow 
front in cleavage stage embryos (Field et al. 1996).  Although the effect on the 
mislocalization of PNUT in dfmr1- embryos appears specific, I have not been able to 
confidently assess if there are also effects on other septins expressed during the cleavage 
stage due to unavailability of effective reagents.  Preliminary results suggest that at least 
SEPT1 localization is normal in dfmr1- embryos (data not shown), but further analysis 
should be done to confirm these results.  An interesting low penetrant phenotype that I 
have observed in dfmr1- embryos that was also reported to occur in pnut- embryos 
(Adam et al. 2000) is a defect in the migration of the posterior midgut.  Normally when 
furrow formation is almost complete the posterior midgut migrates over the dorsal side of 
the embryo, however in the mutants the migration occurs ventrally or to either lateral 
side.  These observations are consistent with the idea that the misregulation of PNUT in 
dfmr1- has morphological consequences.   
The genetic and biochemical relationships between FMRP, CCT, and septins may 
have significance in the nervous system as septins are known to localize to dendritic 
protrusions and branch points.  Misregulation of septins also causes defects in dendritic 
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morphology, similar to what is observed in FMRP mutants and FXS patients (Tada et al. 
2007; Xie et al. 2007).  It is tempting to speculate that misregulation of CCT could cause 
septin defects in neurons of dfmr1 mutants and possibly in FXS patients.   
Our work suggests that three of the eight cct mRNAs are misregulated in dfmr1- 
cleavage stage embryos.  This appears to alter the normal stoichiometry of CCT subunits 
and in turn affects CCT complex assembly.  The aberrant expression of CCT 
holocomplex in turn affects the assembly of some number of its substrates that are 
required for proper furrow formation, suggesting a multi-tiered regulatory system.  We 
have identified at least one of these substrates as the septin PNUT.  The misregulation of 
PNUT results in ectopic accumulation of PNUT to lateral membranes, where is may be 
affecting/impeding how the furrow forms and ingresses.  It seems likely that the cleavage 
furrow formation phenotypes observed in dfmr1- embryos are not due to the 
misregulation of a single transcript or protein but rather the cumulative misregulation of 
many factors that are regulated in a hierarchical manner that contributes to the phenotype.  
Although this screen revealed an important set of targets, it was certainly not to 
saturation.  Other strategies will need to be employed to get closer to identifying as many 
relevant targets as possible (see Appendix 2.2).  The identification and characterization of 
new targets of FMRP will certainly be important for a more complete understanding the 
function of FMRP and the etiology of FXS. 
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Chapter 4:  dFMRP and cell cycle regulation at the MBT 
The data described in this chapter were generated in collaboration with Ophelia Papoulas, 
a Research Associate in the Sisson Lab and the following manuscript describing this 
work is in preparation:  
Papoulas O*, Monzo K*, Cantin GT, Ruse C, Yates JR, and Sisson JC.  Synaptic 
 plasticity regulators control the cell cycle machinery at the midblastula transition.  
 *equal contributing authors. 
  
4.1  INTRODUCTION 
A complex system of regulatory mechanisms governs the events of the MBT.  In 
addition to mRNA degradation and transcriptional activation there also are non-RNA 
based mechanisms that are clearly essential for the MBT in Drosophila which include 
counting of the nucleocytoplasmic ratio (N:C), cell cycle control through fluctuations in 
activity of the cell cycle machinery, and activation of the DNA damage/replication 
checkpoint pathway. There is also accumulating evidence that translational regulation 
plays an important role in mediating the events of the MBT.  Our studies suggest that 
dFMRP functions as a translational regulator during the MBT to affect some of the non-
RNA based mechanisms that control the timing of the MBT.  
As previously described, dFMRP functions in dynamic mRNP bodies and is 
required for cellular morphogenesis during the cleavage stage at the MBT in Drosophila 
embryos.  In an effort to further understand how dFMRP functions during this time in 
development, a biochemical screen was performed to identify proteins that associate with 
dFMRP specifically during the cleavage stage.  Two proteins were identified: eukaryotic 
initiation factor 4G (eIF4G) and a previously uncharacterized protein that is homologous 
to vertebrate Caprin (CAPR).  eIF4G is an essential component of the eIF4F initiation 
complex which associates with mRNAs and allows them to be assembled into a 
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translation initiation complex (Gebauer and Hentze 2004).  CAPR is a ubiquitous RNA-
binding protein that controls progression through the cell cycle in proliferating cells 
(Wang et al. 2005).  It is enriched in the nervous system where it localizes to neuronal 
granules and is involved in translational control (Solomon et al. 2007).  dFMRP has also 
been shown to localize to neuronal granules in mouse and fly where it functions as a 
translational regulator (Kanai et al. 2004; Barbee et al. 2006).  In this chapter, I will 
describe our efforts to identify new dFMRP-associated proteins and understand how one 
of these proteins, Caprin, functions together with dFMRP to control cell cycle timing and 
mediate the events of the MBT. 
 
4.2  RESULTS 
4.2.1  Identification of dFMRP-associated proteins 
In order to understand the role of dFMRP in early embryonic morphogenesis a 
biochemical screen was carried out to identify dFMRP-associated proteins by performing 
IPs of dFMRP from extracts of cleavage stage Drosophila embryos coupled with 
multidimensional protein identification technology (MudPIT) mass spectrometry.  
Because the embryo is highly enriched in ribosomal material, dFMRP was resolved from 
bulk ribosomal subunits and polyribosomes on sucrose gradients prior to IPs in order to 
avoid ribosomal contamination.  Soluble extracts from WT and dfmr1- embryos were 
fractionated in parallel, and the fractions enriched for dFMRP were pooled.  The pooled 
fractions from WT were used to IP dFMRP (Figure 4.1, sample A) and the pooled 
fractions from dfmr1- embryos were used to mock-IP dFMRP as a control for non-  
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Figure 4.1  Identification of dFMRP-associated proteins by co-IP and MudPIT 
Top panel shows a UV absorbance trace (A254) indicating the positions of ribosomal 
subunits and polyribosomes across fractions 1–22 from a sucrose gradient of WT and 
dfmr1- cleavage stage embryo extracts.  Immunoblots reveal the enrichment of dFMRP in 
fractions 1-3 and the absence of dFMRP in dfmr1- extracts.  Lower schematic describes 
the procedure for identifying proteins that specifically co-IP with dFMRP.  Proteins 
identified in Sample B but not A or C were considered to be associated with dFMRP.  
This figure is adapted from data and a figure generated by Ophelia Papoulas. 
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specific binding (Figure 4.1, sample C).  An additional control was performed with anti-
FLAG antibody and WT extracts (Figure 1, sample A).  Proteins that co-IPd with dFMRP 
were identified by MudPIT mass spectrometry in collaboration with Dr. John Yates 
(Scripps Research Institute). 
Only two proteins specifically co-IPd with dFMRP: eukaryotic initiation factor 
4G (eIF4G) and a previously uncharacterized protein in fly encoded by the gene 
CG18811 homologous to vertebrate Caprin (CAPR).  eIF4G mediates the binding of all 
translationally-competent mRNAs to the 40S ribosome to form a pre-initiation complex 
and is a scaffolding protein that serves as a major target of translational control (Gingras 
et al. 1999).  The association of eIF4G and dFMRP and the previous observation that 
dFMRP does not associate with active polyribosomes in cleavage stage embryos (Figure 
2.4B), suggests that dFMRP may act as a regulator of translational initiation during the 
cleavage stage.  The characterization of eIF4G and dFMRP will be the focus of future 
studies.  Only eIF4G and CAPR were specifically identified as being associated with 
dFMPR in our experiments, likely due to the stringency of the screen.  Interestingly, both 
are clearly implicated in translational regulation suggesting that this screen has likely 
identified proteins relevant to the mechanism of dFMRP function.  In this study, we 
focused on how dFMRP and CAPR function together during the MBT. 
4.2.2  Characterization of Drosophila Caprin 
The CG18811 gene in the Drosophila genome is related by protein sequence 
homology to two vertebrate RNA-binding proteins termed Cytoplasmic 
activation/proliferation-associated proteins (Caprins) that are thought to regulate the 
translation of specific mRNAs.  Vertebrate Caprins have been shown to localize to 
neuronal granules and repress the translation of mRNAs through an unknown mechanism 
within dendrites (Wang et al. 2005; Solomon et al. 2007).  Neuronal granules are 
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important sites of post-translational regulation that are believed to sequester specific 
mRNAs for later release and translation at dendritic synapses in response to external cues 
(Anderson and Kedersha 2006).  The protein and RNA composition of neuronal granules 
is complex, and is thought to include quiescent ribosomal subunits as well as many 
proteins involved in RNA metabolism including FMRP, ME31B, and TRAL (in fly) 
(Anderson and Kedersha 2006; Barbee et al. 2006).  However, Caprin 1 was originally 
identified in proliferating tissues as a mitotic phosphoprotein in Xenopus and is required 
for normal progression through the G1 phase of the cell cycle suggesting it is capable of 
regulating translation in neuronal and non-neuronal tissues (Stukenberg et al. 1997; 
Wang et al. 2005). 
Primary amino acid sequence analysis of CG18811 revealed the presence of a 
highly conserved HR1 (Homology Region 1) domain, apparent G3BP binding motif and 
C-terminal RGG RNA-binding domains suggest CG18811 is related to vertebrate Caprins 
1 and 2 (Grill et al. 2004) however the absence of a CRD domain (C1q-related domain) 
suggests it is more closely related to Caprin 1 (Figure 4.2).  The HR1 domain is the most 
highly conserved domain among the Caprin family members, but its function is unknown.  
Because CG18811 is the only HR1-containing gene in the Drosophila genome we named 






Figure 4.2  CG18811 is homologous to vertebrate Caprin 1 
Schematic of human Caprin 1 and Caprin 2 and fly CG18811/CAPR protein domains.  
Homology Region 1 (HR1), G3BP binding motif (G3BP-bd), C1q-related domain 
(CRD), and arginine-glycine rich RNA-binding motifs (RGG).  This figure was generated 
by Ophelia Papoulas. 
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4.2.3  Functional analysis of Caprin 
To begin to address the relevance of the CAPR/dFMRP association in vivo, IF 
analysis of fixed WT embryos was performed using an antibody against a CAPR peptide 
that was generated in the lab.   The anti-CAPR antibody is highly specific for a single 
band of 140 kD in extracts from adult flies or embryos and absent in mutant extracts 
(Figure 4.3B).  IF analysis of fixed wild type embryos showed that CAPR localizes to the 
cytoplasm and extensively colocalizes with dFMRP prior to cleavage furrow formation in 
the apical cytoplasm (Figure 4.3C).  In gastrulated embryos CAPR and dFMRP are 
highly expressed in the central nervous system consistent with the reported roles of 
vertebrate FMRP and Caprin 1 (Figure 4.4; O'donnell and Warren 2002; Solomon et al. 
2007).  These observations indicate that dFMRP and CAPR associate in vivo and may 
function together to regulate mRNA expression during the MBT. 
To examine the function of CAPR in Drosophila embryos a protein null allele 
capr2 was generated by imprecise transposon excision (Figure 4.3A).  capr2/Df(3L)Cat 
(hereafter refered to as capr-) flies are viable and show no obvious morphological 
defects, however females are semi-fertile and when mated to WT males, produce 
embryos (capr- embryos) with a cleavage furrow phenotype strikingly similar to the 
furrowing delay seen in dfmr1- embryos (Figures 4.5 and 2.2).  Specifically, capr- 
embryos develop normally until the onset of cleavage furrow formation at NC14 when 









Figure 4.3  CAPR colocalizes with dFMRP in cleavage stage embryos 
(A)  Schematic of genomic region containing capr.  Four small deletions removing the 
predicited ATG were generated by imprecise excision of a P-element inserted into an 
intron of the gene.  The red arrow indicates that the capr2 allele was used for all 
subsequent functional studies.  (B)  Immunoblot analysis of WT, +/Df,  EY/Df, and the 
four capr deletions alleles in trans to the deficiency.  The deficiency, Df(3L)Cat, is 
indicated by Df and completely removes capr and other surrounding genes.  (C)  IF 
analysis of WT fixed embryo in interphase of NC12 shows cytoplasmic distribution of 
CAPR and colocalization with dFMRP as indicated with arrows.  Scale bar indicates 10 





Figure 4.4  dFMRP and CAPR colocalizes in the CNS 
IF images of sagital (top) and oblique (bottom) WT embryos showing CAPR (green) and 






Figure 4.5  capr is required for proper furrow formation and controls cell cycle 
timing with dfmr1 
Frames from representative DIC movies of WT and different mutant cleavage stage 
embryos.  Mutant type is indicated at top.  Total number of embryos examined (n) with 
those with shown phenotype is indicated at top.  Time (t) indicating in minutes after start 
of interphase of nuclear cycle 14.  Arrowheads and brackets indicate the furrow front 
position and nuclear elongation, respectively.  Asterisk indicates nuclei in mitosis.  Scale 




4.2.4  dfmr1 and capr interact during the MBT 
The similarity in capr- and dfmr1- cleavage furrow phenotypes suggested that the 
proteins could be functioning to regulate the same process and/or the same target 
mRNAs.  If so, then double mutants would be predicted to show enhanced defects.  To 
test this, embryos from double mutant females of the genotype capr2, +/ Df(3L)Cat, 
dfmr13 mated to WT males (hereafter refered to as capr-/-, dfmr1-/+ embryos) were 
examined.  A significant portion of the embryos (approximately 50%, data not shown) 
examined by live imaging showed a decreased furrowing rate relative to WT, however 
the remaining showed a distinct phenotype that was never observed in either capr-/- or 
dfmr1-/+ alone.  The first observation was that many of the capr-/-, dfmr1-/+ embryos 
underwent cleavage furrow formation with an increased nuclear density or patches of 
increased density suggesting that the normal nuclear division cycle was disrupted.  A 
more detailed analysis showed that approximately 50% of capr-/-, dfmr1-/+ embryos 
underwent a premature mitosis approximately 20 minutes into interphase of NC14 and 
completed cleavage furrow formation during interphase of NC15 (Figure 4.5 and 4.6).  In 
many of these embryos, cleavage furrows formed but regressed during the premature 
mitosis and then reformed to complete furrow formation with a higher nuclear density.  
An interesting feature of this phenotype is that the rate of furrow ingression in mutants 
during NC15 is faster than the rate in WT embryos during NC14. This may be because 
factors required for furrow formation were able to accumulate to certain levels during the 
abbreviated interphase of NC14 allowing the furrowing machinery to assemble and 
mediate furrow ingression faster than normal. 
 The same phenotype was observed in embryos from females of the genotype     
+, Df(3R)Exel6265/ Df(3L)Cat, dfmr13 (capr-/+, dfmr1-/-) but not from caprrvt, +/ 
Df(3L)Cat, dfmr13 (capr-/+, dfmr1-/+) control females where caprrvt is a precise excision 
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of the transposon indicating that the new phenotype arises from simultaneous reduction 
of dfmr1 and capr.  The premature mitosis was sometimes synchronous throughout the 
embryo but frequently in patches with only a portion of the embryo undergoing a 
premature mitosis prior to attempting furrow formation (Figure 4.7 for patch phenotype).  
Quantification of interphase lengths of live embryos from nuclear cycles 10 through 14 
revealed that the duration of all prior nuclear cycles was unaffected and that the earliest 
observable defect in capr-/-, dfmr1-/+ embryos was the premature mitosis during NC14 
(Figure 4.6).  The disruption of the timing of cell cycle and furrow formation during the 
MBT in capr-/-, dfmr1-/+ embryos is a phenotype not observed in either dfmr1- or capr- 
embryos and indicates that these gene products functionally interact to affect some aspect 
of the cell cycle regulatory machinery.  Spindle morphology and chromosome 
segregation appeared largely normal in capr-/-, dfmr1-/+ embryos (Figure 4.7), 
suggesting that of the known regulators of the timing of the MBT it is unlikely that the 
Smg or the DNA damage checkpoint proteins are affected since mutations in smg, grp or 
Mei41 produce dramatic defects in those processes (see sections 1.3.3 and 1.3.4).  The 
premature mitosis of NC14 phenotype is also seen for genes that regulate M-CDK1 
activity during the MBT, however it should be noted that the phenotype is much more 
penetrant in capr-/-, dfmr1-/+ embryos (see section 1.3.2).  Together these observations 
suggest that dFMRP and CAPR are likely acting together to affect expression of 
regulators of M-CDK1 activity known to affect nuclear cycle lengthening specifically 







Figure 4.6  capr and dfmr1 are required for cell cycle lengthening at NC14 
(A)  Summary of quantification of nuclear cycle lengths from DIC movies of WT, capr-, 
and capr-/-, dfmr1-/+ embryos.  Bars next to cycle indicate nuclear cycle number.  
Number under black lines indicates length of interphase (I) with standard error and 
number under black box indicates length of mitosis (M) with standard error.  The number 
of embryos quantified at any given cycle (n) is under each time.  The duration of furrow 
formation was quantified for interphase of NC14 in WT and capr-.  Note, normal NC14 
mitosis is the first asynchronous mitosis and duration can not be quantified.  Abnormal 
NC14 mitosis and furrow formation in NC15 in capr-/-, dfmr1-/+ embryos is marked 
with an asterisk.  (B)  Stills from DIC movies showing nuclear densities during 
interphase of different nuclear cycles (left) in WT and capr-/-, dfmr1-/+ embryos.  Arrow 












Figure 4.7 on previous page. 
IF images of the surface of fixed WT (a-e, k) and capr-/-, dfmr1-/+ (f-j, l) embryos 
stained to reveal DNA (a-j) and MT (a’-j’) localization during the different stages of 
mitosis of NC13 and interphase of 14 as indicated at top.  Low magnification images of 
embryos in interphase of NC14 (d and i) show an even pattern of nuclei at the surface of 
the embryos.  Higher magnification shows normal mitotic figures of NC14 in capr-/-, 
dfmr1-/+ embryos undergoing premature mitosis of NC14 (j and j’).  Lower panel shows 
an example of a capr-/-, dfmr1-/+ embryo undergoing premature mitosis 14 non-
uniformly.  Embryos in k and l are stained to reveal F-actin (red) and phospho-histone H3 
(a marker for mitosis, green).  Regions i, ii, and iii  show uniform actin rings which 
delineate the position of the cortical nuclei.  Region vi shows nuclei in interphase of 
NC14, region v shows nuclei in metaphase, and region iv shows nuclei in anaphase and 
telophase.  All mitotic figures appear normal.  Scale bar indicates 10 µm in high 
magnification images and 50 µm in low magnification images.   
 
4.2.5  dFMRP and CAPR control expression of CYCB and FRS at the MBT 
To identify which regulators of the cell cycle might be affected in capr-/-, dfmr1-
/+ embryos, immunoblot analysis was performed using hand sorted staged WT, capr-, 
and capr-/-, dfmr1-/+ embryos.  While the phosphorylation state of M-CDK1 appeared 
normal throughout the transition from interphase of NC13 to NC14, the levels of two 
other regulators of M-CDK1 activity were specifically altered in the double mutant 
embryos (Figure 4.8).  Levels of CYCB were inappropriately elevated in mitosis of NC13 
(M13) and early NC14 as compared to WT (Figure 4.8).  In addition, FRS, a zygotic 
inhibitor of CYCB, did not accumulate to appropriate levels until mid NC14 as compared 
to WT (Figure 4.8).  Consistent with the live analysis, this disruption of CYCB and FRS 
expression was not detected in capr- embryos which undergo delayed furrow formation 
but never a premature mitosis during NC14. 
If the inappropriate CYCB expression detected by immunoblot analysis 
contributes to the phenotype observed in live embryos, reducing the dosage of CycB 




Figure 4.8  CYCB and FRS expression is perturbed in capr-/-, dfmr1-/+ embryos 
Immunoblots of handsorted WT, capr-/-, and capr-/-, dfmr1-/+ embryos show abundance 
of proteins (left) as embryos progress from NC13 to NC14 as indicated at top.  I14 
embryos were sorted into three stages based on progression of furrow front.  The four 
phosphoisoforms of CDC2 (CDK1) are indicated to the right.  Form 1 has an activating 
phosphate (T161P), form 2 is unphosphorylated, form 3 and 4 have inhibitory phosphates 
(Y15P and T14P, Y15P) as first described in Edgar and Datar, 1996.  NC13 interphase 
(I13), NC13 mitosis (M13), NC14 interphase (I14).  The data and figure was generated 
by Ophelia Papoulas.  I prepared and assisted in handsorting of embryos.   
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embryos showed a premature mitosis in NC14, loss of one maternal copy of CycB was 
able to significantly rescue this phenotype.  Only 17% of embryos from CycB2/+; capr2, 
+/ Df(3L)Cat, dfmr13 (CycB-/+, capr-/-, dfmr1-/+) females mated to WT males 
underwent premature mitosis in NC14 (Figure 4.9).  Because half the embryos produced 
by CycB-/+, capr-/-, dfmr1-/+ females are zygotically heterozygous for CycB it remained 
possible that elevated CYCB levels could arise from premature aberrant expression of the 
zygotic CycB gene and thus only be sufficient to produce premature mitosis in half the 
progeny of the previous test cross.  To rule out the possibility that zygotic misexpression 
of CycB accounts for the premature mitosis observed in embryos from capr-/-, dfmr1-/+ 
females, females were mated to CycB2/CYO-GFP males and embryos were observed for 
premature mitosis and scored for the presence of GFP, indicating that the embryo 
received a WT copy of CycB.  Reduction of the zygotic contribution of CYCB was 
unable to rescue the premature mitosis phenotype indicating that the elevated levels we 
see are due to misexpression of the maternal CycB mRNA (GFP- bar, Figure 4.9).  We do 
not believe that the observed elevated CYCB levels at mitosis 13 are due to impaired 
degradation by the Anaphase Promoting Complex (APC) because other known targets of 
APC (CYCA and CYCB3) are appropriately degraded at M13, and the CDC20 subunit of 
the APC complex (FZY) is expressed at levels comparable to that in wild type embryos 
(Figure 4.8).  Furthermore, proper degradation of CYCB is necessary for progression 
through the cell cycle (Su et al. 1998; Glotzer 2001), and capr-/-, dfmr1-/+ embryos 
appear to progress through mitosis normally (Figure 4.8).  These observations suggest 
that the premature mitosis in NC14 in capr-/-, dfmr1-/+ embryos is due to premature 






Figure 4.9  Loss of maternal CycB rescues premature mitosis 14 phenotype in    
capr-/-, dfmr1-/+ 
Bar graph shows percentage of embryos laid by females (♀, top row) mated to males (♂, 
bottom row) that displayed a premature mitosis 14.  ‘n’ indicates total number of 
embryos observed from each cross.  The two bars to the right represent embryos fromthe 
same cross and were distinguished by the presence or absence of GFP.  The presence of 
GFP indicates that embryos were CycB+/+, and the absence of GFP indicates that 
embryos were CycB-/+.   
 
 
Our phenotypic analysis argues that CAPR and dFMRP function together and 
affect expression of CycB.  To determine whether CycB, frs, or other cell cycle regulators 
are themselves direct targets of CAPR/dFMRP translational regulation we tested whether 
any of the candidate mRNAs specifically associate with CAPR or dFMRP at this time in 
development.  CAPR or dFMRP IPs were conducted from wild type extracts of embryos 
staged to span NC13 to early NC14, and mock IPs were conducted from correspondingly 
staged mutant embryos (with either capr-/- or dfmr1-/- embryos respectively).  Co-IPd 
RNA was isolated and levels of specific mRNAs in the starting extract (steady-state 
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levels) and in the IPs were determined by qRT-PCR.  While steady-state levels of CycB 
and frs were not altered in mutant embryos prior to the start of NC14 (2-2.5hr, Figure 
4.10), both mRNAs were enriched in IPs performed from wild type extracts suggesting 
that they are part of a dFMRP and CAPR-containing mRNP in vivo and are likely to be 
direct targets of translational regulation (Figure 4.11).  Interestingly, the levels of CycB 
mRNA are significantly higher in 3-3.5hr capr-/-,  dfmr1-/+ embryos compared to WT 
embryos of the same age (Figure 4.10).  One possible explanation is that the maternal 
CycB mRNA is normally repressed in a WT situation, which may destabilize the 
transcript.  In the capr-/-, dfmr1-/+ embryos, the CycB mRNA is not repressed which 
may then result in the stabilization and accumulation of transcript which is apparent at the 
later stage.  Future studies assessing the stability of dFMRP and CAPR target mRNAs 




Figure 4.10  Steady state mRNA levels are not affected prior to NC14 in capr-/-, 
dfmr1-/+ embryos 
Bar graph of cdc2, Cycb, and frs mRNA levels quantified by qRT-PCR from 30 minute 
collections of WT (white bar), capr-/- (grey), and capr-/-, dfmr1-/+ (black) embryos.  0-
0.5 hr embryos are enriched for early NCs well before the onset of zygotic transcription.  
2-2.5 hr embryos are enriched for syncytial stages just prior to NC14.  3-3.5 hr embryos 
are enriched for mid- and late-furrowing cleavage stage.  Error bars indicate standard 
deviations (SD). Significance was assessed using the Student’s t test and significant P -







Figure 4.11  CAPR and dFMRP associate with CycB and frs mRNAs 
Bar graph shows the fold enrichment of each mRNA in WT vs. capr- anti-CAPR IPs (A) 
and WT vs. dfmr1- anti-dFMRP IPs (B) normalized to RpL32 measured by qRT-PCR.  
Error bars indicate standard deviations (SD).  Significance was assessed using the 







To broaden our understanding of how FMRP functions, a stringent biochemical 
screen was performed to identify proteins that associate with dFMRP during the cleavage 
stage at the  Drosophila MBT.  Two dFMRP-associated proteins previously implicated in 
translational regulation were identified: eIF4G and Caprin.  This study focused on the 
genetic interaction between dFMRP and CAPR during the MBT.  We have shown that 
CAPR is required on its own for forming proper cleavage furrows.  In addition, we have 
found that dFMRP and CAPR are required together to lengthen the cell cycle during 
interphase of NC14 by likely responding to changes in the N:C and in turn modulating 
the expression of CYCB and FRS (Figure 4.12).  
 
 
Figure 4.12  Model for dFMRP and CAPR regulation of the cell cycle at the MBT 
Figure generated by John Sisson. 
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4.3.1  dFMRP and CAPR regulate multiple cell cycle regulators 
The specific nature and relatively high penetrance of the premature M14 
phenotype together with what is known about other genes that also display this phenotype 
when altered, lead us to believe that dFMRP and CAPR regulate the expression of a 
number of different proteins involved in cell cycle control during the MBT.  As described 
in Chapter 1, altering levels of CycB has been shown to affect the timing of cleavage 
furrow formation but at a low penetrance.   About 8% of embryos expressing 4X CycB 
fail to elongate interphase of NC11-13 and furrowing never occurs, and 10% of embryos 
that are maternally provided with 1X CycB fail to initiate mitosis of NC13 and embryos 
attempt to form cleavage furrows during an extended interphase of NC13 (Stiffler et al. 
1999).  In addition, loss-of-function mutations in frs and trb, normal inhibitors of M-
CDK1 activity required for the lengthening of interphase of NC14, result in a relatively 
low penetrance of the premature mitosis 14 phenotype (Grosshans and Wieschaus 2000).  
Over expression of cdc25/twe, an activator of M-CDK1 activity has a similar effect 
(Edgar and Datar 1996).  Together with these previous observations, our findings that 
CYCB and FRS levels are disrupted in the capr-/-, dfmr1-/+ embryos and that dFMRP 
and CAPR both associate with the CycB and frs mRNAs suggest that the premature 
mitosis phenotype is due to the disruption of the expression of multiple cell cycle 
regulators. 
4.3.2  Do dFMRP and CAPR spatially regulate CycB expression? 
As discussed in section 1.3.2, the temporal as well as spatial regulation of CycB 
expression is important for progression through the cell cycle, although the specific 
mechanism for controlling CycB mRNA metabolism is unknown.  We have shown that 
the basis for the misregulation of CYCB during the transition from mitosis of NC13 to 
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interphase of NC14 in capr-/-, dfmr1-/+ embryos is likely due to the inappropriate 
translation from maternal CycB mRNA (Figures 4.7 and 4.8).  We attempted to address 
whether the misregulation is of only a subpopulation of CycB mRNA, by assessing the 
subcellular localization of CycB mRNA by fluorescent in situ hybridization (FISH) (data 
not shown generated by Gerrit van der Ende) and protein by IF in fixed embryos (data not 
shown).  Results for both experiments were inconclusive, as we were unable to detect 
spindle-associated mRNA or protein during mitosis of NC13.  These results were most 
likely due to insufficient fixation of spindle MTs and associated proteins and mRNAs.  
The outstanding question of whether dFMRP and CAPR spatially regulate the expression 
of CycB will be interesting to address in future studies. 
4.3.3  dFMRP and CAPR regulate the expression of zygotic genes 
In order for interphase of NC14 to lengthen to allow for cleavage furrow 
formation, Frs protein needs to accumulate shortly after interphase of NC14 is initiated to 
repress M-CDK1 activity.  dFMRP and CAPR are required for the apparent activation of 
the zygotically expressed frs mRNA.  It has been reported that the transcriptional 
activation of the frs gene is dependant on the transcriptional regulator, Zelda (Liang et al. 
2008).  Because the temporal regulation of FRS expression is very strict, it seems 
reasonable that frs mRNA expressed prior to the onset of interphase of NC14 may be in a 
translationally incompetent state and requires activation in order to accumulate the 
protein to sufficient levels to mediate inhibition of M-CDK1.  The premature mitosis of 
NC14 phenotype suggests that M-CDK1 activity is not repressed properly in capr-/-, 
dfmr1-/+ embryos during interphase of NC14.  Our observations that FRS protein levels 
do accumulate normally and that the frs mRNA associates with both dFMRP and CAPR 
suggest that dFMRP and CAPR are likely the proteins responsible for this activation. 
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In conclusion, we have identified new previously unknown dFMRP-associated 
proteins.  One of these proteins, CAPR, functions with dFMRP during the cleavage stage 
to mediate the timing and morphological events of the MBT in Drosophila embryos.  In 
addition, we have shown that CAPR is expressed in the fly CNS where vertebrate 
Caprins have also been shown to function to regulate the expression of specific mRNAs.  
Future studies in the nervous system may reveal possible functional interactions between 
the two proteins where FMRP loss of function is known to cause many of the 
neurological phenotypes seen in FXS patients. 
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Appendix 1:  A characterization of conditional mutants affecting 
Drosophila cleavage furrow formation 
A1.1  INTRODUCTION 
It is known that maternal gene products are sufficient to mediate the events of the 
first phase of cleavage as shown in studies using pharmacological agents to block zygotic 
transcription and a genetic screen using Drosophila embryos completely lacking entire 
chromosome arms (Edgar and Schubiger 1986; Merrill et al. 1988; Wieschaus and 
Sweeton 1988).  It was also demonstrated that the process of cellularization only requires 
zygotic transcription from six discrete genetic loci (Merrill et al. 1988; Wieschaus and 
Sweeton 1988).  Thus, the majority of gene products required for proper cellularization 
are likely to be maternally derived, and some of these gene products may be required for 
viability.  For this reason, conventional loss-of-function genetic screens have a limited 
ability to identify genes required during the cleavage stage.  Conditional mutants offer a 
unique opportunity to identify new genes required for Drosophila cleavage furrow 
formation because any effects of the mutation can be studied during a particular stage of 
development.  Consequently, we obtained a collection of EMS-induced, temperature-
sensitive (ts) zygotic lethal mutants residing on the X-chromosome (W. Sullivan and H. 
Francis-Lang, University of California Santa Cruz).  In this appendix, I describe a screen 
I performed to identify X-linked mutations that affect Drosophila embryonic cleavage 
furrow formation.  I began this work as an undergraduate in the Sisson lab and continued 
to work on it as a graduate student before the FMRP project became my main focus. 
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A1.2  RESULTS 
A1.2.1  Live analysis screen of temperature sensitive mutants 
To identify conditional mutants that affect cellularization I screened an existing 
collection of temperature-sensitive (ts) mutants originally identified as X-linked mutants 
that cause zygotic lethality at a restrictive temperature of 29°C.  From the original 
collection consisting of 158 stocks, 38 stocks were shown to retain ts zygotic lethality 
and also to be ts maternal sterile (W. Sullivan, B. Zhang, UT Austin, and H. Kramer, UT 
Southwestern).  I analyzed cellularizing embryos derived from wild type (WT) and 
homozygous mutant females using time-lapse differential interference contrast (DIC) 
microscopy.  Embryos were collected and allowed to age at the permissive temperature 
on a temperature controlled microscope stage until the onset of interphase of nuclear 
cycle 14 when they were shifted to the restrictive temperature and imaged until 
gastrulation (Figure A1.1).  Rates of nuclear elongation and furrow ingression were 
calculated from live time-lapse recordings.  Five mutants were identified that display 
cellularization defects at the restrictive temperature (Figure A1.2).  These mutants can be 
classified into two distinct phenotypic categories based on either primary disruptions in 
the rates of furrow ingression with relatively normal morphology or severe disruptions in 
furrow ingression, nuclear morphology, and cytoplasmic movements.  
  During normal cellularization cleavage furrows ingress at two distinct rates.  
First, furrowing occurs slowly until the furrow front reaches the basal ends of nuclei.  
The rate then abruptly increases during the fast phase until the cells are formed and 
cellularization is complete.  During the slow phase the nuclei elongate at a constant rate.  
In wild type embryos at 32°C (the restrictive temperature for this screen), nuclei begin to 
elongate within the first 10 min of interphase of nuclear cycle 14.  Membrane furrows 





Figure A1.1  Schematic of screen to identify ts cellularization defects 
Virgin fs(1)ts females were mated to males of the same genotype.  Embryos collected 
from this cross were allowed to develop at the permissive temperature in a perfusion 





the entire inner surface of the embryo that ingresses at two distinct rates.  Initially, the 
furrow front ingresses at a rate of ~0.3 µm/min, referred to as the slow phase.  Once the 
furrow front approaches the basal tips of the elongated nuclei, after approximately 30 
min, the rate of ingression increases to ~1.2 µm/min, referred to as the fast phase.  The 
furrow continues to grow until the membrane surrounding individual nuclei pinches off to 
form individual cells. 
A1.2.2  Moderate cellularization mutants 
     Two mutants were found to have defects during both phases of furrow 
ingression and nuclear elongation.  Cellularization in fs(1)ts448 and fs(1)ts567 embryos 
show uniform and significant delays in furrow ingression at the restrictive temperature 
compared to WT (Figure A1.2).  The average rates of slow phase furrow ingression in 
fs(1)ts448 and fs(1)ts567 embryos are 2-fold slower than WT (fs(1)ts448 = 0.11 µm/min, 
fs(1)ts567 = 0.13 µm/min  and WT = 0.25 µm/min; Table A1.1).  Although the furrowing 
rate of fs(1)ts448 embryos increases 2-fold during the transition from slow phase to fast 
phase, the rate of ingression remains delayed compared to WT (fs(1)ts448 = 0.23 µm/min 
and WT = 1.14 µm/min, Table A1.1).  Nuclei also fail to completely elongate in these 
mutants.  After 50 min into cellularization, the ends of nuclei in fs(1)ts448 and fs(1)ts567 
embryos only reach about half the distance from the cortex (~10 µm) compared to WT 
embryos (20 µm) (Figure A1.1; Table A1.1).  Although embryos derived from both 
fs(1)ts448 and fs(1)ts567 females appear cellularized and initiate gastrulation, they fail to 
hatch at the restrictive temperature.  fs(1)ts448 and fs(1)ts567 homozygous females have 
decreased egg production at both permissive and restrictive temperatures (Table A1.2).  
However, the hatch rates are significantly lower at the restrictive temperature 
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Figure A1.2  Time-lapse imaging reveals temperature-sensitive cellularization 
defects 
Sequential frames (A) from representative DIC movies of WT and ts mutant embryos 
undergoing normal (left panel) and abnormal (middle and right panels) cellularization at 
32°C.  White arrowheads and brackets indicate the furrow front position and nuclear 
position and elongation, respectively.  Times (t) in minutes are relative to onset of nuclear 
cycle 14.  Scale bar represents 10 µm.  The average rates of furrow ingression (B) and 
nuclear elongation (C) in embryos derived from WT, fs(1)ts448, and fs(1)ts567 
homozygous females mated to WT males. Error bars and n indicate the standard 






Table A1.1  Rates of furrow ingression and nuclear elongation 
Rates from embryos laid by females with indicated geneotype mated to WT males.  
Standard error shown next to rates.  Total number of movies quantified indicated by ‘n’.  
Not determined, n.d.  Significance measured by Student’s t-test, *P<0.01, **P<0.001, 
***P<0.0001. 







Oregon-R 0.25 ± 0.03 1.14 ± 0.19 0.28 ± 0.02 4 
fs(1)ts448 0.11 ± 0.02*** 0.23 ± 0.09*** 0.11 ± 0.03*** 4 
fs(1)ts448/Df(1)HF396 0.10 ± 0.03*** 0.35 ± 0.10*** 0.15 ± 0.03*** 3 
fs(1)ts567 0.12 ± 0.01*** 0.17 ± 0.18*** 0.13 ± 0.03** 4 
fs(1)ts567/Df(1)DA622 0.10 ± 0.02*** 0.17 ± 0.15*** 0.15 ± 0.03*** 3 
fs(1)ts148/small bristles 0.13 ± 0.03** 0.35 ± 0.16*** 0.16 ± 0.01*** 4 
fs(1)ts242 0.20 ± 0.07 0.89 ± 0.29 0.18 ± 0.05* 4 
fs(1)ts242/Df(1)JC70 0.14 0.60 0.12 3 
fs(1)ts319 0.10 ± 0.05* 0.49 ± 0.32 0.16 ± 0.03* 4 
fs(1)ts319/RA37 n.d. n.d n.d.  
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(7-fold lower for fs(1)ts448 and 10-fold lower for fs(1)ts567, Table A1.2).  This may 
reflect mutations that are non-conditional with respect to oogenesis but conditional with 
respect to embryogenesis.  In addition, progeny derived from fs(1)ts448 and fs(1)ts567 
adults fail to eclose at the restrictive temperature, with lethal phases during larval or 
pupal stages as indicated in Table A1.2. 
A1.2.3  Severe cellularization mutants 
     Three mutants were identified that display severe defects in nuclear 
morphology and furrow ingression.  Live cellularizing fs(1)319 embryos show severe 
disruptions in nuclear morphology and cytoplasmic movements throughout 
cellularization (Figure A1.2).   The majority of the nuclei appear to remain attached to the 
cortex and increase in volume but fail to elongate.  The shapes of nuclei become 
irregular, possibly due to their failure to elongate and the disruptions in the cytoplasm.  
Despite the turbulent cytoplasmic movements, the birefringence pattern of the furrow 
front suggests that an apparently intact contractile apparatus forms and is capable of 
ingression.  fs(1)ts242 and fs(1)ts148 also display severe disruptions in nuclear 
morphology and furrow ingression during cellularization at the restrictive temperature.  
Although the furrow front in cellularizing fs(1)ts242 embryos is locally abnormal, it 
ingresses globally at rates similar to wild type (Table A1.1).  Rates of furrow ingression 
in cellularizing fs(1)ts319 and fs(1)ts148 embryos show significant departures from wild 
type (Table A1.1).   
     The overall numbers of eggs deposited by fs(1)ts242 and fs(1)ts319 mutant 
females of the severe class are not significantly different at the restrictive compared to the 
permissive temperature or wild type, but the hatch rate is significantly lower at the 
restrictive temperature (3-fold lower for fs(1)ts242 and 7.5-fold lower for fs(1)ts319; 












Table A1.2  Mutants display temperature-sensitive maternal sterility and zygotic 
lethality 
a  females were mated to FM7a males.  b females were mated to fs(1)ts males of the same 
genotype.  n  indicates total number of embryos laid (hatch percentage) or total numbers 
of F1 adults obtained from cross (relative eclosure).  Hatch percentages or total number 
of embryos laid at 29°C significantly different from those at 20°C as measured by 
Student’s t-test are indicated with asterisks, *P<0.01.  Lethal phase indicates stage that 
development is arrested.  E embryonic, L larval, P pupal 
Hatch Percentage a (n) Relative Eclosure b (n) Maternal 
Genotype 20°C 29°C 20°C 29°C lethal phase 
Oregon-R 94.4 (213) 86.7 (279) 1.00 (220) 0.80 (175)  
fs(1)ts448 63.6 (66) 9.1* (11) 0.55 (122) 0.05 (10) L,P 
fs(1)ts567 60.9 (23) 5.9* (34) 0.59 (130) 0.00 (0) L 
fs(1)ts148 85.9 (142) 0.0* (29*) 0.99 (219) 0.00 (0) E 
fs(1)ts242 66.4 (265) 22.1* (181) 0.74 (163) 0.00 (0) L,P 
fs(1)ts319 66.9 (260) 8.9* (123) 0.82 (181) 0.38 (84) L,P 
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production at the restrictive temperature, and none of the embryos laid at the restrictive 
temperature hatch (Table A1.2).  Progeny derived from fs(1)ts148 and fs(1)ts242 adults 
completely fail to eclose at the restrictive temperature, with lethal phases during 
embryonic, larval, or pupal stages as indicated in Table A1.2.  fs(1)ts319 F1 adults eclose 
at the restrictive temperature but do so at a decreased frequency (0.38) compared to wild 
type (1.00) and fs(1)ts319 (0.82) at the permissive temperature.  The majority of 
fs(1)ts319 F1 progeny arrest development as larvae or pupae.  
A1.2.4  fs(1)ts319 embryos display ts MT defects during cellularization 
Due to its strong maternal sterility and cellularization phenotype, I initiated a 
phenotypic characterization of fs(1)ts319 cellularizing embryos.  Analysis of live 
fs(1)ts319 embryos suggests that the contractile apparatus is intact and able to advance 
during cellularization.  Normally, F-actin forms an array of interlocking contractile rings 
under the plasma membrane and during furrow formation is positioned at the ingressing 
furrow front (Figure A1.3).  fs(1)ts319 embryos fixed at the restrictive temperature and 
stained with fluorescent phalloidin, reveal relatively normal F-actin accumulation at the 
ingressing furrows compared to WT at the restrictive temperature (Figure A1.3).  In 
addition, localization of Myosin II and Anillin at the leading edge of the furrow front is 
normal in fs(1)ts319 embryos at the restrictive temperature (data not shown).  In contrast, 
the microtubule cytoskeleton appears disrupted in mutant embryos fixed at the restrictive 
temperature and analyzed by immunofluorescence (IF).  At the onset of cellularization 
microtubule arrays emanate from pairs of cortically positioned centrosomes, extending 
their plus-ends into the interior of the embryo, forming ‘inverted baskets’ around 
individual nuclei (Figure A1.3), and are thought to provide some mechanical force 
required for nuclear elongation (Foe and Alberts 1983).  Microtubule arrays surrounding 




Figure A1.3  The microtubule cytoskeleton is disorganized and centrosome 
morphology is abnormal in fs(1)ts319 mutant embryos at the restrictive 
temperature  
IF analysis of WT (A-D) and fs(1)ts319 (E-I) cellularizing embryos fixed at 32°C shows 
relatively normal cortical F-actin localization by phalloidin (arrowheads in B, G, D, I) 
and disrupted microtubules in mutant embryos (C and H).  Oblique images through the 
apical cytoplasm (D and I) show abnormal centrosome morphology, including 
fragmentation, uneven spacing, and lone centrosomes associated with single hexagonal 
rings (arrows).  Asterisks indicate nuclei.  Scale bars represent 10 µm.  
 104 
A1.3).  In WT cellularizing embryos, normal microtubule arrays are observed at the 
restrictive temperature (Figure A1.3).  In addition, centrosome morphology is abnormal 
in fs(1)ts319 embryos at the restrictive temperature.  In cellularizing wild type embryos, 
pairs of centrosomes are evenly spaced above individual nuclei within hexagonal actin 
cleavage furrows.  The centrosomes are normally discrete structures as indicated by the 
localization of the centrosomal protein, Centrosomin (CNN), in fixed cellularizing 
embryos (Figure A1.3).  In fs(1)ts319 embryos cellularizing at the restrictive temperature, 
the centrosomes are often fragmented and not evenly spaced with respect to the actin 
rings (Figure A1.3).  Furthermore, the live analysis of fs(1)ts319 embryos cellularizing at 
the restrictive temperature shows that nuclei increase in volume, fail to elongate, and the 
majority remain attached to the cortex.  The nuclei that no longer remain at the cortex 
appear to be ripped off the surface by the dramatic cytoplasmic movements rather than 
falling in as is seen when actin is depolymerized (Edgar et al. 1987).  These observations 
are consistent with a microtubule-based rather than an actin-based defect affecting 
cellularization in fs(1)ts319 embryos. 
A1.2.5  fs(1)ts319 embryos display ts defects in endoplasmic reticulum morphology  
Given the observed microtubule and furrow formation defects in fs(1)ts319 
cellularizing embryos, I assessed the morphology of various endomembrane 
compartments (RE, Golgi, and ER) in fs(1)ts319 embryos.  Vesicles trafficked through 
the RE are thought to be involved in membrane addition and recruitment of actin to 
cleavage furrows during cellularization (Pelissier et al. 2003; Riggs et al. 2003).  The 
localization patterns of Rab11 and Nuclear Fallout (NUF), two proteins that localize to 
the RE during cellularization, are relatively normal in fs(1)ts319 at the restrictive 
temperature (data not shown).  During cellularization, Golgi bodies are normally 
observed as punctate structures dispersed in the basal cytoplasm that tend to undergo  
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Figure A1.4  ER morphology is disrupted in fs(1)ts319 mutant embryos at the 
restrictive temperature  
IF analysis of WT (A-E) and fs(1)ts319 (F-J) cellularizing embryos fixed at 32°C shows 
failure of the lumenal ER chaperone HSC70-3 to accumulate normally (arrows) in mutant 
embryos in sagittal (A-C, F-H) and surface projections through the apical cytoplasm (D-
E, I-J).  Centrosome pairs indicate location of individual nuclei relative to ER in merged 
image (E and J).  Scale bars represent 10 µm.  (K) Quantification of Hsc70-3 and RpL32 
(control) mRNA levels by RT-PCR from total RNA extracted from WT and fs(1)ts319 
embryos subjected to the permissive (20°C) or restrictive (32°C) temperature during 
cellularization.  
 106 
microtubule-based apical movement during the fast phase (Papoulas et al. 2005).  
Although fixed fs(1)ts319 embryos cellularizing at the restrictive temperature have 
relatively normal Golgi morphology, their distribution between the apical and basal 
cytoplasm in late cellularizing embryos is abnormal.  Less LVA-associated Golgi are 
observed in the apical cytoplasm of fs(1)ts319 than in WT under the same conditions 
(Figure A1.4).  The possible disruption of Golgi bodies to undergo apical movement in 
the mutant embryos may be due to the disruptions seen in the microtubule cytoskeleton.  
Finally, I assessed the morphology of the ER in fs(1)ts319 cellularizing embryos at the 
restrictive temperature.  The lumenal ER chaperone, Heat shock protein cognate 3 
(HSC70-3), is normally concentrated at the apical perinuclear region with some 
localization extending to the ingressing furrow front of late cellularizing WT embryos.  In 
fs(1)ts319 embryos, HSC70-3 localization is more diffuse in the apical perinuclear region 
than WT and fails to extend to the furrow front as in WT (Figure A1.4).  To ensure that 
the effect I observed on HSC70-3 localization was not due to misexpression of the 
protein in the mutant, I also assessed Hsc70-3 mRNA and HSC70-3 protein levels in WT 
and fs(1)ts319 embryos at the permissive and restrictive temperatures and found that 
abundance of mRNA and protein is not affected in the mutant (Figure A1.4).  Together 
these observations suggest that ER morphology is disrupted in fs(1)ts319 cellularizing 
embryos at the restrictive temperature. 
A1.2.6  fs(1)ts319 embryos display ts defects de novo secretion during cellularization  
      Next, I examined de novo secretion in fs(1)ts319 mutant embryos.  
Neurotactin (Nrt) is expressed zygotically during the syncytial stages, and Nrt protein 
accumulates almost exclusively in the plasma membrane in late cellularizing WT 
embryos (Lecuit and Wieschaus 2000).  Surprisingly, apparent levels of Nrt protein are 




Figure A1.5  De novo secretion of Neurotactin protein is disrupted in fs(1)ts319 
mutant embryos at the restrictive temperature   
IF analysis of WT (A) and fs(1)ts319 (D) cellularizing embryos fixed at 32°C show a 
failure of Neurotactin protein to accumulate along the furrows in mutant embryos.  WT 
(B-C) and fs(1)ts319 (E-F) embryos stained with con-A (C and F) and imaged by DIC (B 
and E) show plasma membrane accumulates at furrows.  Arrows indicate extent of con-A 
staining.  Arrowheads indicate furrow front position.  Scale bar represents 10 µm.  (G)  
Quantification of Nrt and RpL32 (control) mRNA levels by RT-PCR of total RNA 
extracted from WT and fs(1)ts319 embryos subjected to the permissive (20°C) or 
restrictive (32°C) temperature during cellularization. 
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restrictive temperature (Figure A1.5).  To assess if the Nrt gene is properly activated in 
fs(1)ts319 embryos, I performed semi-quantitative reverse transcription polymerase chain 
reaction (RT-PCR) experiments.  The results indicate that Nrt mRNA is present in 
fs(1)ts319 embryos at levels comparable to WT (Figure A1.5).  In addition, the onset of 
expression of a cytoplasmic zygotically expressed protein, Slow as molasses (Slam) 
(Lecuit et al. 2002), appears normal in fs(1)ts319 embryos at the restrictive temperature, 
suggesting that the absence of NRT is not due to defects in the developmental timing of 
zygotic gene expression.  These observations suggest that Nrt protein is not expressed at 
the same level in fs(1)ts319  embryos as in WT embryos, and the absence of Nrt protein 
accumulation may be due to disruptions in cotranslational translocation of NRT into the 
ER.  To further explore the apparent absence of NRT, I performed a quantitative 
immunoblot analysis of whole embryo extracts prepared from WT and fs(1)ts319 
embryos.  I used antibodies against known secreted transmembrane proteins to determine 
if their steady-state levels are affected in mutant embryos.  If the primary effect is in the 
cotranslational translocation of secreted proteins, I expected maternally loaded proteins 
localized to the plasma membrane (eg. Toll) to be expressed at normal levels in 
fs(1)ts319 compared to WT embryos.  Alternatively, plasma membrane proteins 
translated de novo during cellularization such as NRT would be in lower abundance in 
fs(1)ts319 compared to WT embryos.  My observations are consistent with these 
expectations and corroborate the IF in fixed embryos.  I detected lower levels of NRT in 
fs(1)ts319 compared to WT extracts and comparable levels of Toll in fs(1)ts319 and WT 
extracts at the restrictive temperature (Figure A1.6).  In addition, levels of E-Cadherin are 
also reduced in fs(1)ts319 compared to WT extracts at the restrictive temperature (Figure 
A1.6).  E-Cadherin, encoded by shotgun (shg), is a transmembrane protein that localizes 




Figure A1.6  NRT and E-cadherin expression are affected in fs(1)ts319 embryos at 
the restrictive temperature 
Quantitative protein blots of WT (OR) and fs(1)ts319 extracts prepared from embryos at 
the permissive (20°C) and restrictive (32°C) temperatures as indicated at top.  Protein 
probed for indicated to the left.  Ratio of signal intensity indicated in first column and 
ratio corrected for loading errors by normalizing to MYOII signal indicated in second 
column. 
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cellularization (Uemura et al. 1996).  Taken together, these observations suggest that the 
primary defect in fs(1)ts319 is in the regulation of secreted protein synthesis or 
trafficking.  It is known that Nrt is not required for cleavage furrow formation (Speicher 
et al. 1998), so it is likely that the cellularization phenotype in fs(1)ts319 results from the 
misexpression of one or more other secreted proteins.  Although I have not ruled out that 
the disruption of the microtubule cytoskeleton is the primary defect, it has been shown 
that depolymerization of microtubules during cellularization does not significantly 
disrupt ER morphology based on HSC70-3 localization and causes NRT to accumulate in 
punctate structures in the basal cytoplasm (Lecuit and Wieschaus 2000).  Therefore, if the 
primary defect were in the microtubule cytoskeleton, I would expect NRT to be 
detectable but mislocalized and the ER morphology to be normal.  However, it is 
certainly possible that the gene affected in fs(1)ts319 has roles in multiple pathways.  
A1.2.7  Genetic complementation tests of cellularization-defective mutations  
Genetic complementation tests were performed between four of the mutants and a 
Bloomington X-chromosome deficiency kit covering approximately 85% of the X 
chromosome.  fs(1)148 was previously mapped to the gene small bristles, which encodes 
the Drosophila homolog of a human mRNA export factor, NXF1/TAP (Korey et al. 
2001), and was confirmed by non-complementation with a deficiency chromosome that 
removes the sbr gene (TableA1.3).  In addition, I confirmed the presence of the T to A 
mutation at nucleotide 461 of the sbr gene in fs(1)ts148 flies by sequence analysis, which 
is results in the amino acid change valine154 to glutamic acid (V154E) predicted to 
disrupt the RNA binding domain of SBR (Korey et al. 2001; Wilkie et al. 2001).  It is 
likely that at least one or more mRNAs that are required to mediate the events of 
cellularization are blocked from being exported out the nucleus in sbrts148 mutants, 
resulting in the cellularization phenotype at the restrictive temperature.   
 111 
Table A1.3  Temperature-sensitive mutations map to specific cytological loci on the 
X-chromosome 
 
Mutant Location Non-complementing Df & Complementing Dp 































Howard Wang was responsible for coordinating the genetic mapping of fs(1)448, 
fs(1)567, and fs(1)242, but the mapping was a group effort of many former and current 
students in the Sisson lab (including Howard Wang, Poornima Parameswaran, Jessica 
Cobarrubia, and Travis White).  These mutants were mapped to regions on the X-
chromosome using deficiency stocks and the zygotic lethality assay described in A3.5.2 
(Table A1.3). We made some attempts to identify the fs(1)ts242 mutation by sequencing 
candidate genes but were unable to identify a mutation (data not shown).  Otherwise there 
have not been any other efforts to identify the genes affect in these three mutants. 
A1.2.8  Efforts to identify the gene disrupted in fs(1)ts319 
fs(1)ts319 was genetically mapped using the maternal sterility assay described in 
A3.5.2, and I was able to map the mutation to a region of about 30 kilobases in the 
cytological position 10A6 [approximate recombination map unit (m.u.) 33.5].  I later 
meiotically mapped the mutation using the cellularization assay to a region between 
vermillion (m.u. 33.0) and forked (m.u. 56.7), consistent with the original mapping data.  
The candidate gene region contains four genes that could possible be affected: CG11122, 
a novel protein with putative nucleic acid binding domain, Rpt3, a subunit of 19S 
regulatory particle of 26S proteosome, Gtp-bp, the signal recognition particle receptor α 
(SRPRα) subunit, and Klp10A, a minus-end microtubule depolymerizing motor. A lethal 
P element residing in the Rpt3 gene complemented the maternal sterility of fs(1)ts319, 
suggesting that Rpt3 is not affected in fs(1)ts319.  I sequenced 77% of 28785 base pair 
region from genomic DNA and did not identify any missense or nonsense mutations in 
the protein coding regions of the four candidate genes (see A3.5.6 for a summary of 





Figure A1.7  Map for proposed fs(1)ts319 gene region 
 
expression of a gene, but rather affect the function of the gene product at the restrictive 
condition.  Despite this, there is a possibility that the mutated region in the fs(1)ts319 
resides outside of the protein coding sequence and affects the expression level of a gene 
in the candidate gene region at both the permissive and the restrictive temperatures, but 
the aberrant expression level only affects function of the gene product at the restrictive 
temperature.  To test this idea, mRNA levels were measured using qRT-PCR with 
material from WT and fs(1)ts319 cellularizing embryos at the restrictive temperatures.  I 
did not detect a significant change in mRNA abundance for the four candidate genes in 
the mutant embryos suggesting that mRNA expression is not affected (Figure A1.8).  In 
addition, protein levels could be measured by quantitative immunoblot analysis.  
Antibodies against KLP10A and GTP-BP have been described and could potentially be 





Figure A1.8  qRT-PCR analysis of candidate gene expression in WT and fs(1)ts319 
embryos 
Histogram shows fold change of the indicated mRNAs relative to RpL32 in WT vs. 
fs(1)ts319 embryos cellularizing at the restrictive temperature. 
 
Another approach to confirm the genetic position of the mutation is to attempt to 
rescue the mutant phenotype by introducing a WT copy of the gene region in the 
fs(1)ts319 mutant.  I generated germ-line transformants containing independent insertions 
of genomic rescue fragment 2 (pinfr2) using P element mediated transformation (Figure 
A1.7).  These stocks can be used to test for rescue of the cellularization phenotype at the 





A1.3  DISCUSSION 
In this study, I screened a collection of temperature-sensitive zygotic lethal and 
maternal sterile mutants to identify mutations that affect cellularization at the restrictive 
temperature.  Five mutant stocks were found to display cellularization defects at the 
restrictive temperature.  fs(1)ts148 was previously shown to be an allele of sbr, the gene 
that encodes the mRNA export factor, NXF1/TAP (Korey et al. 2001; Wilkie et al. 
2001).  The identification of a cellularization phenotype led us to use sbrts148 in other 
studies as a tool to affect the accumulation of zygotic transcripts in the cytoplasm during 
the MBT (Figure 2.5).  Embryos from fs(1)ts448 and fs(1)ts567 have relatively normal 
morphology during cellularization except that the furrowing rates are significantly 
perturbed (Table A1.1).  This more moderate cellularization phenotype is likely due to 
complete loss-of-function of the gene.  Embryos from hemizygous females (fs(1)ts/Df), 
which completely lack one copy of the gene, do not have a more severe furrowing 
phenotype (Table A1.1).  The genes disrupted in these mutants could have interesting, 
specific roles in furrow formation.  Embryos from fs(1)ts242 and fs(1)ts319 females 
display severe cellularization defects, which make the primary affect difficult to identify.  
Embryos from fs(1)ts242/Df do not display a more severe cellularization defect, yet 
embryos from fs(1)ts319 /Df had earlier defects even at the permissive temperature 
(Table A1.1).  These observations suggest that fs(1)ts242 is a complete loss-of-function 
mutant and that fs(1)ts319  is a partial loss-of-function mutant, suggesting that the gene 
perturbed in fs(1)ts319 is essential for other processes.  I chose to focus on fs(1)ts319 
based on the cellularization phenotype and strong maternal sterility.  
IF of fixed fs(1)ts319 embryos revealed defects in the MT cytoskeleton, ER 
morphology, and most strikingly, secreted protein accumulation.  The mutation was 
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genetically mapped to a region containing 4 candidate genes.  Despite my efforts, I could 
not identify the affected gene in fs(1)ts319.  Regardless, based on the observed phenotype 
affecting the secretion of secreted proteins, Gtp-bp  is an interesting candidate.  GTP-BP 
is a subunit of the receptor for Signal Recognition Particle (SRP).  The SRP binds to the 
signal sequence of nascent peptides of integral membrane proteins destined for the ER 
and targets them to the SPR receptor (SR) (Hegde and Kang 2008).  SR is composed of 
two subunits, alpha and beta, and Drosophila Gtp-bp encodes the alpha subunit.  It is 
tempting to speculate how affecting the function of the SR could result in the phenotypes 
we observe in fs(1)ts319 embryos.  It has been shown in budding yeast that the SRP 
pathway is important for maintaining the reticular structure of the ER.  In a screen for 
mutations that affect ER morphology, mutations in both the alpha and beta subunits of 
SR were found to have effects on ER morphology (Prinz et al. 2000).  These observations 
in yeast could explain the ER morphology defect observed in fs(1)ts319 embryos.  As 
mentioned above, the disruption of MTs is likely a secondary effect and not the cause of 
the abnormal ER morphology.  It is unclear if disruption of the ER could result in defects 
in MT morphology and remains a possibility.   
Unfortunately, without the identification of the mutation present in fs(1)ts319 or 
rescue data confirming the affected gene, we are left with an interesting phenotype and 
no molecular mechanism for its cause.  I have great hopes that the next person who 
tackles this project will identify the affected gene, adding more to our understanding of 







Appendix 2:  Miscellaneous experiments 
A2.1  ANALYSIS OF EARLY MITOTIC WAVES IN dFMR1- EMBRYOS 
I have described in detail the cleavage furrow formation phenotype observed in 
dfmr1- embryos, but as mentioned in Chapter 2, I also found a modest defect in the 
duration and pattern of nuclear cycles 12 and 13.  Here, I will describe the experiments I 
performed to assess these early divisions. 
The early mitotic divisions in the Drosophila embryo are thought to generally 
occur synchronously with highly reproducible timing.  In reality, the mitosis of nuclear 
cycles 10-13 occur metasynchronously, wherein entrance into and exit out of mitosis 
occurs in a wave-like pattern (Foe and Alberts 1983).  This pattern of mitosis can be 
observed by examining embryos expressing GFP-tagged proteins that reveal nuclear or 
MT dyanamics, embryos that have been injected with fluorescently labeled proteins, or 
embryos that have been fixed and stained.  The site from where the wave originates is 
variable, but the rate of the wave at any given cycle is highly reproducible.  It is unclear 
what regulates these mitotic waves.  In an effort to assess the early mitotic divisions, I 
injected fluorescently labeled tubulin into WT and dfmr1- embryos. 
Shortly following injection of rhodamine tubulin (Rhod-TUB) into embryos 
during interphase of NC10, the labeled tubulin is incorporated into MTs.  This 
incorporation is especially apparent during mitosis, when the mitotic spindles can be 
imaged along the surface of the embryo (Figure A2.1).  I injected Rhod-TUB into WT 
and dfmr1- embryos and imaged them as they progressed through NC10-13 on a Leica 
SP2-LCS confocal microscope.  I analyzed the movies by first measuring the time points 
from three locations at distinct locations for each embryo for each transition from 
interphase to mitosis (Figure A2.1).  This analysis showed that interphase of NC12 and 
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13 is slightly longer in dfmr1- compared to WT embryos  (Figure A2.2).  Furthermore, 
when I quantified the rate of the mitotic waves, I found that that the rate in dfmr1- 
embryos is significantly slower that in WT (Figure A2.3).  In addition to abnormal 
mitotic wave delays, I also observed occasional spindle defects, although these defects do 
not affect overall nuclear densities (Figure A2.4).   
Together these observations are consistent with dFMRP having a role in 
controlling the mitotic waves of nuclear cycles 12 and 13.  As I mentioned previously, it 
is unclear what controls these waves and if the regulation originates from nuclear or 
cytoplasmic factors.  As described in Chapter 4, we have discovered that dFMRP controls 
the translational regulation of CycB during the MBT, and as I discussed in section 1.3.2, 
CycB mRNA and protein are thought to be spatially as well as temporally regulated in 
order to control cell cycle progression.  Perhaps the translational regulation of CycB by 
dFMRP is also important for controlling the rates of the mitotic waves.  Future work 
examining the specific mechanism of translational regulation of CycB by dFMRP will 






Figure A2.1  Injected rhodamine tubulin incorporates into MTs in early embryos 
Still from a movie of a WT embryo injected with 10 mg/ml Rhod-TUB (Cytoskeleton, 
Inc.) during mitosis of NC10.  Bleb on lower right side indicates site of injection.  White 
line and three arrows indicate location of spindles scored for timing of transition of 
cycles.  High magnification panels to right show examples of embryos in mitosis and 
interphase.   
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Figure A2.2  Quantification of nuclear cycle length in WT and dfmr1- embryos 
Histogram shows the length in minutes of each mitosis and interphase of the cycles 
shown for WT (blue) and dfmr1- (yellow) embryos injected with Rhod-TUB during 
interphase of NC10.  Embryos were injected and imaged in a temperature controlled 
perfusion incubator at 25°C.  Number of movies quantified for each stage was as follows 
(M10=2, I11=4, M11=6, I12=6, M12=6, I13=6, M13=6).  Bars indicate standard error. 
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Figure A2.3  Quantification of mitotic wave rates show defects in dfmr1- embryos 
Histogram shows rates of mitotic waves in WT (blue) and dfmr1- (yellow) embryos 
injected with Rhod-TUB.  Rate was quantified by measuring the time points the nuclei 
entered the cycle from the three locations of the embryo as well as distance between the 
locations as described in the text.  Embryos were injected and imaged in a temperature 
controlled perfusion incubator at 25°C.  Five movies of each genotype were quantified.  


















Figure A2.4  Surface nuclear density of dmfr1- embryos is comparable to WT 
Histogram shows nuclear densities of WT (blue) and dfmr1- (yellow) embryos injected 
with Rhod-TUB during prophase of NC 11-13.  The total number of nuclei within a 7000 
µm2 area were counted using the Leica confocal system software.  Five embryos from 
each genotype were quantified.  Bars indicate standard error. 
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A2.2  STABLE ISOTOPE METABOLIC LABELING OF dFMR1- EMBRYOS 
In collaboration with John Yates at Scripps, John Sisson initiated an additional 
proteomic screen to identify targets of dFMRP regulation using stable isotope metabolic 
labeling.  This method has been successfully used in yeast and flies to label all proteins in 
vivo (Washburn et al. 2002; Krijgsveld et al. 2003).  Proteins can be metabolically 
labeled with either 14N or 15N and the relative abundance of an individual protein can be 
determined by mass spectrometry.  We decided to use this method to compare the 
proteomes of control and dfmr1- cleavage stage embryos, and I have established the 
protocol to be used in the Sisson lab.    
To label the proteins in Drosophila embryos, adult flies were fed 14N- or 15N-
labeled yeast.  Embryos that were morphologically stage matched were collected, quickly 
frozen, and used to make extracts.  These extracts were then sent to the Yates lab where 
the two extracts were combined and subjected to MudPIT mass spectrometry.  I was able 
to complete one round of labeling and protein identification in collaboration with Lujian 
Liao, a post-doc in the Yates lab.  At least two more rounds of labeling and mass 
spectrometry will be required to detect significant changes in the dfmr1- embryos.  Here, 
I will describe the procedure for these experiments in detail, which I adapted from 
Washburn et al. 2002; Krijgsveld et al. 2003. 
Prepare 1L cultures of S. cerevisiae Type II strain grown to high OD ~5.0 in 
Yeast 14N or 15N Minimal Media [1.7 g/L yeast nitrogen base w/o amino acids w/o 
ammonium sulfate (Difco), 20.0 g/L  dextrose (Difco), 5.0 g/L ammonium sulfate (14N) 
(Sigma) OR  ammonium sulfate (15N) (Cambridge Isotope Laboratories, Inc)] at 30°C for 
~24-36 hours in 2.5L high yield flasks (Thomson Instruments CO) with AirOTop Seal - 
start from 5ml overnight cultures.  This strategy was shown to label close to 98% of total 
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protein (John Yates, email correspondence).  Pellet yeast in 500ml dry-spin bottles in 
SLA-3000 at 700rpm for 15min. Prepare agar mix for condos (Nalgene #2119-1000) and 
collection caps (35 x 10 mm Petri dish) [15 g/L  granulated agar, 10% (w/v) sucrose, 
0.03% (v/v) propionic acid, 0.2% (v/v), phosphoric acid, 0.1 mg/ml ampicillin] by 
pouring ~100 ml into each condo and ~3 ml into each collection cap and allowing to cool 
overnight.  Cover half of agar with one layer of sterile cotton.  Pipette ~30ml fly food 
mix [10% (w/v) sucrose, 0.03% (v/v), propionic acid, 0.2% (v/v) phosphoric acid, 0.1 
mg/ml ampicillin] on cotton (add enough so cotton is almost saturated).  Smear 1/3rd of 
pelleted yeast on agar. 
Collect 0-24 hr WT and mutant embryos, remove agar from caps and place on 
agar in condo, and allow to develop at 25°C in humidified incubator.  Labeling must be 
done in reciprocal, so I always set up two experiments in parallel as follows: 
experiment 1 = w1118 and Df(3R)exel6265/TM3 embryos on unlabeled yeast 
  fmr13/TM3 and Df(3R)exel6265/TM3 embryos on 15N-labeled yeast 
experiment 2 = fmr13/TM3 and Df(3R)exel6265/TM3 embryos on unlabeled yeast 
  w1118 and Df(3R)exel6265/TM3 embryos on 15N-labeled yeast 
Transfer ~5 ml 15N-labeled or unlabeled adult flies to collection cages and repeat 
two additional times.  During final round collect virgin females from fmr13/TM3 and w1118 
and mate to  Df/TM3 in collection bottles, and repeat.  Finally, transfer ~5 ml 15N-labeled 
or unlabeled adult flies to collection cages and hand sort mid-cellularizing embryos from 
2-3 hr collections.  The following procedure was adapted from Gong et al., Development 
2004, Minden et al., Drosophila Protocols 2000, and email correspondence with Jon 
Minden (Carnegie Mellon University).   
Prepare two 15 ml falcon tubes each with 10 ml ethanol (95%), one tube on ice 
and the other half way inserted into dry ice/EtOH bath.  Dechorionate embryos in 50% 
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bleach, rinse with embryo wash buffer (EWB; 0.7% NaCl, 0.03% Triton X-100) and 
transfer to small petri dish or dissecting dish with EWB and sweep embryos into center of 
dish with gentle swirling.  Examine embryos under dissecting stereomicroscope with 
transmitted-light illumination and form a pile of appropriate staged embryos by gently 
pushing embryos with stainless steel probe.  Remove the desired embryos in a minimal 
volume of EWB with pasteur pipette and drop into the iced ethanol. As the embryos settle 
to the bottom, the EWB is diluted. Replace this ethanol every once in a while to keep the 
fraction of EWB low.  Typically, transfer the embryos in less than 0.2 ml and change the 
ethanol every 1 ml of EWB added.  Remove the settle embryos from the ice-cold ethanol 
and drop into the ethanol on dry ice, again using a minimal volume. The reason for only 
having the tube half way into the dry ice is to prevent any of the carry over water from 
freezing.  Embryos can be stock-piled in the iced or the dry-iced ethanol.  Once the 
embryos are frozen, do not let them thaw until ready to prepare them for gel 
electrophoresis.  For long-term storage, transfer the embryos out of the falcon tube into 
an eppendorf tube, pre-cooled on dry ice. This can be store at -80°C or shipped on dry 
ice. 
I made whole embryo lysates from each set of embryos by homogenizing 
embryos in 1.5 ml tubes with a plastic kontes pestle in 4X volumes of metabolic labeling 
extraction buffer [MLEB; 25mM  HEPES pH 7.5 (with KOH), 100mM KCl, 500mM 
EDTA pH 8.0, 0.05% Triton X-100, protease inhibitor cocktail at 1:1000].  Concentration 
of each sample was quantified using Bradford assay, frozen in liquid N2 and stored at      





  Appendix 3:  Materials and Methods 
A3.1  FLY HUSBANDRY 
All fly stocks were grown on standard corn meal molasses and kept in incubators 
at 20°C, 25°C or 29°C as indicated.  Genetic crosses were set up using standard methods.  
Fly food was prepared by John Loera, a laboratory research assistant at the University of 
Texas at Austin, using the following recipe: 76  g/L corn meal , 76 mL/L Karo syrup, 
18 g/L brewer’s yeast, 9 g/L agar, 1 g/L nipagin (mold inhibitor), 111 mL/L malt extract , 
5 m/L propionic acid , and 5 mL/L 100% ethanol.  
 
A3.2  CHAPTER 2 
A3.2.1  Fly stocks and genetics 
Oregon-R (WT) and w1118; Df(3R)Exel6265/TM6B Tb, and Df(3L)iro-2, Sbsbd−2/TM3, Sb1 
(Bloomington Stock Center), tral2/TM6B and tral3/TM6B (Exelixis collection), w1118; 
fmr13/TM6C, Tb, Sb, and w1118; P(WTfmr1); fmr13/TM6C, Tb, Sb (T. Jongens, University 
of Pennsylvania), and yw, sbrts148 (W. Sullivan, University of California, and I. Davis, 
University of Edinburgh) were used. We believe there are additional mutations on the 
chromosome containing the dfmr13 allele.  In our hands, homozygous dfmr13 females 
have a very severe maternal sterility defect, but dfmr13/Df have a more moderate maternal 
sterility defect.   
A3.2.2  Maternal and paternal fertility  
Female and male fertility was assessed by measuring egg hatch percentages using 
the following procedure.  ~12-15 virgin females were collected in a single day and 
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allowed to age 48 hours in yeasted vial. The absolute number of females was not 
important, but the same number must be used among genotypes being compared.  The 
females were then mated to 4-5 males for 48 hr in yeasted vial.  The adult flies were then 
transferred to an egg laying cluster (14 x10 ml plastic vials glued together with air holes 
drilled into bottom of tubes), with each cross in a single tube.  The cluster was placed on 
grape juice agar plates [3% granulated agar (w/v), 5.5% sucrose (w/v), 25% grape juice, 
1.25% glacial acetic acid (v/v), and 2.5% ethanol (v/v)] with a small amount of wet yeast 
for each tube and placed in a humidified chamber at 25°C.  Embryos were collected for 
12 hr and allowed to age for 24 hr.  The numbers of hatched (empty) and unhatched egg 
shells were counted.  I found that the collection and age times varied with experiment, 
and so I adjust as needed so WT control laid about 100-200 eggs with 95-100% hatch 
percentage.  Hatch Percentage = # empty shells / total # eggs laid 
A3.2.3  Live embryo imaging 
Embryos were collected from WT or specified mutant females mated to WT 
males at 25°C.  Embryos were hand dechorionated, lined up on heptane glue (mixture of 
heptane and doublestick tape) on glass slides, and covered in Halocarbon 700 oil.  Live 
embryos were imaged in a microincubator (PDMI-2; Harvard Apparatus) at 25°C every 
15 sec using a Leica SP2-LCS confocal microscope with differential interference contrast 
(DIC) optics.  Movies were compressed to 5 frames per second using either the Leica 
system software or QuicktimePro.  
A3.2.4  Fixed embryo analysis 
Embryo fixations and indirect immunofluorescence was performed as described 
in Sisson et al. 2000. Embryos were dechorionated in 50% bleach and rinsed in embryo 
wash buffer (EB; 0.7% NaCl, 0.03% Triton X-100).  The embryos were fixed in 19% 
 128 
formaldehyde/paraformaldehyde/3% methanol in 1X PBS (1.4 M NaCl, 0.02 M KCl, 0.1 
M Na2HPO4, 0.02 M KH2PO4  pH 7.4) over heptane for 25-30 min with gentle agitation. 
After fixation embryos were affixed to double stick tape and covered with 1X PBTA (1X 
PBS, 1% BSA, 0.05% Triton X-100, 0.02% NaN3).  Detection of ME31B required 1× 
PBTA with 0.5% Triton X-100. For temperature-shift experiments, WT and sbrts148 
embryos were kept at 20°C or shifted to 32°C for 25 min in 0.7% NaCl/0.03% Triton X-
100 on a slide warmer and fixed as described above.  The vitelline membranes were 
removed by hand using a 27g needle on a syringe by gently nudging embryos with 
needles.  Before incubating devitellinized embryos with primary antibody they were 
blocked in 1XPBTA for 1 hr at room temperature with agitation on Nutator (TCS 
Scientific).  For immunofluorescence detection, embryos were incubated in primary 
antibody dilution overnight at 4°C on Nutator, washed 4-6 times in 1X PBTA at room 
temp, incubated in secondary antibody dilution for 2 hours at room temp on Nutator, 
washed 4-6 times in 1X PBTA at room temp on rocker, rinsed once in 1X PBS and 
mounted in Vectashield (Vector Labs) (~35ul Vectashield for 22x22mm coverslip). 
A3.2.5  Colocalization analysis 
The colocalization between dFMRP and other proteins was quantified as follows. 
Fixed WT embryos of the exact same stage of cellularization were prepared for IF by 
using antibodies against dFMRP and either TRAL, ME31B, dAGO2, or LVA and imaged 
by scanning confocal microscopy. Optical sections were collected through the apical or 
basal cytoplasm, and a minimum of five identically staged embryos were analyzed for 
each IF experiment. Leica confocal system software was used to identify punctate protein 
localization within two separate 16 µm2 fields of view along the length of each embryo. 
Puncta were defined as discrete localization that fit within electronically drawn 0.75 µm 
diameter circles with a mean fluorescence intensity of ≥175. The normal range for the 
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mean fluorescence intensity of a 0.75 µm diameter circular area within a 16 µm2 field of 
view was 80-225. Generally, 20-30 punctate structures were observed within a given 16 
µm2 field of view for each of the proteins of interest. Any two distinct puncta within the 
same field of view that overlapped by 50% or more were considered to colocalize. 
Overlap below 50% was not considered colocalization. As a control to quantify a baseline 
colocalization for each double IF experiment, we electronically flipped the dFMRP IF 
images with respect to their matched image for TRAL, ME31B, dAGO2, or LVA and 
calculated the extent of colocalization between distinct puncta as before. Statistical 
analysis of colocalization compared with control colocalization data sets was performed 
using a two-tailed Student's t test.   
A3.2.6  General biochemistry and protein immunoblot analysis 
Except as noted, extract preparation, protease inhibitor mixture, and standard 
Protein immunoblotting procedures were performed according to Sisson et al. 2000. 
Adult flies were collected on ice, homogenized in SDS sample buffer lacking dye, and 
boiled for 10 min. Clarified extracts were analyzed by standard immunoblot analysis. For 
quantitative immunoblots, S14 supernatants were prepared (see below) from WT or 
dfmr1- embryos and processed by using the manufacturer's protocol for the Odyssey 
Infrared Imaging System (LI-COR Biosciences). Antibodies described in above and 
mouse monoclonal anti-humanP68 (MAD1; F. Fuller-Pace, University of Dundee, 
Dundee, Scotland) were used for immunoblotting.  
A3.2.7  Sucrose Density Gradients 
Cellularizing embryos were collected, dechorionated in 50% bleach, flash frozen, 
and stored at −80°C for a few days, then glass dounce homogenized in 5 volumes of 
Polysome Gradient Buffer [PGB; 15 mM Tris, pH 7.5/100 mM KCl/10 mM MgCl2/2 mM 
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DTT/200 μg/ml cycloheximide/50 units/ml rRNasin (Promega) and protease inhibitors] 
and centrifuged at 3,000 × g for 10 min. The postnuclear supernatant was centrifuged at 
14,000 × g for 10 min and the resulting supernatant (S14) was quantified for protein and 
nucleic acid. Gradients (12 ml) of equal layers of 5%, 20%, 35%, and 50% sucrose in 
PGB were allowed to equilibrate during horizontal storage at 4°C for ≈1.5 hr and then 
were loaded with 1.2 mg of S14, centrifuged at 285,000 × g (max) for 2.5 h in a SW40 
rotor, and fractions were collected through a UV flow cell monitoring A 254. All of 
fractions 10–22 and 20% of fractions 1–9 were precipitated in 75 μg/ml insulin with 10% 
trichloroacetic acid and resuspended in SDS/PAGE sample buffer for protein immunoblot 
analysis.  
A3.2.8  Immunoprecipitations (IPs) 
Postnuclear supernatants were made from frozen embryos homogenized in TKT100 
buffer (10 mM Tris·HCl, pH 8.0/100 mM KCl/0.05% Triton X-100 with 1 mM DTT/50 
units/ml rRNasin/protease inhibitors) and centrifuged at 10,000 × g for 10 min. The S10A 
was diluted to 1 mg/ml, placed on ice for 30 min, and centrifuged as before to make a 
working S10B. Anti-dFMRP (6A15; AbCam) and anti-FLAG (M2; Sigma) antibodies 
were coupled to protein G Sepharose 4B (Sigma), and anti-TRAL polyclonal serum was 
coupled to Affi-Prep Protein A Gel for 1 hr at room temperature (Bio-Rad). The latter 
also was BSA-coated as a control. IPs were carried out for 1 h at 4°C with 25 μl of anti-
dFMRP/beads or anti-FLAG/beads and 0.25 mg of S10B or 15 μl of anti-TRAL/beads or 
BSA/beads and 0.1 mg of S10B, washed extensively in TKT100 buffer, eluted with 
SDS/PAGE sample buffer at 90°C for 2 min, and analyzed by immunoblot analysis.  
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A3.2.9  Quantitative reverse transcription PCR (qRT-PCR) 
RNA was isolated by using TRIzol-LS reagent (Invitrogen) from fresh 
cellularizing embryos (derived from WT or dfmr1 − females), IPs, and corresponding 
S10B. RNA was treated with RQ1 DNase (Promega) according to the manufacturer's 
protocol, followed by the addition of EGTA and heat treatment (65°C for 10 min) or 
phenol-chloroform extraction and ethanol precipitation. IPd RNA samples were 
reprecipitated with NaCl and ethanol before reverse transcription. Treated RNA (1 μg 
from embryos or 73 ng from IPs and S10B) was reverse transcribed by using oligo(dT) 
and the SuperScript II RNase-H-Reverse Transcriptase protocol (Invitrogen). Real-time 
PCR was performed by using a 7900HT Sequence Detector and Power SYBR PCR 
Master Mix [Applied Biosystems (ABI)]. Levels of specific mRNAs were determined by 
relative quantification with a standard curve and normalized to RpL32 mRNA. Specificity 
was confirmed by dissociation curve analysis and agarose gel electrophoresis. Statistical 
analysis was based on a minimum of triplicate samples.  
A3.2.10  Antibodies 
The following antibodies were used: DSHB mouse monoclonal Abs dFMRP 
5A11 (1:10), Tubulin (1:250) and Futsch 22C10 (1:50), rabbit polyclonal antibodies 
Trailer Hitch [1:500; M. Snee and P. Macdonald (University of Texas)], ME31B [1:500; 
A. Nakamura (RIKEN Genomic Sciences Center)], dAGO2-90 [1:50; G. Hannon (Cold 
Springs Harbor Laboratory)], Lava Lamp (1:5,000), Myosin II [1:100; C. Field (Harvard 
Medical School)], and Anillin 4-11 1:500 [C. Field (Harvard Medical School)].  Primary 
antibodies were detected with species-specific secondary affinity-purified Alexa Fluor 
antibodies (Molecular Probes, Invitrogen).  RNase-treatment was done with 10 mg/ml 
RNase A (Sigma) in 1X PBS for 4 h at 37°C prior to incubation with primary antibodies. 
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All other fixed embryos were not RNase-treated. Rhodamine-Phallodin was used at 1:100 
to detect F-actin (Cytoskeleton).   
 
A3.3  CHAPTER 3 
A3.3.1  Fly stocks and genetics 
The following stocks were obtained from the Bloomington Stock Center: 
w1118; TM3, Sb/CxD 
y1w; RpS131/CyO 
w1118; Df(3R)Exel6191 /TM6B, Tb1 - cct1 
w1118; Df(3R)Exel6270 /TM6B, Tb1 - cct3 
w1118; Df(2L)Exel6034 /CyO - cct4 
w67c23 P{w[+mC]=lacW}Tcp-1zeta[G0057]/FM7c - cct6 
w1118; Df(3R)Exel6150/TM6B, Tb1 - cct7 
w1118; Df(2R)Exel6052 /CyO - scra 
For the proteomic screen, to limit variation in genetic background between control 
and mutant embryos, single flies from w; dfmr13/TM6C, Tb, Sb and w1118; 
Df(3R)Exel6265/TM6B Tb, Sb1 and w1118 were outcrossed to w1118; CxD/TM3 over three 
generations, and stocks were established from single flies.   
A3.3.2  Two dimensional difference gel electrophoresis and mass spectrometry (2D 
DIGE/MS) 
Embryos were collected from w1118; dfmr13/Df(3R)Exel6265 (dfmr1-) and w1118; +/ 
Df(3R)Exel6265 (control), and midcellularizing embryos were hand sorted and frozen as 
described in (Gong et al. 2004).  Mutant and control proteins were labeled and separated 
in 2D gels as described in (Gong et al. 2004; Viswanathan et al. 2006).  In brief, equal 
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masses (100-150 ug) of total protein from control and mutant embryos were labeled with 
Cy3-NHS or Cy5-NHS, subjected to isoelectric focusing on 13 cm, pH 3-10 non-linear 
Immobiline strips according to the manufacturer's protocol (Amersham Biosciences), and 
separated through 10-15% SDS-PAGE gradient gels.  For each experiment control and 
mutant proteins were reciprocally labeled in parallel: Cy3-NHS-labeled control/ Cy5-
NHS-labeled mutant and Cy5-NHS-labeled control/ Cy3-NHS-labeled mutant.  To 
control for loading error, 1 µg of BSA was added to each sample prior to labeling.  Gels 
were imaged with imager integrated with robotic gel cutter.  Gel images were analyzed 
using IPLab (Scanalytics) and QuickTime, and protein intensities were quantified using 
SExtractor (https://sourceforge.net/projects/sextractor) as described in (Viswanathan et 
al. 2006).  Proteins of interest were excised from gels and mass spectrometry fingerprint 
analysis and protein identification was performed as described in (Gong et al. 2004).  
A3.3.3  Immunoprecipitations  
WT and dfmr1- mid-cellularizing embryos were collected, dechorionated, and 
frozen.  Because dfmr1- embryos are slightly developmentally delayed, dfmr1- embryos 
were allowed to age an additional 15 min (~2.25-3.25 hr for WT and ~2.5-3.5 hr for  
dfmr1-).  A sample of each embryo collection was checked to ensure equivalent staging 
between the two genotypes.  Anti-dFMRP IPs were performed using extracts made from 
the embryos (10,000 x g supernatants (S10) in TKT100 buffer [10 mM Tris􏰌HCl pH 8.0, 
100 mM KCl, 0.05% Triton X-100, 1 mM DTT, 50 units/ml rRNasin, protease 
inhibitors]) as described in 3.2.7.  Anti-PNUT IPs were performed as follows.  250 µg 
WT and dfmr1- S10 was incubated with 0.75 µg Rabbit anti-PNUT antibody for 10-12 
hrs at 4°C.  A mock-IP was performed with WT extract and no antibody.  25 µl BSA-
coated protein G Sepharose 4B (Sigma) was added to each mixture for 4 hrs at 4°C.  
 134 
After supernatants were removed, beads were washed 5 times in TKT100, eluted with 
SDS/PAGE sample buffer at 90°C for 2 min, and analyzed by immunoblot analysis.  
A3.3.4  qRT-PCR  
Total RNA was extracted from embryos, immunoprecipitateed material and 
corresponding input S10 extracts using TRIzol-LS reagent (Invitrogen).  1 µg of total 
embryonic RNA or 100 ng of total immunoprecipitated or S10 RNA were digested with 
amplification grade DNAse I (Invitrogen) and heat inactivated according to 
manufacturer’s protocol followed by reverse transcription using the High Capacity cDNA 
Reverse Transcription Kit (ABI) including RNase Inhibitors (Promega).  Quantitative 
PCR was performed in 10µl reactions in 384-well plates with Power SYBR PCR Master 
Mix in a 7900HT Sequence Detector (ABI) using the following parameters:  
1.  50° x 2min 
2.  95° x 10min 
3.  95° x 15sec 
4.  60° x 1min (this temp will vary depending on primer set) 
5.  repeat steps 3 and 4 for 40 cycles 
6.  95° x 15sec 
7.  60° x 15sec 
8.  95° x 15sec 
PCR data was analyzed using SDS 2.3 software according to manufacturer’s 
recommendations and relative levels of specific mRNAs were quantified as in A3.2.9. 
When designing primers for these experiments I tried to stay within the following 
parameters: try to choose a primer pair that straddles an intron, limit amplification size to 
60-175bp, limit GC content to 30-70%, the five nucleotides at the 3’ end should have no 
more than two G and/or C bases, limit Tm to 57-60°C, check primer pair to ensure no 
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dimers will form, and blast primer to ensure there are no sites in the genome that have 
100% identity to 18 consecutive bases.  
A3.3.5  Quantitative protein immunoblot analysis 
Supernatants (S10) were prepared from WT or dfmr1- embryos as in A3.3.3, 
quantified using Bradford reagent (Biorad), and processed by using the manufacturer's 
protocol for the Odyssey Infrared Imaging System (LI-COR Biosciences).  Blots were 
imaged using the Odyssey two-color infrared imaging system, and proteins were 
quantified using the system software (Institute for Cell and Molecular Biology Core 
Facility).  
A3.3.6  Gel filtration chromatography 
WT and dfmr1- embryos were collected and extracts were prepared as described 
for IPs above.  Between 1.0 mg and 1.3 mg of total protein from each genotype was 
separated by gel filtration chromatography on a Superose 6 column (GE Healthcare) at a 
rate of 0.2 ml/min with 1 ml fractions collected over the entire run.  Fractions were 
precipitated using with 10% trichloroacetic acid, resuspended in SDS/PAGE sample 
buffer, and analyzed by immunoblot analysis.  Molecular weight standards were 
separated through column prior to embryonic extracts. 
A3.3.7  Live embryo imaging 
Embryos were collected from wild type or mutant females mated to wild type 
males at 25°C.  Analysis of cellularization was done as described in A3.2.3 (Monzo et al. 
2006).  Embryos were imaged using a Zeiss AxioVert 200 microscope with a 40x EC 
Plan Neofluor objective equipped with differential interference contrast optics. 
A3.3.8  Fixed embryo analysis 
Fixed analysis was performed as described in A3.2.4. 
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A3.3.9  Antibodies 
The following antibodies and stains were used in this study: anti-dFMRP (6A15; 
AbCam, Cambridge, MA), anti-alpha Tubulin (DM1A, Sigma), anti-PNUT [1:500; 
KEKK, C. Field (Field et al. 1996)], anti-PNUT (no dilution; 4C9H4, Developmental 
Studies Hybridoma Bank), anti-Anillin (1:500; C. Field), and anti-CCT1 (1:500; 91A, 
AbCam).  Dilutions in parenthesis indicate those used for IF analysis on fixed embryos.  
Typically, a 100-fold dilution of the dilution for IF worked well for immunoblot analysis.   
 
A3.4  CHAPTER 4 
The results in this chapter have not been published but are being prepared for 
submission for publication.  Because of this, I am only including the methods for the 
experiments I performed.  The methods of the experiments performed by Ophelia 
Papoulas will be published at a later date.  
A3.4.1  Fly stocks and genetics 
The following stocks were obtained from the Bloomington Stock Center: 
w; Df(3L)cat ri sbd e/TM3 Ser ri e and y1 w67c23; P{EPgy2}CG18811EY0749 and w*; 
CycB2/CyO.  Ophelia Papoulas generated w; capr2/TM6B Hu using standard imprecise P 
element excision techniques.  Loss of capr was confirmed by PCR analysis and loss of 
CAPR was confirmed by immunoblot analysis.  
A3.4.2  Live embryo imaging 
  Initial analysis of cellularization was done as described in A3.2.3.  For analysis 
of the cortical nuclear divisions, embryos were prepared as above and imaged using a 
Zeiss AxioVert 200 microscope with a 40X EC Plan Neofluar objective equipped with 
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differential interference contrast optics.  Imaging was started just prior to nuclear cycle 
10 shortly after pole buds were formed and imaged every 15 sec until the end of 
cellularization at room temperature (23.5-25.5°C).  Duration of interphase and mitosis of 
each cortical division was determined by measuring lengths between nuclear envelope 
breakdown and reassembly.  Penetrance of precocious mitosis 14 was determined by 
counting the total number of embryos imaged that either partially or completely 
cellularized during interphase of nuclear cycle 15.  Nuclear densities at cortex were 
measured to confirm that mutant embryos begin cortical divisions relative to pole bud 
formation normally.  In addition, mutant embryos that cellularize during nuclear cycle 15 
have an increased nuclear density compared to wild type cellularizing embryos at nuclear 
cycle 14. 
To test if reduction of zygotic Cyclin B can reduce the penetrance of the 
precocious mitosis 14 phenotype, embryos were collected from virgin w1118; +/+; 
capr2/Df(3L)Cat, dfmr13 females mated to w1118; CycB2/CyO-GFP; +/+ males and imaged 
as described above.  Embryos were allowed to age at least 2 hr and imaged using a 
fluorescent microscope to determine if embryo received the CycB- or CyO-GFP 
chromosome.    
A3.4.3  Fixed embryo analysis 
Fixed analysis was performed as described in A3.2.4.  For visualization of spindle 
microtubules paclitaxel (Sigma) was added to a final concentration of 2.5 µM as 
described in Maldonado-Codina and Glover 1992.  
A3.4.4  qRT-PCR 
Quantification of steady state mRNA levels was done as described in A3.3.4. 
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A3.4.5  Antibodies 
The following antibodies and stains were used  for IF in this study:  anti-dFMRP 
(1:10; 5A11, DSHB), anti-Caprin (1:500; 592), anti-alpha Tubulin (1:250; DM1A, 
Sigma), anti-phospho-Histone H3 (Ser10) (1:250; Cell Signaling Technology).  DNA was 
visualized with TO-PRO-3 iodide (Invitrogen Molecular Probes). 
 
A3.5  APPENDIX 1 
A3.5.1  Fly stocks and genetics 
All fly stocks were maintained at 20°C or 29°C as indicated.  The collection of 
EMS-induced, X chromosome-linked, temperature-sensitive (ts) mutants was generated 
by Helen Francis-Lang and William Sullivan (Macdougall et al. 2001).  The collection 
was screened for ts zygotic lethality and maternal sterility in collaboration with Drs. 
William Sullivan, Helmut Kramer and Bing Zhang.  The following stocks were screened 
for ts cellularization defects: 
Oregon-R, the X-chromosome deficiency kit, and other deficiency stocks were 
obtained from the Bloomington Stock Center.  Df(1)DA622/FM7 was a gift of N. 
Perrimon.  
A3.5.2  Maternal fertility and zygotic viability 
Temperature-sensitive zygotic lethality was determined by comparing numbers of 
homozygous mutant flies reared at 20°C or 29°C.  Homozygous mutant females were 
mated to hemizygous mutant males at 20°C.  48-72 hr collections of embryos were kept 
at either 20°C or shifted to 29°C and allowed to develop.  Relative eclosure was 
calculated by dividing the total number of F1 adults eclosed from each cross by total 
number of WT F1 adults eclosed at 20°C.  Maternal fertility was determined by counting 
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the numbers of embryos laid and hatched from homozygous mutant females mated to 
FM7a balancer males at 20°C and 29°C, as described in A3.2.2.   
A3.5.3  Complementation analysis 
Genetic complementation tests for those mutations that displayed strong ts zygotic 
lethality were performed by crossing virgin females with the deficiency to ts males at 
20°C in two replicate vials.  After 48-72 hr collections at 20°C, adults were flipped into 
new vials.  One replicate vial was kept at 20°C, and the other was shifted to 29°C.  The 
total number of eclosed adults were counted from two collections and compared.  We 
expected that crosses with non-complementing deficiencies would produce less adults in 
the cross reared at 29°C compared to the cross at 20°C. 
To test for genetic complementation with fs(1)ts319, maternal fertility at the 
restrictive temperature was assayed.  Virgin females from the deficiency stocks were 
crossed to fs(1)ts319 males to obtain virgin fs(1)ts319/Df females at 20°C.  These females 
were mated to FM7a males at 20°C for 5 days.  Adults were flipped into new vials and 
shifted to 29°C and the 5 day collection of embryos was allowed to develop at 20°C.  
Adults at 29°C were flipped into new vial after 2 days (essentially to ‘equilibrate 
females’ to the restrictive temperature) and kept at 29°C.  The numbers of adults hatched 
from 20° and 29° vials were compared. We expected that females heterozygous for  
fs(1)ts319 and a non-complementing deficiency would produce less adults in the cross 
reared at 29°C compared to the cross at 20°C. 
A3.5.4  Live embryo imaging 
Time-lapse recordings of all embryos were performed as follows.  Embryos were 
hand prepared for imaging as described in A3.2.3.  The development of the embryos was 
monitored at 20°C.  At the onset of nuclear cycle 14, the temperature of the incubator 
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was increased to 32°C and time-lapse imaging began.  Embryos were imaged with a 15 
sec delay between frames until the onset of gastrulation.  Movies were compressed to 5 
frames per second in QuickTime Pro with Sorenson Video 3 Codec.  Rates of nuclear 
elongation and furrow ingression were calculated from live time-lapse recordings.  The 
distance from the cortex to the basal ends of representative nuclei and the corresponding 
furrow front at 25, 50, and 75% egg length were measured every 5 min using the Leica 
imaging software.  
A3.5.5  Fixed embryo analysis 
Embryos were collected from homozygous mutant females and allowed to age at 
20°C.  Embryos were incubated at 32°C in small volume of embryo wash buffer (0.7% 
NaCl, 0.03% Triton X-100) for 25 min on a slide warmer and fixation and 
immunodetection of proteins was performed as described in A3.2.4.  Detection of cell 
surface using concanavalin-A required embryos to be fixed in the absence of all 
detergent.  Detection of Neurotactin required heat/methanol fixation.  Dechorionated 
embryos were added to 10 ml of 150 mM NaCl, 0.05% Triton X-100 at 90°C in a test 
tube and were vortexed for 5 sec, decanted into 40 ml chilled 150 mM NaCl, 0.05% 
Triton X-100, and incubated on ice for 5 min.  Embryos were then transferred to a 1.5 ml 
tube and devitellinized by adding equal parts hepatane and 100% methanol and shaking 
vigorously for about 30 sec.  All of the liquid was aspirated off from the devitellinized 
embryos that were at the bottom of the tube.  Fresh 10% methanol was added.  Embryos 
were then rehydrated using changes of 75%, 50% and 25% methanol in 1X PBS. 
A3.5.6  Semi-quantitative RT-PCR and qRT-PCR 
Oregon-R and fs(1)ts319 cellularizing embryos were subjected to permissive or 
restrictive temperature during cellularization as described above except after 
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dechorionating, total RNA was extracted with TRIzol Reagent (Invitrogen) according to 
manufacturer’s protocol.  First strand cDNA synthesis was performed with 1 mg total 
RNA using SuperScript II Reverse Transcriptase and an oligo(dT) primer (Stratagene).   
2 ul of RT reaction was used for PCR amplification using the following parameters:  26-
28 cycles of 94°C x 20 sec, 55°C x 30 sec, 72°C for 20 sec.  Cycle number was optimized 
to identify linear range of amplification for each gene. Primers were designed to span an 
intron.  qRT-PCR was performed as described in A3.2.9. 
A3.2.7  Quantitative protein immunoblot analysis 
Whole embryo extracts were prepared from WT or fs(1)ts319 embryos as in 
A3.3.3, quantified using Bradford reagent (Biorad), and processed using the 
manufacturer's protocol for the Odyssey Infrared Imaging System (LI-COR Biosciences).  
Blots were imaged using the Odyssey two-color infrared imaging system, and proteins 
were quantified using the system software (Institute for Cell and Molecular Biology Core 
Facility, The University of Texas at Austin).  
A3.5.8  gDNA rescue fragment 
Three genomic rescue fragments that overlap the candidate genes were designed 
by Howard Wang (Figure A1.7).  Ophelia Papoulas subcloned rescue fragment 2 (infr2) 
containing Rpt3 and Gtp-bp from a BAC clone (BACN02C07) into pCaSperR 4 vector 
using standard techniques.  I used standard P-element mediated transformation 
techniques to generate germ-line clones:  0.5 mg/ml pinfr2 and 0.15 mg/ml Transposase 
in 1X injection buffer (0.1 mM potassium phosphate pH 7.8, 5 mM  KCl) was injected 
into posterior end of desiccated embryos.  Insertions were mapped to chromosome using 
standard genetic techniques.  The name of the rescue fragment (infr2) comes from our 
original name we gave the fs(1)ts319 allele.  Before mapping the mutation we named the 
 142 
fs(1)ts319 allele inferno because the disruptions observed during the live analysis was 
reminiscent of an inferno.  The stocks have been maintained at 20°C. 
A3.5.9  Sequence analysis 
Genomic DNA (gDNA) was extracted from homozygous whole fs(1)ts319 
females using a protocol adapted from Ken Burtis, Stanford University.  Fragments of 
candidate genes were amplified by PCR.  PCR products were purified using the 
QIAquick PCR Purification Kit (Qiagen).  Sequencing was performed by the Institute for 
Cellular and Molecular Biology DNA Core Facility at UT Austin.  Sequence from 5’ and 
3’ strand was analyzed in MacVector against sequence from the D. melanogaster 
sequence Release 5.1.  Because we could not obtain the parental stock that was 
mutaginized, gDNA from other stocks in the collection was used as a control when 
needed.  Because the ts stocks had been carried for many years here was a concern that 
the fs(1)ts319 stock may not be homogenous for the affected chromosome, so I also 
sequenced gDNA from single fs(1)ts319/Df(1)RA37 females that were tested for ts 
maternal sterility. Single-fly DNA preps was performed as described in (Gloor et al. 
1993).  
The following is a summary of the sequence results:  77% of 28785bp gene region 
sequenced (excludes sequence 5’ of Hsp60 and 3’ of Klp10A) and 47% of unsequenced 
gDNA is in introns of Hsp60 and Klp10A. 
Missing sequence for ts319 gDNA 
Coordinates  Gene region annotation 
1-406   intergenic 5’ of Hsp60 
764-1823  Hsp60 intron 
4359-4395  intergenic Hsp60-CG11122 
5640-5704  CG11122 exon 
 143 
7406-7460  CG11122 exon 
15855-16001  CG11122 exon 
1-1082   intergenic CG11122-Rpt3 
1171-1220  intergenic CG11122-Rpt3 
1220-1334  Rpt3 5’UTR 
4213-6257  intergenic Gtpbp-Klp10A 
6257-6336  Klp10A 3’UTR 
7447-8572  Klp10A intron 
9960-10858  Klp10A intron 
11571   Klp10A exon 
11620   Klp10A exon 
13191-14000  intergenic 3’ of Klp10A 
 
Altered sequence in ts319 gDNA 
Coord  gene region   change  result of change 
11297  CG11122 exon T  to  G CCA to CCC  silent Proline 
2997  Gtpbp 3’UTR  C  to  A 
2999  Gtpbp 3’UTR  A  to  G 
3007  Gtpbp 3’UTR  C  to  G 
5211-5223 intergenic Gtp-Klp Extra A nucleotide 
7328  Klp10A exon  G  to  A CAC to CAT  silent Histidine 
7351  Klp10A intron  G   to A  
11377  Klp10A exon  T   to  C CAA to CAG silent  Glutamine 
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A3.5.10  Antibodies  
Embryos were incubated in mouse monoclonal antibodies against Neurotactin 
(1:5, DSHB) and Tubulin (1:250, W. Sullivan), rabbit antibodies against Centrosomin 
(1:1000, T. Kaufmann), Myosin II (1:100, C. Field), Anillin 4-11 (1:500, C. Field), 
SLAM (1:1000, R. Lehmann), Lava Lamp (1:2500), mouse antibody against Tubulin 
(1:250, W. Sullivan), and rat antibodies against Rab11 (1:250, W. Sullivan) and MAC143 
(BIP) (1:5, Babraham Institute) diluted as indicated in 1X PBTA at 4° overnight.  
Embryos were stained with 25 µg/ml concanavalin-A Alexa Fluor 488 in 1X PBS for 
20 min and washed in 1X PBS.   
 
 
Appendix 4:  Primer sequences 
 
A4.1  CHAPTER 2 
primer name Sequence 5’ to 3’ 
RpL32 (rp49)+ GCGCACACCAAGCAAGCACTTCATC 








A4.2  CHAPTER 3 
























Yp1+ GCCGTATGGACAACTCCGTCAAC  
Yp1- TCTGCGACAGGTGGTAGACTTGC  
CG5525+ CAAAGCCGTTTCCGATGCTATC 
CG5525- TGGACACCTCGCCGTTGC  
CG7433+ CGAGGAAGTCGTGAAGGTCATCC 
CG7433- TCCAGGCTCAGCAAACCGTTC  
GstD3+ TCGCCGACATTGCCATTCTC 
GstD3- TGCCCAGTTTTCTTCCCATCC  
RpLp0+ TCACCCGACGAGTCCCTAATACAC  
RpLp0- GCCCACGATGAAGCACTTTGG  
Sod+ GTCAACGGGCAACGCTGG  
Sod- ATCGCTTAGACCTTGGCAATGC  
SpdS+ CGCTGAAGGATGACGGAATCG  
SpdS- GAACGGAGGTGACGGCATAGG  
Tsf1+ GCAGAGGGCTCAGGATGATGTC  
Tsf1- TTCAACAAGGCGGCAGCAG  
vib+ CAATCGCACTCCCCAGTTCG  





CG3590+ TCGTGCTATGTGGGCGACAAC  
CG3590- GCTCTGGGCAAACTGGCTTAGAC  
CG6045+ TGTGCCAGGAGGGAGGATGTG  
CG6045- CGCAGGTATTCAGCAGAGTGAGG  
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CG32473+ CTGCCACCACCGAGGATTACC  
CG32473- GAAGACCCATCTGCTCCGTCC  
Hsc70Cb+ GCTAATCTCGTCCGCCACTTTG  
Hsc70Cb- CGCCCTCTTGCTGACCATCC  
Mms19+ ATTCGCTGAGGGCACAGTGG  
Mms19- CGGCTCCAGAACGGAAGGC  
tsr+ AGAAATGCGGACCTGGAGAGTG  
tsr- GGACACCACGACATAAGGAACAGC  
cct1+ TCCTCATCAAGGGCACTAAGGC 
cct1- CACGCTTCACCACGCACAGAG  
cct2+ CATCATTTTCGGTGGCGGC  
cct2- AACCAGTTGGGCTGAATCGTAGC  
cct5+ GCTCAGAGTCATCCGAATCCGAG  
cct5- CGTGTCTTCTTGCTGCGTGTCAG 
cct6+ CAGGAGGAGCACTTGGGATACG  
cct6- CGGACAGCGGGTTCTTGC  
cct8+ TCAGGAGGAGTTGGGCTACTGC  
cct8- GGGCACGCTCAATGTCATCC  
 
A4.3  CHAPTER 4 
cdc2+ AGGGTCGCAACCGCCTGAC  
cdc2- CTCCATCAAAACATCCTCCAAACAG  
cycB+ CCGAGGACGAGCACCATACG  
cycB- GCAGCGACAGGAACAGTGAGG  
frs+ TCCCTGGACAGCAAGAAGTATTCC 
frs- CGCTTTTTGAGTTCGGTTTGG 
stg+ CCTATGCCCTGCCCCTGATG  
stg- CTGTTTCGCTGGAGATGCTCTTC  
twn+ TCCCACGCTGACCTCCAATC  
twn- GGTATGCTGACTTCTGTCGTTGCTC  
sev+ GTATGCGGCGAGGAACAACTTC  
sev- GCAAAGCAGGAGCAGGGAGTAAAG  
 
A4.4  APPENDIX 1 
gene primer set #  sequence 5' to 3' 
Hsp60 1+ CATTGGCTTTTGCTGTCAG 
 1- TCCTTGACGGTGATAACGC 
 2+ ATCCCGTCGAGATTCGTC 
 2- CAGCTTCTCCTTCTCGTACTC 
 3+ AGCACCCTCACCGATATG 
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 3- GGTTGTGTTGGATTTGTGTG 
 4+ ATGTAAGCGACTGCCACTG 
 4- TCTCATTTGGGATGCCAG 
 5prime+ TTACTTGAATGCGAGTCCC 
CG11122 1+ CAATAGTGTCCGATAACAGAGC 
 1- GCAGGCGAAATACTTATCTG 
 2+ GGACAAGTTTCACACCGAG 
 2- GAGGTGATTCTGGAGGTTG 
 3+ GTCGCCAACTCAGTGTTC 
 3- CTTTTGGTTCCTGCTACG 
 4+ GAACAGGCGGTCATCAAG 
 4- TTGGTGCCGCAGTAGTAG 
 5+ ACTGGAGCAGCAACAACC 
 5- TGCTGCTTCTGTTTGCG 
 6+ CAAGAACAAGGCGAAGG 
 6- GCACTTGCTCCGTTTTG 
 7+ GCAGCAAGAGGATTAGCG 
 7- TTCCAGCGGAGGATACTG 
 8+ TTCATCCACCGACGAGAC 
 8- ACCAACTGGCGTAGGAAG 
 9+ AAGTCGAGCAGGAAACCG 
 9- GCAACAATGGCTGGAATAG 
 10+ AAAGGGAGAGGGAGAAGG 
 10- CGACGAGGTGTTGTTGTTC 
 11+ ATCCTGTGCCCGTAAACC 
 11- CGCAGGATGGAACTAACC 
 12+ CTATCGAAGGGGAAAGGC 
 12- CTCATCGTTCAGATTCGG 
 13+ CAACGAGGACTTTGAGTTTG 
 13- TCGGGATTGAGATTGAGAC 
 14+ CAGGAGCAGGAGAGAATG 
 14- ACTACCCAACGCAATGTC 
 15+ GCGATGAAGGGCTATGAG 
 15- GCTGGCGTGCTTAAATATC 
 16+ TCAGAGGTGGAGTTGTAGCC 
 16- GGCTTCCACCTTTGATTTC 
 17+ CATCAGCACCATCATCAC 
 17- CACTGGAGTTTTGCTCTTG 
 18+ CGCCAGAAGTGCTAACTC 
 18- GCCTATGGCTATGACTTGTC 
 19+ ACAAGAAGCTCGTGAAGC 
 19- TTACTGGCATCCCAAATG 
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Rpt3 1+ CTCGCAGAAAACGCAAAC 
  1- TACAGCTCGAAGTGGGTCAG 
  2+ AGCTCCATTTCGATGCTG 
  2- GAAGAGTTTAGTGTGTTGGGG 
  5prime+ CACCAGATGCTTTGAAACG 
  3prime- GGCTATCCTTCCAATGCTC 
Gtp-bp 1+ CGAGTAGAGTGCGTTGTTGTTG 
  1- CGCCGTTTCTCCATGATGATC 
  2+ CATCCAAATCACAGCCGTC 
  2- GACACCGCAGAAGATTATCG 
  3+ CGCATCGACATCATACGCGAT 
  3- 
  
GATTCGGTGAAAAGAGTGG 
  5prime+ ACAGGGAATCCTCTAACTGC 
Klp10A 1+ AGGTGGAGTCAAAGAGGAAG 
  1- GGCAATGTGTTATTAGGCAC 
  2+ ACGACCACTGGATTACAGC 
  2- TTGGAATGTGTGGTCACC 
  3+ ATACACAGCCAAGCCGTTG 
  3- ACAATCTGGAAAACGGCG 
  4+ TCGAGGAGGTACTGAAGCTC 
  4- GCCTTGTGTGTAACTTCTAGG 
  5+ TTCCCCTTTGGGTCATAC 
  5- GTGATTGTGGATGAACGG 
  6+ CTTAGCCAATAGTAACCCTGC 
  6- ACACTGACACACACATAGCG 
  7+ GCGGAAAGCATTGATTGG 
  7- ATGGCGTCCAGTTCTACCTC 
  3prime- TTACTGGCTATGGGAATACG 
sbr + TATCGCAGAACCAACACG 
 - CCATCACATTCTGACGAAAG 
nrt + GGACGAACAGAAATCTCGC 
 - TGGCGTTCAAAAGTCCCAC 
Hsc70-3 
(bip) + CATTGATTTGGGCA 
 - TCAACTGATTCTTG 
actin5c + GCCACTTGCGTTTA 
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